

<!doctype html>
    <html lang="en-US" id="template-archives" class="base">
        <head>
        
        <script defer data-domain="context.center" src="https://plausible.io/js/plausible.js"></script>
        <link rel="alternate" type="application/rss+xml" title="Context Center RSS" href="https://context.center/rss/" />
    	<link rel="alternate" type="application/atom+xml" title="Context Center Feed" href="https://context.center/feed/" />
        <meta charset="utf-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <title>American multinational pharmaceutical corporation</title>
        <link rel="original" http-equiv href="https://en.wikipedia.org/wiki/Pfizer" />
        
            
                <!-- <link rel="stylesheet" href="https://context.center/assets/css/template-archives.css?v=2109509706" /> -->
                <link rel="stylesheet" href="https://context.center/assets/css/template-archives.css?v=2109509706" id=""></link>

            
        
        
            <link rel="canonical" href="https://en.wikipedia.org/wiki/Pfizer" />
            

            <meta property="og:title"
                content="American multinational pharmaceutical corporation">

            <meta property="og:description"
                content="Coordinates: 40°45′01″N 73°58′21″W / 40.75028°N 73.97250°W">


            <meta property="og:url"
                content="https://en.wikipedia.org/wiki/Pfizer" />

            <meta property="og:site_name" content="Context Center" />

            <meta property="og:locale" content="en_US" />

            <meta name="twitter:site" content="@chronotope" />

            <meta name="twitter:description" content="Coordinates: 40°45′01″N 73°58′21″W / 40.75028°N 73.97250°W" />

            <!-- I prefer the summary_large_image Twitter card for posts. -->
            <meta name="twitter:card" content="summary_large_image" />
            <!-- You, you're the creator. -->
            <meta name="twitter:creator" content="@chronotope" />
            <!-- This property is for the article title, not site title. -->
            <meta name="twitter:title" content="American multinational pharmaceutical corporation" />

            

            <meta property="og:image" content="https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPfizer//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPfizer/Pfizer_World_Headquarters_Entrance.jpg" />
            <meta name="twitter:image" content="https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPfizer//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPfizer/Pfizer_World_Headquarters_Entrance.jpg" />

            

            <meta property="og:type" content="website" />

            <script type="application/ld+json">
                {
                    "@context": "http://schema.org",
                    "@type": "WebPage",
                    "url": "https://en.wikipedia.org/wiki/Pfizer",
                    "headline": "American multinational pharmaceutical corporation",
                    "about": "Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W",

                    "image": [
                        
                        "https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg"
                        
                        
                        "https://context.center/assets/images/contexter/httpsenwikipediaorgwikiPfizer//Users/zuckerscharffa/Dev/context-center/_contexterCache/images/httpsenwikipediaorgwikiPfizer/Pfizer_World_Headquarters_Entrance.jpg"
                        
                    ],
                    "isAccessibleForFree": "True",
                    "isPartOf": {
                        "@type": ["CreativeWork", "Product"],
                        "name": "Fight With Tools",
                        "productID": "fightwithtools.dev"
                    },
                    "license": "http://creativecommons.org/licenses/by-sa/4.0/",
                    "archivedAt": "https://context.center/timegate/https:/en.wikipedia.org/wiki/Pfizer/",
                    "sameAs": "https://en.wikipedia.org/wiki/Pfizer",
                }
            </script>


        
        
        </head>
        <body >
            <div class="wrapper">
                <header>
                    <div class="left">
                        <h1>Archived: American multinational pharmaceutical corporation</h1>
                        <p>This is a simplified archive of the page at <a href="https://en.wikipedia.org/wiki/Pfizer" target="_blank">https://en.wikipedia.org/wiki/Pfizer</a></p>
                    </div>

                            <div id="share-embed">
                                <span>Use this page embed on your own site:</span>
                                <textarea id="html-embed" name="story" rows="8" cols="40">
                                    <script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute("target","_blank")}}customElements.define("contexter-link",ContexterLink,{extends:"a"}),customElements.define("contexter-inner",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__inner"}}),customElements.define("contexter-thumbnail",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__thumbnail"}}),customElements.define("contexter-byline",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__byline"}}),customElements.define("contexter-keywordset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__keywordset"}}),customElements.define("contexter-linkset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__linkset"}}),customElements.define("contexter-meta",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__meta"}}),customElements.define("contexter-summary",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="p-summary entry-summary"}}),customElements.define("contexter-box-head",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className="contexter-box__head"}}),customElements.define("contexter-box-inner",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:"open"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement("style"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: "|";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement("style"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement("contexter-box-inner"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement("slot")),innerSlotHeader=(innerSlotThumbnail.name="thumbnail",innerContainer.appendChild(innerSlotThumbnail),document.createElement("slot")),innerSlotAuthor=(innerSlotHeader.name="header",innerContainer.appendChild(innerSlotHeader),document.createElement("slot")),innerSlotTime=(innerSlotAuthor.name="author",innerContainer.appendChild(innerSlotAuthor),document.createElement("slot")),innerSlotSummary=(innerSlotTime.name="time",innerContainer.appendChild(innerSlotTime),document.createElement("slot")),metaContainer=(innerSlotSummary.name="summary",innerContainer.appendChild(innerSlotSummary),document.createElement("contexter-meta")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement("slot")),linkContainer=(innerSlotInfo.name="keywords",metaContainer.appendChild(innerSlotInfo),document.createElement("contexter-linkset")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement("slot")),innerSlotReadLink=(innerSlotArchiveLink.name="archive-link",linkContainer.appendChild(innerSlotArchiveLink),document.createElement("slot"));innerSlotReadLink.name="read-link",linkContainer.appendChild(innerSlotReadLink),this.className="contexter-box",this.onclick=e=>{if(!e.target.className.includes("read-link")&&!e.target.className.includes("title-link")){const mainLinks=this.querySelectorAll("a.main-link");mainLinks[0].click()}}}}}customElements.define("contexter-box",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class="link-card h-entry hentry" itemscope="" itemtype="https://schema.org/CreativeWork"><contexter-thumbnail class="thumbnail" slot="thumbnail"><img src="https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg" alt="" itemprop="image" /></contexter-thumbnail><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><a is="contexter-link" href="https://en.wikipedia.org/wiki/Pfizer" itemprop="url">American multinational pharmaceutical corporation</a></contexter-box-head></contexter-box-head><contexter-byline class="p-author author" slot="author"><span class="p-name byline" rel="author" itemprop="author">Contributors to Wikimedia projects</span></contexter-byline><time class="dt-published published" slot="time" itemprop="datePublished" datetime="2002-07-15T03:25:40.000Z">6/14/2002</time><contexter-summary class="p-summary entry-summary" itemprop="abstract" slot="summary"><p>Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W</p></contexter-summary><contexter-keywordset itemprop="keywords" slot="keywords"></contexter-keywordset><a is="contexter-link" href="https://en.wikipedia.org/wiki/Pfizer" class="read-link main-link" itemprop="sameAs" slot="read-link">Read</a><a href="https://context.center/timegate/https://en.wikipedia.org/wiki/Pfizer" is="contexter-link" target="_blank" class="read-link archive-link" itemprop="archivedAt" slot="archive-link">Archived</a></contexter-box>
                                </textarea><br />
                                <button onclick="(function(e){ navigator.clipboard.writeText(document.getElementById('html-embed').value); })()">Copy</button>
                            </div>
                            
                            <script>window.contexterSetup=window.contexterSetup||function(){window.contexterSetupComplete=!0;class ContexterLink extends HTMLAnchorElement{constructor(){super()}connectedCallback(){this.setAttribute("target","_blank")}}customElements.define("contexter-link",ContexterLink,{extends:"a"}),customElements.define("contexter-inner",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__inner"}}),customElements.define("contexter-thumbnail",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__thumbnail"}}),customElements.define("contexter-byline",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__byline"}}),customElements.define("contexter-keywordset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__keywordset"}}),customElements.define("contexter-linkset",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__linkset"}}),customElements.define("contexter-meta",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="contexter-box__meta"}}),customElements.define("contexter-summary",class extends HTMLElement{constructor(){super()}attributeChangedCallback(name,oldValue,newValue){}connectedCallback(){this.className="p-summary entry-summary"}}),customElements.define("contexter-box-head",class extends HTMLElement{constructor(){super()}connectedCallback(){this.className="contexter-box__head"}}),customElements.define("contexter-box-inner",class extends HTMLElement{constructor(){super()}connectedCallback(){}});class ContexterBox extends HTMLElement{constructor(){super(),this.first=!0,this.shadow=this.attachShadow({mode:"open"})}connectedCallback(){if(this.first){this.first=!1;var style=document.createElement("style"),lightDomStyle=(style.innerHTML=`:host {--background: #f5f6f7;--border: darkblue;--blue: #0000ee;--font-color: black;--inner-border: black;font-family: Franklin,Arial,Helvetica,sans-serif;font-size: 14px;background: var(--background);width: 600px;color: var(--font-color);min-height: 90px;display: block;padding: 8px;border: 1px solid var(--border);cursor: pointer;box-sizing: border-box;margin: 6px;contain: content;margin: 6px auto;}// can only select top-level nodes with slotted::slotted(*) {max-width: 100%;display:block;}::slotted([slot=thumbnail]) {max-width: 100%;display:block;}::slotted([slot=header]) {width: 100%;font-size: 1.25rem;font-weight: bold;display:block;margin-bottom: 6px;}::slotted([slot=author]) {max-width: 50%;font-size: 12px;display:inline-block;float: left;}::slotted([slot=time]) {max-width: 50%;font-size: 12px;display:inline-block;float: right;}::slotted([slot=summary]) {width: 100%;margin-top: 6px;padding: 10px 2px;border-top: 1px solid var(--inner-border);font-size: 15px;display:inline-block;margin-bottom: 6px;}contexter-meta {height: auto;margin-bottom: 4px;width: 100%;display: grid;position: relative;min-height: 16px;grid-template-columns: repeat(2, 1fr);}::slotted([slot=keywords]) {width: 80%;padding: 2px 4px;border-top: 1px solid var(--inner-border);font-size: 11px;display: block;float: right;font-style: italic;text-align: right;grid-column: 2/2;grid-row: 1;align-self: end;justify-self: end;}::slotted([slot=keywords]):empty {border-top: 0px solid var(--inner-border);}::slotted([slot=archive-link]) {font-size: 1em;display: inline;}::slotted([slot=archive-link])::after {content: "|";display: inline;color: var(--font-color);text-decoration: none;margin: 0 .5em;}::slotted([slot=read-link]) {font-size: 1em;display: inline;}contexter-linkset {width: 80%;padding: 2px 4px;font-size: 13px;float: left;font-weight: bold;grid-row: 1;grid-column: 1/2;align-self: end;justify-self: start;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {:host {width: 310px;}}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){:host {--background: #354150;--border: #1f2b37;--blue: #55b0ff;--font-color: #ffffff;--inner-border: #787a7c;background: var(--background);border: 1px solid var(--border)}}`,document.createElement("style"));lightDomStyle.innerHTML=`contexter-box {contain: content;}contexter-box .read-link {font-weight: bold;}contexter-box a {color: #0000ee;}contexter-box img {width: 100%;border: 0;padding: 0;margin: 0;}/* Extra small devices (phones, 600px and down) */@media only screen and (max-width: 600px) {...}/* Small devices (portrait tablets and large phones, 600px and up) */@media only screen and (min-width: 600px) {...}/* Medium devices (landscape tablets, 768px and up) */@media only screen and (min-width: 768px) {...}/* Large devices (laptops/desktops, 992px and up) */@media only screen and (min-width: 992px) {...}/* Extra large devices (large laptops and desktops, 1200px and up) */@media only screen and (min-width: 1200px) {...}@media (prefers-color-scheme: dark){contexter-box a {color: #55b0ff;}}`,this.appendChild(lightDomStyle),this.shadow.appendChild(style);const innerContainer=document.createElement("contexter-box-inner"),innerSlotThumbnail=(this.shadow.appendChild(innerContainer),document.createElement("slot")),innerSlotHeader=(innerSlotThumbnail.name="thumbnail",innerContainer.appendChild(innerSlotThumbnail),document.createElement("slot")),innerSlotAuthor=(innerSlotHeader.name="header",innerContainer.appendChild(innerSlotHeader),document.createElement("slot")),innerSlotTime=(innerSlotAuthor.name="author",innerContainer.appendChild(innerSlotAuthor),document.createElement("slot")),innerSlotSummary=(innerSlotTime.name="time",innerContainer.appendChild(innerSlotTime),document.createElement("slot")),metaContainer=(innerSlotSummary.name="summary",innerContainer.appendChild(innerSlotSummary),document.createElement("contexter-meta")),innerSlotInfo=(innerContainer.appendChild(metaContainer),document.createElement("slot")),linkContainer=(innerSlotInfo.name="keywords",metaContainer.appendChild(innerSlotInfo),document.createElement("contexter-linkset")),innerSlotArchiveLink=(metaContainer.appendChild(linkContainer),document.createElement("slot")),innerSlotReadLink=(innerSlotArchiveLink.name="archive-link",linkContainer.appendChild(innerSlotArchiveLink),document.createElement("slot"));innerSlotReadLink.name="read-link",linkContainer.appendChild(innerSlotReadLink),this.className="contexter-box",this.onclick=e=>{if(!e.target.className.includes("read-link")&&!e.target.className.includes("title-link")){const mainLinks=this.querySelectorAll("a.main-link");mainLinks[0].click()}}}}}customElements.define("contexter-box",ContexterBox)},window.contexterSetupComplete||window.contexterSetup();</script><contexter-box class="link-card h-entry hentry" itemscope="" itemtype="https://schema.org/CreativeWork"><contexter-thumbnail class="thumbnail" slot="thumbnail"><img src="https://upload.wikimedia.org/wikipedia/commons/9/94/Pfizer_World_Headquarters_Entrance.jpg" alt="" itemprop="image" /></contexter-thumbnail><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><contexter-box-head slot="header" class="p-name entry-title" itemprop="headline"><a is="contexter-link" href="https://en.wikipedia.org/wiki/Pfizer" itemprop="url">American multinational pharmaceutical corporation</a></contexter-box-head></contexter-box-head><contexter-byline class="p-author author" slot="author"><span class="p-name byline" rel="author" itemprop="author">Contributors to Wikimedia projects</span></contexter-byline><time class="dt-published published" slot="time" itemprop="datePublished" datetime="2002-07-15T03:25:40.000Z">6/14/2002</time><contexter-summary class="p-summary entry-summary" itemprop="abstract" slot="summary"><p>Coordinates: 40°45′01″N 73°58′21″W﻿ / ﻿40.75028°N 73.97250°W</p></contexter-summary><contexter-keywordset itemprop="keywords" slot="keywords"></contexter-keywordset><a is="contexter-link" href="https://en.wikipedia.org/wiki/Pfizer" class="read-link main-link" itemprop="sameAs" slot="read-link">Read</a><a href="https://context.center/timegate/https://en.wikipedia.org/wiki/Pfizer" is="contexter-link" target="_blank" class="read-link archive-link" itemprop="archivedAt" slot="archive-link">Archived</a></contexter-box>
                            


                </header>
                <main>
                
                    <div id="readability-page-1" class="page"><div id="mw-content-text" lang="en" dir="ltr">

<p>

<span><span id="coordinates"><a href="/wiki/Geographic_coordinate_system" title="Geographic coordinate system">Coordinates</a>: <span><a href="//geohack.toolforge.org/geohack.php?pagename=Pfizer&amp;params=40_45_01_N_73_58_21_W_"><span><span title="Maps, aerial photos, and other data for this location"><span>40°45′01″N</span> <span>73°58′21″W</span></span></span><span>﻿ / ﻿</span><span><span title="Maps, aerial photos, and other data for this location">40.75028°N 73.97250°W</span></span></a></span></span></span>
</p>
<table><caption>Pfizer Inc.</caption><tbody><tr><td colspan="2"><a href="/wiki/File:Pfizer_(2021).svg"><img alt="Pfizer (2021).svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/220px-Pfizer_%282021%29.svg.png" decoding="async" width="220" height="90" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/330px-Pfizer_%282021%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/57/Pfizer_%282021%29.svg/440px-Pfizer_%282021%29.svg.png 2x" data-file-width="1000" data-file-height="409"></a></td></tr><tr><td colspan="2"><a href="/wiki/File:Pfizer_World_Headquarters_Entrance.jpg"><img alt="Pfizer World Headquarters Entrance.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/250px-Pfizer_World_Headquarters_Entrance.jpg" decoding="async" width="250" height="170" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/375px-Pfizer_World_Headquarters_Entrance.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/94/Pfizer_World_Headquarters_Entrance.jpg/500px-Pfizer_World_Headquarters_Entrance.jpg 2x" data-file-width="4908" data-file-height="3330"></a><div><p>Pfizer <a href="/wiki/Headquarters" title="Headquarters">headquarters</a> on <a href="/wiki/42nd_Street_(Manhattan)" title="42nd Street (Manhattan)">42nd Street</a> in Midtown Manhattan</p></div></td></tr><tr><th scope="row">Type</th><td><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row"><div><p><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></p></div></th><td><div><ul><li><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>:&nbsp;<a rel="nofollow" href="https://www.nyse.com/quote/XNYS:PFE">PFE</a></li><li><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component</li><li><a href="/wiki/S%26P_500" title="S&amp;P 500">S&amp;P 500</a> component</li><li><a href="/wiki/Russell_1000_Index" title="Russell 1000 Index">Russell 1000 Index</a> component</li></ul></div></td></tr><tr><th scope="row">Industry</th><td><div><ul><li><a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">Pharmaceutical</a></li><li><a href="/wiki/Biotechnology" title="Biotechnology">Biotechnology</a></li></ul></div></td></tr><tr><th scope="row">Founded</th><td>1849<span>; 173&nbsp;years ago</span> in New York City</td></tr><tr><th scope="row">Founders</th><td><div><ul><li><a href="/wiki/Charles_Pfizer" title="Charles Pfizer">Charles Pfizer</a></li><li><a href="/wiki/Charles_F._Erhart" title="Charles F. Erhart">Charles F. Erhart</a></li></ul></div></td></tr><tr><th scope="row">Headquarters</th><td>235 East 42nd Street, <p>New York City</p>, <p>U.S.</p></td></tr><tr><th scope="row"><p>Area served</p></th><td>Worldwide</td></tr><tr><th scope="row"><p>Key people</p></th><td><a href="/wiki/Albert_Bourla" title="Albert Bourla">Albert Bourla</a>, <a href="/wiki/CEO" title="CEO">CEO</a><br>Frank A. D’Amelio, <a href="/wiki/CFO" title="CFO">CFO</a><br><a href="/wiki/Scott_Gottlieb" title="Scott Gottlieb">Scott Gottlieb</a>, Director<br><a href="/wiki/Helen_Hobbs" title="Helen Hobbs">Helen Hobbs</a>, Director<br><a href="/wiki/Susan_Hockfield" title="Susan Hockfield">Susan Hockfield</a>, Director<br><a href="/wiki/Dan_Littman" title="Dan Littman">Dan Littman</a>, Director<br><a href="/wiki/Shantanu_Narayen" title="Shantanu Narayen">Shantanu Narayen</a>, Director<br><a href="/wiki/Suzanne_Nora_Johnson" title="Suzanne Nora Johnson">Suzanne Nora Johnson</a>, Director<br><a href="/wiki/James_Quincey" title="James Quincey">James Quincey</a>, Director<br><a href="/wiki/Jim_Smith_(business_executive)" title="Jim Smith (business executive)">Jim Smith</a>, Director</td></tr><tr><th scope="row">Products</th><td><div><ul><li><a href="/wiki/Pharmaceutical" title="Pharmaceutical">Pharmaceuticals</a></li><li><a href="/wiki/Vaccine" title="Vaccine">vaccines</a></li></ul></div></td></tr><tr><th scope="row">Revenue</th><td><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> $41.908 billion&nbsp;(2020)</td></tr><tr><th scope="row"><div><p><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></p></div></th><td><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> $7.497 billion&nbsp;(2020)</td></tr><tr><th scope="row"><div><p><a href="/wiki/Net_income" title="Net income">Net income</a></p></div></th><td><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> $9.616 billion&nbsp;(2020)</td></tr><tr><th scope="row"><span><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td><img alt="Decrease" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/11px-Decrease2.svg.png" decoding="async" title="Decrease" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/17px-Decrease2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Decrease2.svg/22px-Decrease2.svg.png 2x" data-file-width="300" data-file-height="300"> $154.229 billion&nbsp;(2020)</td></tr><tr><th scope="row"><span><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> $63.473 billion&nbsp;(2020)</td></tr><tr><th scope="row"><p>Number of employees</p></th><td>78,500&nbsp;(2020)</td></tr><tr><th scope="row">Website</th><td><span><a rel="nofollow" href="https://www.pfizer.com/">www<wbr>.pfizer<wbr>.com</a></span> <a href="https://www.wikidata.org/wiki/Q206921#P856" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></td></tr><tr><td colspan="2"><b>Footnotes&nbsp;/ references</b><br><sup id="cite_ref-10K_1-0"><a href="#cite_note-10K-1">[1]</a></sup></td></tr></tbody></table>
<div><p><a href="/wiki/File:Shinjuku_Bunka_Quint_Building.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/170px-Shinjuku_Bunka_Quint_Building.jpg" decoding="async" width="170" height="227" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/255px-Shinjuku_Bunka_Quint_Building.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/36/Shinjuku_Bunka_Quint_Building.jpg/340px-Shinjuku_Bunka_Quint_Building.jpg 2x" data-file-width="600" data-file-height="800"></a></p><div><p>The headquarters of Pfizer In Tokyo, Japan</p></div></div>
<p><b>Pfizer Inc.</b> ( <a href="/wiki/Help:Pronunciation_respelling_key" title="Help:Pronunciation respelling key"><i title="English pronunciation respelling"><span>FY</span>-zər</i></a>)<sup id="cite_ref-2"><a href="#cite_note-2">[2]</a></sup> is an American <a href="/wiki/Multinational_corporation" title="Multinational corporation">multinational</a> <a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">pharmaceutical</a> and <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> corporation headquartered on <a href="/wiki/42nd_Street_(Manhattan)" title="42nd Street (Manhattan)">42nd Street</a> in <a href="/wiki/Manhattan" title="Manhattan">Manhattan, New York City</a>. The company was established in 1849 in New York by two German immigrants, <a href="/wiki/Charles_Pfizer" title="Charles Pfizer">Charles Pfizer</a> (1824–1906) and his cousin <a href="/wiki/Charles_F._Erhart" title="Charles F. Erhart">Charles F. Erhart</a> (1821–1891).
</p><p>Pfizer develops and produces <a href="/wiki/Medicine" title="Medicine">medicines</a> and <a href="/wiki/Vaccine" title="Vaccine">vaccines</a> for <a href="/wiki/Immunology" title="Immunology">immunology</a>, <a href="/wiki/Oncology" title="Oncology">oncology</a>, <a href="/wiki/Cardiology" title="Cardiology">cardiology</a>, <a href="/wiki/Endocrinology" title="Endocrinology">endocrinology</a>, and <a href="/wiki/Neurology" title="Neurology">neurology</a>. The company has several <a href="/wiki/Medication#Blockbuster_drug" title="Medication">blockbuster drugs</a> or products that each generate more than <span>US$1</span><span>&nbsp;</span>billion in annual revenues.<sup id="cite_ref-10K_1-1"><a href="#cite_note-10K-1">[1]</a></sup> In 2020, 52% of the company's revenues came from the United States, 6% came from each of China and Japan, and 36% came from other countries.<sup id="cite_ref-10K_1-2"><a href="#cite_note-10K-1">[1]</a></sup>
</p><p>Pfizer was a component of the <a href="/wiki/Dow_Jones_Industrial_Average" title="Dow Jones Industrial Average">Dow Jones Industrial Average</a> <a href="/wiki/Stock_market_index" title="Stock market index">stock market index</a> from 2004 to August 2020.<sup id="cite_ref-3"><a href="#cite_note-3">[3]</a></sup><sup id="cite_ref-4"><a href="#cite_note-4">[4]</a></sup><sup id="cite_ref-5"><a href="#cite_note-5">[5]</a></sup><sup id="cite_ref-6"><a href="#cite_note-6">[6]</a></sup> The company ranks 64th on the <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a><sup id="cite_ref-7"><a href="#cite_note-7">[7]</a></sup> and 49th on the <a href="/wiki/Forbes_Global_2000" title="Forbes Global 2000">Forbes Global 2000</a>.<sup id="cite_ref-8"><a href="#cite_note-8">[8]</a></sup>
</p>


<h2><span id="History">History</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=1" title="Edit section: History">edit</a><span>]</span></span></h2>
<div><p><a href="/wiki/File:Charlespfizer.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/30/Charlespfizer.jpg/170px-Charlespfizer.jpg" decoding="async" width="170" height="220" srcset="//upload.wikimedia.org/wikipedia/commons/3/30/Charlespfizer.jpg 1.5x" data-file-width="190" data-file-height="246"></a></p><div><p>Charles Pfizer (1824–1906)</p></div></div>
<h3><span id="1849.E2.80.931950:_Early_history"></span><span id="1849–1950:_Early_history">1849–1950: Early history</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=2" title="Edit section: 1849–1950: Early history">edit</a><span>]</span></span></h3>
<p>Pfizer was founded in 1849 by <a href="/wiki/Charles_Pfizer" title="Charles Pfizer">Charles Pfizer</a> and <a href="/wiki/Charles_F._Erhart" title="Charles F. Erhart">Charles F. Erhart</a>, two cousins who had immigrated to the United States from <a href="/wiki/Ludwigsburg" title="Ludwigsburg">Ludwigsburg, Germany</a>, the year before. The business produced chemical compounds, and was headquartered on Bartlett Street<sup id="cite_ref-Citycyclopedia_9-0"><a href="#cite_note-Citycyclopedia-9">[9]</a></sup> in <a href="/wiki/Williamsburg,_Brooklyn" title="Williamsburg, Brooklyn">Williamsburgh, New York</a>, where they produced an <a href="/wiki/Antiparasitic" title="Antiparasitic">antiparasitic</a> called <a href="/wiki/Santonin" title="Santonin">santonin</a>. This was an immediate success, although it was production of <a href="/wiki/Citric_acid" title="Citric acid">citric acid</a> that led to Pfizer's growth in the 1880s. Pfizer continued to buy property in the area (by now the Williamsburg district of the city of <a href="/wiki/Brooklyn,_New_York" title="Brooklyn, New York">Brooklyn, New York</a> and, beginning in 1898, the <a href="/wiki/City_of_Greater_New_York" title="City of Greater New York">City of Greater New York</a>) to expand its lab and factory, retaining offices on Flushing Avenue until the 1960s; the Brooklyn plant ultimately closed in 2009.<sup id="cite_ref-10"><a href="#cite_note-10">[10]</a></sup> Following the success of citric acid, Pfizer (at the now-demolished 295 Washington Avenue) and Erhart (at 280 Washington Avenue) established their main residences in the nearby <a href="/wiki/Clinton_Hill,_Brooklyn" title="Clinton Hill, Brooklyn">Clinton Hill</a> district, known for its concentration of <a href="/wiki/Gilded_Age" title="Gilded Age">Gilded Age</a> wealth. Pfizer spent summers in similarly exclusive <a href="/wiki/Newport,_Rhode_Island" title="Newport, Rhode Island">Newport, Rhode Island</a>, where he died in 1906.
</p><p>In 1881, Pfizer moved its administrative headquarters to 81 Maiden Lane in <a href="/wiki/Manhattan" title="Manhattan">Manhattan</a>, presaging the company's expansion to <a href="/wiki/Chicago,_Illinois" title="Chicago, Illinois">Chicago, Illinois</a> a year later.<sup id="cite_ref-Citycyclopedia_9-1"><a href="#cite_note-Citycyclopedia-9">[9]</a></sup><sup id="cite_ref-collection_11-0"><a href="#cite_note-collection-11">[11]</a></sup> By 1906, sales exceeded $3<span>&nbsp;</span>million.<sup id="cite_ref-history_12-0"><a href="#cite_note-history-12">[12]</a></sup>
</p><p><a href="/wiki/World_War_I" title="World War I">World War I</a> caused a shortage of <a href="/wiki/Calcium_citrate" title="Calcium citrate">calcium citrate</a>, which Pfizer imported from Italy for the manufacture of citric acid, and the company began a search for an alternative supply. Pfizer chemists learned of a fungus that ferments sugar to citric acid, and they were able to commercialize production of citric acid from this source in 1919. The company developed expertise in fermentation technology as a result. These skills were applied to the mass production of <a href="/wiki/Penicillin" title="Penicillin">penicillin</a>, an <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a>, during <a href="/wiki/World_War_II" title="World War II">World War II</a> in response to the need to treat injured Allied soldiers.<sup id="cite_ref-Fermentation_13-0"><a href="#cite_note-Fermentation-13">[13]</a></sup>
</p><p>On June 2, 1942, the company incorporated in <a href="/wiki/Delaware" title="Delaware">Delaware</a>.<sup id="cite_ref-10K_1-3"><a href="#cite_note-10K-1">[1]</a></sup>
</p>
<h3><span id="1950.E2.80.931980:_Pivot_to_pharmaceutical_research_and_global_expansion"></span><span id="1950–1980:_Pivot_to_pharmaceutical_research_and_global_expansion">1950–1980: Pivot to pharmaceutical research and global expansion</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=3" title="Edit section: 1950–1980: Pivot to pharmaceutical research and global expansion">edit</a><span>]</span></span></h3>
<p>Due to price declines for <a href="/wiki/Penicillin" title="Penicillin">penicillin</a>, Pfizer searched for new antibiotics with greater profit potential. Pfizer discovered <a href="/wiki/Oxytetracycline" title="Oxytetracycline">oxytetracycline</a> in 1950, and this changed the company from a manufacturer of <a href="/wiki/Fine_chemical" title="Fine chemical">fine chemicals</a> to a research-based pharmaceutical company. Pfizer developed a <a href="/wiki/Drug_discovery" title="Drug discovery">drug discovery</a> program focused on in vitro synthesis to augment its research in fermentation technology. In 1959, the company established an <a href="/wiki/Animal_health" title="Animal health">animal health</a> division with a 700-acre (2.8&nbsp;km<sup>2</sup>) farm and research facility in <a href="/wiki/Terre_Haute,_Indiana" title="Terre Haute, Indiana">Terre Haute, Indiana</a>.<sup id="cite_ref-Fermentation_13-1"><a href="#cite_note-Fermentation-13">[13]</a></sup>
</p><p>By the 1950s, Pfizer had established offices in <a href="/wiki/Belgium" title="Belgium">Belgium</a>, <a href="/wiki/Brazil" title="Brazil">Brazil</a>, <a href="/wiki/Canada" title="Canada">Canada</a>, <a href="/wiki/Cuba" title="Cuba">Cuba</a>, <a href="/wiki/Mexico" title="Mexico">Mexico</a>, <a href="/wiki/Panama" title="Panama">Panama</a>, <a href="/wiki/Puerto_Rico" title="Puerto Rico">Puerto Rico</a>, and the <a href="/wiki/United_Kingdom" title="United Kingdom">United Kingdom</a>. In 1960, the company moved its medical research laboratory operations out of <a href="/wiki/New_York_City" title="New York City">New York City</a> to a new facility in <a href="/wiki/Groton,_Connecticut" title="Groton, Connecticut">Groton, Connecticut</a>. In 1980, Pfizer launched <i>Feldene</i> (<a href="/wiki/Piroxicam" title="Piroxicam">piroxicam</a>), a prescription anti-inflammatory medication that became Pfizer's first product to reach $1<span>&nbsp;</span>billion in revenue.<sup id="cite_ref-history_12-1"><a href="#cite_note-history-12">[12]</a></sup>
</p><p>In 1965, John Powers, Jr. became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company, succeeding John McKeen.<sup id="cite_ref-history_12-2"><a href="#cite_note-history-12">[12]</a></sup>
</p><p>As the area surrounding its <a href="/wiki/Brooklyn" title="Brooklyn">Brooklyn</a> plant fell into decline in the 1970s and 1980s, the company formed a public-private partnership with New York City that encompassed the construction of low- and middle-income housing, the refurbishment of apartment buildings for the homeless and the establishment of a <a href="/wiki/Charter_school" title="Charter school">charter school</a>.<sup id="cite_ref-collection_11-1"><a href="#cite_note-collection-11">[11]</a></sup>
</p><p>In 1972, <a href="/wiki/Edmund_T._Pratt_Jr." title="Edmund T. Pratt Jr.">Edmund T. Pratt Jr.</a> became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company, succeeding John Powers, Jr.<sup id="cite_ref-history_12-3"><a href="#cite_note-history-12">[12]</a></sup>
</p>
<h3><span id="1980.E2.80.932000:_Development_of_Viagra.2C_Zoloft.2C_and_Lipitor"></span><span id="1980–2000:_Development_of_Viagra,_Zoloft,_and_Lipitor">1980–2000: Development of Viagra, Zoloft, and Lipitor</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=4" title="Edit section: 1980–2000: Development of Viagra, Zoloft, and Lipitor">edit</a><span>]</span></span></h3>
<p>In 1981, the company received approval for <i>Diflucan</i> (<a href="/wiki/Fluconazole" title="Fluconazole">fluconazole</a>), the first oral treatment for severe <a href="/wiki/Fungal_infection" title="Fungal infection">fungal infections</a> including <a href="/wiki/Candidiasis" title="Candidiasis">candidiasis</a>, <a href="/wiki/Blastomycosis" title="Blastomycosis">blastomycosis</a>, <a href="/wiki/Coccidiodomycosis" title="Coccidiodomycosis">coccidiodomycosis</a>, <a href="/wiki/Cryptococcosis" title="Cryptococcosis">cryptococcosis</a>, <a href="/wiki/Histoplasmosis" title="Histoplasmosis">histoplasmosis</a>, <a href="/wiki/Dermatophytosis" title="Dermatophytosis">dermatophytosis</a>, and <a href="/wiki/Pityriasis_versicolor" title="Pityriasis versicolor">pityriasis versicolor</a>.<sup id="cite_ref-14"><a href="#cite_note-14">[14]</a></sup>
</p><p>In 1986, Pfizer acquired the worldwide rights to <i>Zithromax</i> (<a href="/wiki/Azithromycin" title="Azithromycin">azithromycin</a>), a macrolide antibiotic that is recommended by the <a href="/wiki/Infectious_Disease_Society_of_America" title="Infectious Disease Society of America">Infectious Disease Society of America</a> as a first line treatment for certain cases of community-acquired pneumonia, from <a href="/wiki/Pliva" title="Pliva">Pliva</a>.<sup id="cite_ref-best_15-0"><a href="#cite_note-best-15">[15]</a></sup><sup id="cite_ref-16"><a href="#cite_note-16">[16]</a></sup>
</p><p>In 1989, Pfizer scientists Peter Dunn and Albert Wood created <i>Viagra</i> (<a href="/wiki/Sildenafil" title="Sildenafil">sildenafil</a>) for treating <a href="/wiki/High_blood_pressure" title="High blood pressure">high blood pressure</a> and <a href="/wiki/Angina" title="Angina">angina</a>, a chest pain associated with <a href="/wiki/Coronary_artery_disease" title="Coronary artery disease">coronary artery disease</a>. In 1991, it was patented in the United Kingdom as a heart medication. Early trials for the medication showed that it did not work for the treatment of heart disease, but volunteers in the clinical trials had increased <a href="/wiki/Erection" title="Erection">erections</a> several days after taking the drug. It was patented in the United States in 1996 and received approval by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> in March 1998. In December 1998, Pfizer hired <a href="/wiki/Bob_Dole" title="Bob Dole">Bob Dole</a> as a spokesperson for the drug.<sup id="cite_ref-17"><a href="#cite_note-17">[17]</a></sup> The patents for Viagra expired in 2020.<sup id="cite_ref-18"><a href="#cite_note-18">[18]</a></sup>
</p><p>In 1991, <a href="/wiki/William_C._Steere,_Jr." title="William C. Steere, Jr.">William C. Steere, Jr.</a> became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company, succeeding <a href="/wiki/Edmund_T._Pratt_Jr." title="Edmund T. Pratt Jr.">Edmund T. Pratt Jr.</a><sup id="cite_ref-19"><a href="#cite_note-19">[19]</a></sup>
</p><p>In 1991 Pfizer also began marketing <i>Zoloft</i> (<a href="/wiki/Sertraline" title="Sertraline">sertraline</a>), an <a href="/wiki/Antidepressant" title="Antidepressant">antidepressant</a> of the <a href="/wiki/Selective_serotonin_reuptake_inhibitor" title="Selective serotonin reuptake inhibitor">selective serotonin reuptake inhibitor</a> (SSRI) class developed nine years earlier by Pfizer chemists <a href="/wiki/Kenneth_Koe" title="Kenneth Koe">Kenneth Koe</a> and Willard Welch. Sertraline is primarily prescribed for <a href="/wiki/Major_depressive_disorder" title="Major depressive disorder">major depressive disorder</a> in adult <a href="/wiki/Outpatients" title="Outpatients">outpatients</a> as well as <a href="/wiki/Obsessive-compulsive_disorder" title="Obsessive-compulsive disorder">obsessive-compulsive disorder</a>, <a href="/wiki/Panic_disorder" title="Panic disorder">panic disorder</a>, and <a href="/wiki/Social_anxiety_disorder" title="Social anxiety disorder">social anxiety disorder</a> in both adults and children. In 2005, the year before it became a generic drug, sales were over $3<span>&nbsp;</span>billion and over 100<span>&nbsp;</span>million people had been treated with the drug.<sup id="cite_ref-20"><a href="#cite_note-20">[20]</a></sup> The patent for Zoloft expired in the summer of 2006.<sup id="cite_ref-21"><a href="#cite_note-21">[21]</a></sup>
</p><p>In 1996, <a href="/wiki/Eisai_(company)" title="Eisai (company)">Eisai</a>, in partnership with Pfizer, received <a href="/wiki/Approved_drug" title="Approved drug">approval</a> from the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> for <a href="/wiki/Donepezil" title="Donepezil">donepezil</a> under the brand Aricept for treatment of <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a>;<sup id="cite_ref-22"><a href="#cite_note-22">[22]</a></sup> Pfizer also received approval for <i>Norvasc</i> (<a href="/wiki/Amlodipine" title="Amlodipine">amlodipine</a>), an <a href="/wiki/Antihypertensive" title="Antihypertensive">antihypertensive</a> drug of the dihydropyridine calcium channel blocker class.<sup id="cite_ref-23"><a href="#cite_note-23">[23]</a></sup>
</p>
<div><p><a href="/wiki/File:Zoloft_bottles.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/220px-Zoloft_bottles.jpg" decoding="async" width="220" height="196" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/330px-Zoloft_bottles.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/48/Zoloft_bottles.jpg/440px-Zoloft_bottles.jpg 2x" data-file-width="1223" data-file-height="1088"></a></p></div>
<p>In 1997, the company entered into a co-marketing agreement with <a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a> for <i>Lipitor</i> (<a href="/wiki/Atorvastatin" title="Atorvastatin">atorvastatin</a>), a <a href="/wiki/Statin" title="Statin">statin</a> for the treatment of <a href="/wiki/Hypercholesterolemia" title="Hypercholesterolemia">hypercholesterolemia</a>. Although atorvastatin was the fifth <a href="/wiki/Statin" title="Statin">statin</a> to be developed, clinical trials showed that atorvastatin caused a more dramatic reduction in <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">low-density lipoprotein</a> pattern C (LDL-C) than the other statin drugs. Upon its patent expiration in 2011, Lipitor was the best-selling drug ever, with approximately $125<span>&nbsp;</span>billion in sales over 14.5 years.<sup id="cite_ref-24"><a href="#cite_note-24">[24]</a></sup>
</p>
<h3><span id="2000.E2.80.932010:_Further_expansion"></span><span id="2000–2010:_Further_expansion">2000–2010: Further expansion</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=5" title="Edit section: 2000–2010: Further expansion">edit</a><span>]</span></span></h3>
<p>In 2001, <a href="/wiki/Henry_McKinnell" title="Henry McKinnell">Henry McKinnell</a> became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company, replacing <a href="/wiki/William_C._Steere,_Jr." title="William C. Steere, Jr.">William C. Steere, Jr.</a><sup id="cite_ref-longshot_25-0"><a href="#cite_note-longshot-25">[25]</a></sup>
</p><p>In 2004, the company received approval for <i>Lyrica</i> (<a href="/wiki/Pregabalin" title="Pregabalin">pregabalin</a>), an <a href="/wiki/Anticonvulsant" title="Anticonvulsant">anticonvulsant</a> and <a href="/wiki/Anxiolytic" title="Anxiolytic">anxiolytic</a> medication used to treat <a href="/wiki/Epilepsy" title="Epilepsy">epilepsy</a>, <a href="/wiki/Neuropathic_pain" title="Neuropathic pain">neuropathic pain</a>, <a href="/wiki/Fibromyalgia" title="Fibromyalgia">fibromyalgia</a>, <a href="/wiki/Restless_leg_syndrome" title="Restless leg syndrome">restless leg syndrome</a>, and <a href="/wiki/Generalized_anxiety_disorder" title="Generalized anxiety disorder">generalized anxiety disorder</a>.<sup id="cite_ref-26"><a href="#cite_note-26">[26]</a></sup><sup id="cite_ref-27"><a href="#cite_note-27">[27]</a></sup><sup id="cite_ref-28"><a href="#cite_note-28">[28]</a></sup> The United States patent on Lyrica was challenged by generic manufacturers and was upheld in 2014, extending the expiration date to 2018.<sup id="cite_ref-29"><a href="#cite_note-29">[29]</a></sup> In 2016, the drug had sales of $4.2 billion.<sup id="cite_ref-30"><a href="#cite_note-30">[30]</a></sup>
</p><p>In July 2006, <a href="/wiki/Jeff_Kindler" title="Jeff Kindler">Jeff Kindler</a> was named <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company, replacing <a href="/wiki/Henry_McKinnell" title="Henry McKinnell">Henry McKinnell</a>.<sup id="cite_ref-longshot_25-1"><a href="#cite_note-longshot-25">[25]</a></sup><sup id="cite_ref-31"><a href="#cite_note-31">[31]</a></sup>
</p><p>On December 3, 2006, Pfizer ceased development of <a href="/wiki/Torcetrapib" title="Torcetrapib">torcetrapib</a>, a drug that increases production of <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein">HDL</a>, or "good cholesterol", which reduces <a href="/wiki/Low_density_lipoprotein" title="Low density lipoprotein">LDL</a> thought to be correlated to heart disease. During a <a href="/wiki/Phase_III_clinical_trial" title="Phase III clinical trial">Phase III clinical trial</a> involving 15,000 patients, more deaths than expected occurred in the group that took the medicine, and the <a href="/wiki/Mortality_rate" title="Mortality rate">mortality rate</a> of patients taking the combination of torcetrapib and Lipitor (82 deaths during the study) was 60% higher than those taking Lipitor alone (52 deaths during the study). Lipitor alone was not implicated in the results, but Pfizer lost nearly $1<span>&nbsp;</span>billion developing the failed drug and its stock price dropped 11% on the day of the announcement.<sup id="cite_ref-32"><a href="#cite_note-32">[32]</a></sup><sup id="cite_ref-33"><a href="#cite_note-33">[33]</a></sup><sup id="cite_ref-34"><a href="#cite_note-34">[34]</a></sup><sup id="cite_ref-35"><a href="#cite_note-35">[35]</a></sup>
</p><p>Between 2007 and 2010, Pfizer spent $3.3<span>&nbsp;</span>million on investigations and legal fees and recovered about $5.1<span>&nbsp;</span>million, and had another $5<span>&nbsp;</span>million of pending recoveries from civil lawsuits against makers of <a href="/wiki/Counterfeit" title="Counterfeit">counterfeit</a> prescription drugs. Pfizer has hired customs and narcotics experts worldwide to track down fakes and assemble evidence that can be used to pursue civil suits for <a href="/wiki/Trademark_infringement" title="Trademark infringement">trademark infringement</a>.<sup id="cite_ref-36"><a href="#cite_note-36">[36]</a></sup>
</p><p>In July 2008, Pfizer announced 275 job cuts at its manufacturing facility in <a href="/wiki/Kalamazoo,_Michigan" title="Kalamazoo, Michigan">Kalamazoo, Michigan</a>. Kalamazoo was previously the world headquarters of <a href="/wiki/Upjohn_Company" title="Upjohn Company">Upjohn Company</a>, which had been acquired as part of Pharmacia.<sup id="cite_ref-37"><a href="#cite_note-37">[37]</a></sup><sup id="cite_ref-:0_38-0"><a href="#cite_note-:0-38">[38]</a></sup>
</p>
<h4><span id="Acquisitions_and_mergers">Acquisitions and mergers</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=6" title="Edit section: Acquisitions and mergers">edit</a><span>]</span></span></h4>
<p>In June 2000, Pfizer acquired Warner-Lambert outright for $116<span>&nbsp;</span>billion. To satisfy conditions imposed by antitrust regulators at the <a href="/wiki/Federal_Trade_Commission" title="Federal Trade Commission">Federal Trade Commission</a>, Pfizer sold off or transferred stakes in several minor products, including RID (a shampoo for treatment of <a href="/wiki/Head_lice_infestation" title="Head lice infestation">head lice</a>, sold to <a href="/wiki/Bayer" title="Bayer">Bayer</a>) and Warner-Lambert's antidepressant <a href="/wiki/Celexa" title="Celexa">Celexa</a> (which competes with Zoloft).<sup id="cite_ref-39"><a href="#cite_note-39">[39]</a></sup> The acquisition created what was, at the time, the second-largest pharmaceutical company worldwide.<sup id="cite_ref-40"><a href="#cite_note-40">[40]</a></sup>
</p><p>In 2003, Pfizer merged with <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a>, and in the process acquired <a href="/wiki/G.D._Searle,_LLC" title="G.D. Searle, LLC">Searle</a> and <a href="/wiki/SUGEN" title="SUGEN">SUGEN</a>. Searle had developed <i>Flagyl</i> (<a href="/wiki/Metronidazole" title="Metronidazole">metronidazole</a>), a <a href="/wiki/Nitroimidazole" title="Nitroimidazole">nitroimidazole</a> antibiotic medication used particularly for <a href="/wiki/Anaerobe" title="Anaerobe">anaerobic</a> <a href="/wiki/Bacterium" title="Bacterium">bacteria</a> and <a href="/wiki/Protozoa" title="Protozoa">protozoa</a>.<sup id="cite_ref-:0_38-1"><a href="#cite_note-:0-38">[38]</a></sup><sup id="cite_ref-41"><a href="#cite_note-41">[41]</a></sup> Searle also developed <a href="/wiki/Celecoxib" title="Celecoxib">celecoxib</a> (<i>Celebrex</i>) a <a href="/wiki/COX-2_inhibitor" title="COX-2 inhibitor">COX-2 inhibitor</a> and <a href="/wiki/Nonsteroidal_anti-inflammatory_drug" title="Nonsteroidal anti-inflammatory drug">nonsteroidal anti-inflammatory drug</a> (NSAID) used to treat the <a href="/wiki/Pain" title="Pain">pain</a> and <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> in <a href="/wiki/Osteoarthritis" title="Osteoarthritis">osteoarthritis</a>, <a href="/wiki/Acute_pain" title="Acute pain">acute pain</a> in adults, <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a>, <a href="/wiki/Ankylosing_spondylitis" title="Ankylosing spondylitis">ankylosing spondylitis</a>, <a href="/wiki/Painful_menstruation" title="Painful menstruation">painful menstruation</a>, and <a href="/wiki/Juvenile_rheumatoid_arthritis" title="Juvenile rheumatoid arthritis">juvenile rheumatoid arthritis</a>.<sup id="cite_ref-42"><a href="#cite_note-42">[42]</a></sup> <a href="/wiki/SUGEN" title="SUGEN">SUGEN</a>, a company focused on <a href="/wiki/Protein_kinase" title="Protein kinase">protein kinase</a> inhibitors, had pioneered the use of ATP-mimetic small molecules to block <a href="/wiki/Signal_transduction" title="Signal transduction">signal transduction</a>. The <a href="/wiki/SUGEN" title="SUGEN">SUGEN</a> facility was shut down in 2003 by Pfizer, with the loss of more than 300 jobs, and several programs were transferred to Pfizer. These included <a href="/wiki/Sunitinib" title="Sunitinib">sunitinib</a> (<i>Sutent</i>), a cancer medication which was approved for human use by the FDA in January 2006.<sup id="cite_ref-43"><a href="#cite_note-43">[43]</a></sup><sup id="cite_ref-44"><a href="#cite_note-44">[44]</a></sup> A related compound, SU11654 (<a href="/wiki/Toceranib" title="Toceranib">Toceranib</a>), was also approved for <a href="/wiki/Cancer_in_dogs" title="Cancer in dogs">cancer in dogs</a>, and the <a href="/wiki/ALK_inhibitor" title="ALK inhibitor">ALK inhibitor</a> <a href="/wiki/Crizotinib" title="Crizotinib">Crizotinib</a> also grew out of a SUGEN program.<sup id="cite_ref-45"><a href="#cite_note-45">[45]</a></sup><sup id="cite_ref-46"><a href="#cite_note-46">[46]</a></sup>
</p><p>In October 2006, the company announced it would acquire PowerMed.<sup id="cite_ref-47"><a href="#cite_note-47">[47]</a></sup>
</p><p>On October 15, 2009, Pfizer acquired <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> for $68<span>&nbsp;</span>billion in cash and stock, including the assumption of debt, making Pfizer the largest pharmaceutical company in the world.<sup id="cite_ref-48"><a href="#cite_note-48">[48]</a></sup><sup id="cite_ref-49"><a href="#cite_note-49">[49]</a></sup><sup id="cite_ref-50"><a href="#cite_note-50">[50]</a></sup><sup id="cite_ref-worst_51-0"><a href="#cite_note-worst-51">[51]</a></sup><sup id="cite_ref-wyethpr_52-0"><a href="#cite_note-wyethpr-52">[52]</a></sup> The acquisition of Wyeth provided Pfizer with a <a href="/wiki/Pneumococcal_conjugate_vaccine" title="Pneumococcal conjugate vaccine">pneumococcal conjugate vaccine</a>, trademarked <a href="/wiki/Pneumococcal_conjugate_vaccine#Prevnar" title="Pneumococcal conjugate vaccine">Prevnar 13</a>; this is used for the prevention of invasive pneumococcal infections. The introduction of the original, 7-valent version of the vaccine, developed by <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> in February 2000, led to a 75% reduction in the incidence of invasive pneumococcal infections among children under age<span>&nbsp;</span>5 in the United States. Pfizer introduced an improved version of the vaccine in 2010, for which it was granted a patent in India in 2017. Prevnar 13 provides coverage of 13 bacterial variants, expanding beyond the original 7-valent version.<sup id="cite_ref-wyethpr_52-1"><a href="#cite_note-wyethpr-52">[52]</a></sup> By 2012, the rate of invasive infections among children under age<span>&nbsp;</span>5 had been reduced by an additional 50%.<sup id="cite_ref-cdc.gov_53-0"><a href="#cite_note-cdc.gov-53">[53]</a></sup><sup id="cite_ref-54"><a href="#cite_note-54">[54]</a></sup>
</p>
<h3><span id="2010.E2.80.932020:_Further_discoveries_and_acquisitions"></span><span id="2010–2020:_Further_discoveries_and_acquisitions">2010–2020: Further discoveries and acquisitions</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=7" title="Edit section: 2010–2020: Further discoveries and acquisitions">edit</a><span>]</span></span></h3>
<p>In 2010, <a href="/wiki/Ian_Read" title="Ian Read">Ian Read</a> was named <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a> of the company.<sup id="cite_ref-55"><a href="#cite_note-55">[55]</a></sup>
</p><p>In February 2011, Pfizer announced the closure of its UK research and development facility (formerly also a manufacturing plant) in <a href="/wiki/Sandwich,_Kent" title="Sandwich, Kent">Sandwich, Kent</a>, which at the time employed 2,400 people.<sup id="cite_ref-56"><a href="#cite_note-56">[56]</a></sup> In March 2011, Pfizer acquired <a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King Pharmaceuticals</a> for $3.6<span>&nbsp;</span>billion in cash. King produced emergency injectables such as the <a href="/wiki/EpiPen" title="EpiPen">EpiPen</a>.<sup id="cite_ref-57"><a href="#cite_note-57">[57]</a></sup>
</p><p>On September 4, 2012, the FDA approved <a href="/wiki/Bosutinib" title="Bosutinib">bosutinib</a> (<i>Bosulif</i>) for <a href="/wiki/Chronic_myelogenous_leukemia" title="Chronic myelogenous leukemia">chronic myelogenous leukemia</a> (CML), a rare type of <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> and a blood and <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> disease that affects primarily older adults.<sup id="cite_ref-58"><a href="#cite_note-58">[58]</a></sup> In November 2012, Pfizer received approval from the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> for Xeljanz, a <a href="/wiki/Tofacitinib" title="Tofacitinib">tofacitinib</a>, for <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> and <a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">ulcerative colitis</a>.<sup id="cite_ref-59"><a href="#cite_note-59">[59]</a></sup> The drug had sales of $1.77<span>&nbsp;</span>billion in 2018, and in January 2019, it was the top drug in the United States for <a href="/wiki/Direct-to-consumer_advertising" title="Direct-to-consumer advertising">direct-to-consumer advertising</a>, passing <a href="/wiki/Adalimumab" title="Adalimumab">adalimumab</a> (<i>Humira</i>).<sup id="cite_ref-60"><a href="#cite_note-60">[60]</a></sup>
</p><p>On February 1, 2013, <a href="/wiki/Zoetis" title="Zoetis">Zoetis</a>, the Agriculture Division of Pfizer and later Pfizer Animal Health, became a <a href="/wiki/Public_company" title="Public company">public company</a> via an <a href="/wiki/Initial_public_offering" title="Initial public offering">initial public offering</a>, raising $2.2<span>&nbsp;</span>billion.<sup id="cite_ref-61"><a href="#cite_note-61">[61]</a></sup><sup id="cite_ref-62"><a href="#cite_note-62">[62]</a></sup><sup id="cite_ref-63"><a href="#cite_note-63">[63]</a></sup><sup id="cite_ref-64"><a href="#cite_note-64">[64]</a></sup> Later in 2013, Pfizer completed the <a href="/wiki/Corporate_spin-off" title="Corporate spin-off">corporate spin-off</a> of its remaining stake in <a href="/wiki/Zoetis" title="Zoetis">Zoetis</a>.<sup id="cite_ref-65"><a href="#cite_note-65">[65]</a></sup><sup id="cite_ref-66"><a href="#cite_note-66">[66]</a></sup>
</p><p>In September 2014, the company acquired Innopharma for $225<span>&nbsp;</span>million, plus up to $135<span>&nbsp;</span>million in milestone payments, in a deal that expanded Pfizer's range of generic and injectable drugs.<sup id="cite_ref-67"><a href="#cite_note-67">[67]</a></sup><sup id="cite_ref-68"><a href="#cite_note-68">[68]</a></sup>
</p><p>On January 5, 2015, the company announced it would acquire a controlling interest in Redvax, expanding its vaccine portfolio targeting human <a href="/wiki/Cytomegalovirus" title="Cytomegalovirus">cytomegalovirus</a>.<sup id="cite_ref-69"><a href="#cite_note-69">[69]</a></sup> In February 2015, the company received approval from the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> for <a href="/wiki/Palbociclib" title="Palbociclib">palbociclib</a> (<i>Ibrance</i>) for treatment of certain types of <a href="/wiki/Breast_cancer" title="Breast cancer">breast cancer</a>.<sup id="cite_ref-70"><a href="#cite_note-70">[70]</a></sup><sup id="cite_ref-71"><a href="#cite_note-71">[71]</a></sup> In March 2015, the company announced it would restart its collaboration with <a href="/wiki/Eli_Lilly_and_Company" title="Eli Lilly and Company">Eli Lilly and Company</a> surrounding the <a href="/wiki/Phase_III_trial" title="Phase III trial">Phase III trial</a> of <a href="/wiki/Tanezumab" title="Tanezumab">Tanezumab</a>.<sup id="cite_ref-72"><a href="#cite_note-72">[72]</a></sup> In May 2015, Pfizer and a <a href="/wiki/Bar-Ilan_University" title="Bar-Ilan University">Bar-Ilan University</a> laboratory announced a partnership based on the development of medical <a href="/wiki/DNA_nanotechnology" title="DNA nanotechnology">DNA nanotechnology</a>.<sup id="cite_ref-73"><a href="#cite_note-73">[73]</a></sup> In June 2015, the company acquired <i>Nimenrix</i> and <i>Mencevax</i>, <a href="/wiki/Meningococcal_vaccine" title="Meningococcal vaccine">meningococcal vaccines</a>, from GlaxoSmithKline for around $130<span>&nbsp;</span>million.<sup id="cite_ref-74"><a href="#cite_note-74">[74]</a></sup> In September 2015, Pfizer acquired <a href="/wiki/Hospira" title="Hospira">Hospira</a> for $17<span>&nbsp;</span>billion, including the assumption of debt.<sup id="cite_ref-75"><a href="#cite_note-75">[75]</a></sup><sup id="cite_ref-76"><a href="#cite_note-76">[76]</a></sup><sup id="cite_ref-77"><a href="#cite_note-77">[77]</a></sup><sup id="cite_ref-78"><a href="#cite_note-78">[78]</a></sup><sup id="cite_ref-79"><a href="#cite_note-79">[79]</a></sup><sup id="cite_ref-80"><a href="#cite_note-80">[80]</a></sup> <a href="/wiki/Hospira" title="Hospira">Hospira</a> was the largest producer of generic injectable pharmaceuticals in the world.<sup id="cite_ref-81"><a href="#cite_note-81">[81]</a></sup> On November 23, 2015, Pfizer and <a href="/wiki/Allergan" title="Allergan">Allergan</a> announced a planned $160<span>&nbsp;</span>billion merger, in the largest pharmaceutical deal ever and the third largest corporate merger in history. The proposed transaction contemplated that the merged company maintain Allergan's <a href="/wiki/Republic_of_Ireland" title="Republic of Ireland">Republic of Ireland</a> domicile, resulting in the new company being subject to <a href="/wiki/Corporation_tax" title="Corporation tax">corporation tax</a> at the relatively low rate of 12.5%.<sup id="cite_ref-82"><a href="#cite_note-82">[82]</a></sup> The deal was to constitute a <a href="/wiki/Reverse_merger" title="Reverse merger">reverse merger</a>, whereby Allergan acquired Pfizer, with the new company then changing its name to "Pfizer, plc".<sup id="cite_ref-83"><a href="#cite_note-83">[83]</a></sup><sup id="cite_ref-84"><a href="#cite_note-84">[84]</a></sup><sup id="cite_ref-85"><a href="#cite_note-85">[85]</a></sup> On April 6, 2016, Pfizer and Allergan terminated the merger agreement after the <a href="/wiki/Obama_administration" title="Obama administration">Obama administration</a> and the <a href="/wiki/United_States_Department_of_the_Treasury" title="United States Department of the Treasury">United States Department of the Treasury</a> introduced new laws intended to limit <a href="/wiki/Corporate_inversion" title="Corporate inversion">corporate inversions</a> (the extent to which companies could move their headquarters overseas in order to reduce the amount of taxes they pay).<sup id="cite_ref-86"><a href="#cite_note-86">[86]</a></sup><sup id="cite_ref-87"><a href="#cite_note-87">[87]</a></sup>
</p><p>In June 2016, the company acquired <a href="/wiki/Anacor_Pharmaceuticals" title="Anacor Pharmaceuticals">Anacor Pharmaceuticals</a> for $5.2<span>&nbsp;</span>billion, expanding its portfolio in both inflammation and immunology drugs areas.<sup id="cite_ref-88"><a href="#cite_note-88">[88]</a></sup><sup id="cite_ref-89"><a href="#cite_note-89">[89]</a></sup> In August 2016, the company made a $40<span>&nbsp;</span>million bid for the assets of BIND Therapeutics, which was in <a href="/wiki/Bankruptcy" title="Bankruptcy">bankruptcy</a>.<sup id="cite_ref-90"><a href="#cite_note-90">[90]</a></sup> The same month, the company acquired Bamboo Therapeutics for $645<span>&nbsp;</span>million, expanding its gene therapy offerings.<sup id="cite_ref-91"><a href="#cite_note-91">[91]</a></sup> In September 2016, the company acquired cancer drug-maker <a href="/wiki/Medivation" title="Medivation">Medivation</a> for $14<span>&nbsp;</span>billion.<sup id="cite_ref-92"><a href="#cite_note-92">[92]</a></sup><sup id="cite_ref-93"><a href="#cite_note-93">[93]</a></sup><sup id="cite_ref-94"><a href="#cite_note-94">[94]</a></sup> In October 2016, the company licensed the anti-<a href="/wiki/CTLA4" title="CTLA4">CTLA4</a> monoclonal antibody, ONC-392, from OncoImmune.<sup id="cite_ref-95"><a href="#cite_note-95">[95]</a></sup><sup id="cite_ref-96"><a href="#cite_note-96">[96]</a></sup> In December 2016, Pfizer acquired <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a>'s small-molecule antibiotics business for $1.575 billion.<sup id="cite_ref-97"><a href="#cite_note-97">[97]</a></sup><sup id="cite_ref-98"><a href="#cite_note-98">[98]</a></sup><sup id="cite_ref-99"><a href="#cite_note-99">[99]</a></sup>
</p><p>In January 2018, Pfizer announced that it would end its work on research into treatments for <a href="/wiki/Alzheimer%27s_disease" title="Alzheimer's disease">Alzheimer's disease</a> and <a href="/wiki/Parkinsonism" title="Parkinsonism">Parkinsonism</a> (a symptom of <a href="/wiki/Parkinson%27s_disease" title="Parkinson's disease">Parkinson's disease</a> and other conditions). The company said about 300 researchers would lose their jobs.<sup id="cite_ref-100"><a href="#cite_note-100">[100]</a></sup> In July 2018, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> approved <a href="/wiki/Enzalutamide" title="Enzalutamide">enzalutamide</a>, developed by Pfizer and <a href="/wiki/Astellas_Pharma" title="Astellas Pharma">Astellas Pharma</a> for patients with <a href="/wiki/Castration" title="Castration">castration</a>-resistant <a href="/wiki/Prostate_cancer" title="Prostate cancer">prostate cancer</a>.<sup id="cite_ref-101"><a href="#cite_note-101">[101]</a></sup> In August 2018, Pfizer signed an agreement with <a href="/wiki/BioNTech" title="BioNTech">BioNTech</a> to conduct joint research and development activities regarding <a href="/wiki/MRNA" title="MRNA">mRNA</a>-based <a href="/wiki/Influenza_vaccine" title="Influenza vaccine">influenza vaccines</a>.<sup id="cite_ref-102"><a href="#cite_note-102">[102]</a></sup> In October 2018, effective January 1, 2019, <a href="/wiki/Albert_Bourla" title="Albert Bourla">Albert Bourla</a> was promoted to <a href="/wiki/Chief_executive_officer" title="Chief executive officer">chief executive officer</a>, succeeding <a href="/wiki/Ian_Read" title="Ian Read">Ian Read</a>, his mentor.<sup id="cite_ref-103"><a href="#cite_note-103">[103]</a></sup><sup id="cite_ref-104"><a href="#cite_note-104">[104]</a></sup><sup id="cite_ref-105"><a href="#cite_note-105">[105]</a></sup><sup id="cite_ref-106"><a href="#cite_note-106">[106]</a></sup>
</p><p>In July 2019, the company acquired Therachon for up to $810<span>&nbsp;</span>million, expanding its rare disease portfolio through Therachon's recombinant human fibroblast growth factor receptor 3 compound, aimed at treating conditions such as <a href="/wiki/Achondroplasia" title="Achondroplasia">achondroplasia</a>.<sup id="cite_ref-107"><a href="#cite_note-107">[107]</a></sup> Also in July, Pfizer acquired <a href="/wiki/Array_Biopharma" title="Array Biopharma">Array Biopharma</a> for $10.6<span>&nbsp;</span>billion, boosting its oncology pipeline.<sup id="cite_ref-108"><a href="#cite_note-108">[108]</a></sup> In August 2019, Pfizer merged its consumer health business with that of GlaxoSmithKline, into a <a href="/wiki/Joint_venture" title="Joint venture">joint venture</a> owned 68% by GlaxoSmithKline and 32% by Pfizer, with plans to make it a <a href="/wiki/Public_company" title="Public company">public company</a>. The transaction built on a 2018 transaction where GlaxoSmithKline acquired <a href="/wiki/Novartis" title="Novartis">Novartis</a>' stake in the GSK-Novartis consumer healthcare joint business.<sup id="cite_ref-109"><a href="#cite_note-109">[109]</a></sup><sup id="cite_ref-110"><a href="#cite_note-110">[110]</a></sup><sup id="cite_ref-111"><a href="#cite_note-111">[111]</a></sup><sup id="cite_ref-112"><a href="#cite_note-112">[112]</a></sup> The transaction followed negotiations with other companies including <a href="/wiki/Reckitt_Benckiser" title="Reckitt Benckiser">Reckitt Benckiser</a>,<sup id="cite_ref-113"><a href="#cite_note-113">[113]</a></sup> <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a>, <a href="/wiki/Johnson_%26_Johnson" title="Johnson &amp; Johnson">Johnson &amp; Johnson</a>,<sup id="cite_ref-114"><a href="#cite_note-114">[114]</a></sup> and <a href="/wiki/Procter_%26_Gamble" title="Procter &amp; Gamble">Procter &amp; Gamble</a>.<sup id="cite_ref-115"><a href="#cite_note-115">[115]</a></sup>
</p><p>In September 2020, the company acquired a 9.9% stake in <a href="/w/index.php?title=CStone_Pharmaceuticals&amp;action=edit&amp;redlink=1" title="CStone Pharmaceuticals (page does not exist)">CStone Pharmaceuticals</a> for $200<span>&nbsp;</span>million (HK$1.55<span>&nbsp;</span>billion), helping to commercialise its anti-<a href="/wiki/PD-L1" title="PD-L1">PD-L1</a> monoclonal antibody, CS1001.<sup id="cite_ref-116"><a href="#cite_note-116">[116]</a></sup> In October 2020, the company acquired Arixa Pharmaceuticals.<sup id="cite_ref-117"><a href="#cite_note-117">[117]</a></sup> In November 2020, using a <a href="/wiki/Reverse_Morris_Trust" title="Reverse Morris Trust">Reverse Morris Trust</a> structure, Pfizer merged its off-patent branded and <a href="/wiki/Generic_drug" title="Generic drug">generic drug</a> business, known as Upjohn, with <a href="/wiki/Mylan" title="Mylan">Mylan</a> to form <a href="/wiki/Viatris" title="Viatris">Viatris</a>, owned 57% by Pfizer shareholders.<sup id="cite_ref-118"><a href="#cite_note-118">[118]</a></sup><sup id="cite_ref-119"><a href="#cite_note-119">[119]</a></sup><sup id="cite_ref-120"><a href="#cite_note-120">[120]</a></sup>
</p>
<h3><span id="2021.E2.80.93onwards:_Corporate_developments_and_acquisitions"></span><span id="2021–onwards:_Corporate_developments_and_acquisitions">2021–onwards: Corporate developments and acquisitions</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=8" title="Edit section: 2021–onwards: Corporate developments and acquisitions">edit</a><span>]</span></span></h3>
<p>On January 5, 2021, Pfizer introduced a new <a href="/wiki/Logo" title="Logo">logo</a>.<sup id="cite_ref-121"><a href="#cite_note-121">[121]</a></sup> In April 2021, Pfizer acquired Amplyx Pharmaceuticals and its anti-fungal compound Fosmanogepix (APX001).<sup id="cite_ref-122"><a href="#cite_note-122">[122]</a></sup><sup id="cite_ref-123"><a href="#cite_note-123">[123]</a></sup><sup id="cite_ref-124"><a href="#cite_note-124">[124]</a></sup> In August, the company announced it would acquire Trillium Therapeutics Inc and its immuno-oncology portfolio for $2.3 billion ($18.50 per share).<sup id="cite_ref-125"><a href="#cite_note-125">[125]</a></sup><sup id="cite_ref-126"><a href="#cite_note-126">[126]</a></sup> In December, Pfizer announced that it had agreed to acquire <a href="/wiki/Arena_Pharmaceuticals" title="Arena Pharmaceuticals">Arena Pharmaceuticals</a> for $6.7 billion in cash.<sup id="cite_ref-127"><a href="#cite_note-127">[127]</a></sup><sup id="cite_ref-128"><a href="#cite_note-128">[128]</a></sup> In March 2022, it was announced the acquisition of Arena Pharmaceuticals had been concluded.<sup id="cite_ref-129"><a href="#cite_note-129">[129]</a></sup>
</p>
<h3><span id="Acquisition_history">Acquisition history</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=9" title="Edit section: Acquisition history">edit</a><span>]</span></span></h3>
<div><p>Pfizer acquisitions</p><div>
<ul><li><b>Pfizer</b> <small>(Founded 1849 as Charles Pfizer &amp; Company)</small>
<ul><li><a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a>
<ul><li>William R. Warner <small>(Founded 1856, merged 1955)</small></li>
<li>Lambert Pharmacal Company <small>(Merged 1955)</small></li>
<li>Parke-Davis <small>(Founded 1860, Acq 1976)</small></li>
<li>Wilkinson Sword <small>(Acq 1993, divested 2003)</small></li>
<li>Agouron <small>(Acq 1999)</small></li></ul></li>
<li><a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> <small>(Acq 2002)</small>
<ul><li><a href="/wiki/Pharmacia_%26_Upjohn" title="Pharmacia &amp; Upjohn">Pharmacia &amp; Upjohn</a> <small>(Merged 2000)</small>
<ul><li><a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> <small>(Merged 1995)</small>
<ul><li>Farmitalia Carlo Erba</li>
<li>Kabi Pharmacia</li>
<li>Pharmacia Aktiebolaget</li></ul></li>
<li><a href="/wiki/The_Upjohn_Company" title="The Upjohn Company">The Upjohn Company</a> <small>(Merged 1995)</small></li>
<li><a href="/wiki/Monsanto" title="Monsanto">Monsanto</a> <small>(Merged 2000, divested 2002)</small></li>
<li><a href="/wiki/G.D._Searle,_LLC" title="G.D. Searle, LLC">Searle</a> <small>(Merged 2000)</small></li></ul></li></ul></li>
<li>Esperion Therapeutics <small>(Acq 2003, divested 2008)</small></li>
<li>Meridica <small>(Acq 2004)</small></li>
<li>Vicuron Pharmaceuticals <small>(Acq 2005)</small></li>
<li>Idun <small>(Acq 2005)</small></li>
<li>Angiosyn <small>(Acq 2005)</small></li>
<li>Powermed <small>(Acq 2006)</small></li>
<li>Rinat <small>(Acq 2006)</small></li>
<li>Coley Pharmaceutical Group <small>(Acq 2007)</small></li>
<li>CovX <small>(Acq 2007)</small></li>
<li>Encysive Pharmaceuticals Inc <small>(Acq 2008)</small></li>
<li><a href="/wiki/Wyeth" title="Wyeth">Wyeth</a> <small>(Acq 2009)</small>
<ul><li><a href="/wiki/Chef_Boyardee" title="Chef Boyardee">Chef Boyardee</a> <small>(Acq 1946, divested 1996 with food div)</small></li>
<li>S.M.A. Corporation</li>
<li>Ayerst Laboratories <small>(Acq 1943)</small></li>
<li>Fort Dodge Serum Company <small>(Acq 1945)</small></li>
<li><a href="/wiki/Bristol-Myers" title="Bristol-Myers">Bristol-Myers</a> <small>(Animal Health div)</small></li>
<li><a href="/wiki/Parke-Davis" title="Parke-Davis">Parke-Davis</a> <small>(Animal Health div)</small></li>
<li>A.H. Robins</li>
<li>Sherwood Medical <small>(Acq 1982)</small></li>
<li><a href="/wiki/Genetics_Institute,_Inc." title="Genetics Institute, Inc.">Genetics Institute, Inc.</a> <small>(Acq 1992)</small></li>
<li><a href="/wiki/American_Cyanamid" title="American Cyanamid">American Cyanamid</a> <small>(Acq 1994)</small></li>
<li>Lederle Laboratories</li>
<li><a href="/wiki/Solvay_S.A." title="Solvay S.A.">Solvay</a> <small>(Acq 1995, Animal Health div)</small></li></ul></li>
<li><a href="/wiki/King_Pharmaceuticals" title="King Pharmaceuticals">King Pharmaceuticals</a> <small>(Acq 2010)</small>
<ul><li>Monarch Pharmaceuticals, Inc.</li>
<li>King Pharmaceuticals Research and Development, Inc.</li>
<li>Meridian Medical Technologies, Inc.</li>
<li>Parkedale Pharmaceuticals, Inc.</li>
<li>King Pharmaceuticals Canada Inc.</li>
<li>Monarch Pharmaceuticals Ireland Limited</li></ul></li>
<li>Synbiotics Corporation <small>(Acq 2011)</small></li>
<li>Icagen <small>(Acq 2011)</small></li>
<li>Ferrosan <small>(Consumer Health div, Acq 2011)</small></li>
<li>Excaliard Pharmaceuticals <small>(Acq 2011)</small></li>
<li>Alacer Corp <small>(Acq 2012)</small></li>
<li>NextWave Pharmaceuticals, Inc <small>(Acq 2012)</small></li>
<li>Innopharma <small>(Acq 2014)</small></li>
<li>Redvax GmbH <small>(Acq 2014)</small></li>
<li>Hospira <small>(Spun off from Abbott Laboratories 2004, Acq 2015)</small> 
<ul><li>Mayne Pharma Ltd <small>(Acq 2007)</small></li>
<li>Pliva-Croatia</li>
<li><a href="/wiki/Orchid_Chemicals_%26_Pharmaceuticals_Ltd." title="Orchid Chemicals &amp; Pharmaceuticals Ltd.">Orchid Chemicals &amp; Pharmaceuticals Ltd.</a> <small>(Generics &amp; Injectables div, Acq 2009)</small> </li>
<li>Javelin Pharmaceuticals, Inc. <small>(Acq 2010)</small></li>
<li>TheraDoc <small>(Acq 2010)</small></li>
<li>Arixa Pharmaceuticals <small>(Acq 2020)</small></li></ul></li>
<li><a href="/wiki/Anacor_Pharmaceuticals" title="Anacor Pharmaceuticals">Anacor Pharmaceuticals</a> <small>(Acq 2016)</small></li>
<li>Bamboo Therapeutics <small>(Acq 2016)</small></li>
<li><a href="/wiki/Medivation" title="Medivation">Medivation</a> <small>(Acq 2016)</small></li>
<li><a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a> <small>(Small molecule antibiotic div, Acq 2016)</small></li>
<li><a href="/wiki/Array_BioPharma" title="Array BioPharma">Array BioPharma</a> <small>(Acq 2019)</small></li>
<li>Amplyx Pharmaceuticals <small>(Acq 2021)</small></li>
<li>Trillium Therapeutics <small>(Acq 2021)</small></li>
<li><a href="/wiki/Arena_Pharmaceuticals" title="Arena Pharmaceuticals">Arena Pharmaceuticals</a> <small>(Acq TBA)</small></li></ul></li></ul>
</div></div>

<div><p><a href="/wiki/File:Covid19_vaccine_biontech_pfizer_2.jpg"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/220px-Covid19_vaccine_biontech_pfizer_2.jpg" decoding="async" width="220" height="113" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/330px-Covid19_vaccine_biontech_pfizer_2.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/5b/Covid19_vaccine_biontech_pfizer_2.jpg/440px-Covid19_vaccine_biontech_pfizer_2.jpg 2x" data-file-width="2909" data-file-height="1496"></a></p></div>
<h3><span id="COVID-19_vaccine_and_other_initiatives">COVID-19 vaccine and other initiatives</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=10" title="Edit section: COVID-19 vaccine and other initiatives">edit</a><span>]</span></span></h3>
<h4><span id="COVID-19_pandemic_and_vaccine_development">COVID-19 pandemic and vaccine development</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=11" title="Edit section: COVID-19 pandemic and vaccine development">edit</a><span>]</span></span></h4>

<h5><span id="Initial_development_and_testing">Initial development and testing</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=12" title="Edit section: Initial development and testing">edit</a><span>]</span></span></h5>
<p>In March 2020, as the scale of the <a href="/wiki/COVID-19_pandemic" title="COVID-19 pandemic">COVID-19 pandemic</a> became apparent, Pfizer partnered with BioNTech to study and develop <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a> mRNA vaccine candidates. Unlike many of its competitors, Pfizer took no initial research funds from the United States' <a href="/wiki/Operation_Warp_Speed" title="Operation Warp Speed">Operation Warp Speed</a> vaccine development program, instead choosing to invest roughly $2 billion of its own funds. Pfizer CEO Albert Bourla has said that he declined money from Operation Warp Speed to avoid government intervention, stating later that "when you get money from someone that always comes with strings. They want to see how we are going to progress, what type of moves you are going to do. They want reports. And also, I wanted to keep Pfizer out of politics, by the way."<sup id="cite_ref-130"><a href="#cite_note-130">[130]</a></sup>
</p><p>In May 2020, Pfizer began testing four different <a href="/wiki/COVID-19_vaccine" title="COVID-19 vaccine">COVID-19 vaccine</a> variations. Vaccines were injected into the first human participants in the U.S. in early May.<sup id="cite_ref-131"><a href="#cite_note-131">[131]</a></sup> In July 2020, Pfizer and BioNTech announced that two of the partners' four <a href="/wiki/Messenger_RNA" title="Messenger RNA">mRNA</a> vaccine candidates had won fast track designation from the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">FDA</a>.<sup id="cite_ref-132"><a href="#cite_note-132">[132]</a></sup><sup id="cite_ref-133"><a href="#cite_note-133">[133]</a></sup> The company began Phase<span>&nbsp;</span>II-III testing on 30,000 people in the last week of July 2020 and was slated to be paid $1.95<span>&nbsp;</span>billion for 100<span>&nbsp;</span>million doses of the vaccine by the US government.<sup id="cite_ref-134"><a href="#cite_note-134">[134]</a></sup> The U.S. deal priced two doses at $39, and the company stated that it would not lower the rates for other countries until the outbreak is no longer a pandemic.<sup id="cite_ref-135"><a href="#cite_note-135">[135]</a></sup> Pfizer's CEO stated the companies in the private sector producing a vaccine should make a profit.<sup id="cite_ref-136"><a href="#cite_note-136">[136]</a></sup> In September 2020, Pfizer and BioNTech announced that they had completed talks with the European Commission to provide an initial 200<span>&nbsp;</span>million vaccine doses to the EU, with the option to supply another 100<span>&nbsp;</span>million doses at a later date.<sup id="cite_ref-137"><a href="#cite_note-137">[137]</a></sup><sup id="cite_ref-138"><a href="#cite_note-138">[138]</a></sup>
</p>
<h5><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=13" title="Edit section: Efficacy results and authorization">edit</a><span>]</span></span></h5>

<p>On November 9, 2020, Pfizer announced that BioNTech's COVID-19 vaccine, tested on 43,500 people, was found to be 90% effective at preventing symptomatic COVID-19.<sup id="cite_ref-139"><a href="#cite_note-139">[139]</a></sup> The efficacy was updated to 95% a week later.<sup id="cite_ref-:1_140-0"><a href="#cite_note-:1-140">[140]</a></sup> Akiko Iwasaki, an immunologist interviewed by the <i>New York Times</i>, described the efficacy figure as "really a spectacular number."<sup id="cite_ref-141"><a href="#cite_note-141">[141]</a></sup> The announcement made Pfizer and BioNTech the first companies to develop and test a working vaccine for COVID-19.<sup id="cite_ref-:1_140-1"><a href="#cite_note-:1-140">[140]</a></sup>
</p><p>Over the following month and a half, regulators in various countries approved Pfizer's vaccine for emergency use. The United Kingdom approved the vaccine first, on December 2,<sup id="cite_ref-142"><a href="#cite_note-142">[142]</a></sup> followed by <a href="/wiki/Bahrain" title="Bahrain">Bahrain</a> on December 4,<sup id="cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0"><a href="#cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143">[143]</a></sup> Canada on December 9,<sup id="cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0"><a href="#cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144">[144]</a></sup> and Saudi Arabia on December 10.<sup id="cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0"><a href="#cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145">[145]</a></sup> On December 10, 2020, the United States FDA held an advisory committee meeting to discuss authorization of the vaccine.<sup id="cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0"><a href="#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146">[146]</a></sup> The next day, the US officially became the 5th country to approve use of Pfizer's vaccine under an Emergency Use Authorization (EUA), with an independent panel voting 17–4 in support of approval.<sup id="cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1"><a href="#cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146">[146]</a></sup><sup id="cite_ref-147"><a href="#cite_note-147">[147]</a></sup> On December 14, Singapore became one of the first in Asia to approve the vaccine through the <a href="/wiki/Health_Sciences_Authority" title="Health Sciences Authority">Health Sciences Authority</a>.<sup id="cite_ref-148"><a href="#cite_note-148">[148]</a></sup> On December 21, the <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA) recommended granting a conditional marketing authorisation for the vaccine in the <a href="/wiki/European_Union" title="European Union">European Union</a>, under the brand name "Comirnaty."<sup id="cite_ref-149"><a href="#cite_note-149">[149]</a></sup>
</p>
<h5><span id="Manufacturing_and_distribution">Manufacturing and distribution</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=14" title="Edit section: Manufacturing and distribution">edit</a><span>]</span></span></h5>

<p>As of early May 2021, Pfizer and BioNTech had manufactured at least 430 million vaccine doses, which have been distributed to 91 countries and territories. The companies have said they expect to manufacture nearly 3 billion total vaccine doses in 2021.<sup id="cite_ref-150"><a href="#cite_note-150">[150]</a></sup>
</p>
<h5><span id="Controversy">Controversy</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=15" title="Edit section: Controversy">edit</a><span>]</span></span></h5>
<p>In February 2021, after a year long investigation relying on unnamed officials, Pfizer was accused by <a href="/wiki/The_Bureau_of_Investigative_Journalism" title="The Bureau of Investigative Journalism">The Bureau of Investigative Journalism</a> (TBIJ) of employing "high-level bullying" against at least two <a href="/wiki/Latin_America" title="Latin America">Latin American</a> countries during negotiations to acquire COVID-19 vaccines, including requesting that the countries put sovereign assets as <a href="/wiki/Collateral_(finance)" title="Collateral (finance)">collateral</a> for payments.<sup id="cite_ref-bullied_151-0"><a href="#cite_note-bullied-151">[151]</a></sup> According to TBIJ, these negotiation tactics resulted in a months long delay in Pfizer reaching a vaccine agreement with one country and a complete failure to reach agreements with two other countries, including <a href="/wiki/Argentina" title="Argentina">Argentina</a> and Brazil.<sup id="cite_ref-bullied_151-1"><a href="#cite_note-bullied-151">[151]</a></sup>
</p><p>On 2 November 2021, <a href="/wiki/The_BMJ" title="The BMJ">The BMJ</a> published an article after obtaining information from a <a href="/wiki/Whistleblower" title="Whistleblower">whistleblower</a> from the Ventavia Research Group. Ventavia was hired by Pfizer as a research subcontractor. The company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in <a href="/wiki/Pfizer%E2%80%93BioNTech_COVID-19_vaccine#Clinical_trials" title="Pfizer–BioNTech COVID-19 vaccine">Pfizer’s pivotal phase III trial</a>. The regional director, Brook Jackson, emailed a complaint to the US <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA). Ventavia fired her later the same day.<sup id="cite_ref-152"><a href="#cite_note-152">[152]</a></sup> The <a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (EMA) stated in a response to the <a href="/wiki/European_Parliament" title="European Parliament">European Parliament</a>, that "the deficiencies identified do not jeopardize the quality and integrity of the data from the main Comirnaty trial and have no impact on the benefit-risk assessment or on the conclusions on the safety, effectiveness and quality of the vaccine”.<sup id="cite_ref-153"><a href="#cite_note-153">[153]</a></sup>
</p>
<h4><span id="Other_initiatives">Other initiatives</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=16" title="Edit section: Other initiatives">edit</a><span>]</span></span></h4>
<p>In November 2021 Pfizer started a new COVID-19 oral antivirus treatment, known as <a href="/wiki/Nirmatrelvir/ritonavir" title="Nirmatrelvir/ritonavir">Paxlovid</a>, which according to a recent study reduces the risk of hospitalisation or death by 89%.<sup id="cite_ref-154"><a href="#cite_note-154">[154]</a></sup> In January 2022, the Pfizer CEO <a href="/wiki/Albert_Bourla" title="Albert Bourla">Albert Bourla</a> confirmed that the trial results of a fourth dose were pending until March 2022. He also said that the firm was setting up a collaboration to develop an anti-Covid pill treatment along with French company, <a href="/wiki/Novasep" title="Novasep">Novasep</a>. He also said the Covid vaccine was “safe and efficient” for children.<sup id="cite_ref-155"><a href="#cite_note-155">[155]</a></sup> <sup id="cite_ref-156"><a href="#cite_note-156">[156]</a></sup>
</p>
<h2><span id="Legal_issues">Legal issues</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=17" title="Edit section: Legal issues">edit</a><span>]</span></span></h2>
<h3><span id="Aggressive_pharmaceutical_marketing">Aggressive pharmaceutical marketing</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=18" title="Edit section: Aggressive pharmaceutical marketing">edit</a><span>]</span></span></h3>

<p>Pfizer has been accused of aggressive <a href="/wiki/Pharmaceutical_marketing" title="Pharmaceutical marketing">pharmaceutical marketing</a>.<sup id="cite_ref-157"><a href="#cite_note-157">[157]</a></sup><sup id="cite_ref-158"><a href="#cite_note-158">[158]</a></sup><sup id="cite_ref-159"><a href="#cite_note-159">[159]</a></sup>
</p>
<h4><span id="Illegal_marketing_of_gabapentin_for_off-label_uses">Illegal marketing of gabapentin for off-label uses</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=19" title="Edit section: Illegal marketing of gabapentin for off-label uses">edit</a><span>]</span></span></h4>
<p>In 1993, the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) approved <a href="/wiki/Gabapentin" title="Gabapentin">gabapentin</a> only for treatment of <a href="/wiki/Seizures" title="Seizures">seizures</a>. <a href="/wiki/Warner%E2%80%93Lambert" title="Warner–Lambert">Warner–Lambert</a>, which merged with Pfizer in 2000, used <a href="/wiki/Continuing_medical_education" title="Continuing medical education">continuing medical education</a> and <a href="/wiki/Medical_research" title="Medical research">medical research</a>, sponsored articles about the drug for the medical literature, and alleged suppression of unfavorable study results, to promote gabapentin. Within five years, the drug was being widely used for <a href="/wiki/Off-label_use" title="Off-label use">off-label uses</a> such as treatment of pain and psychiatric conditions. Warner–Lambert admitted to violating FDA regulations by promoting the drug for pain, psychiatric conditions, migraine, and other unapproved uses.<sup id="cite_ref-160"><a href="#cite_note-160">[160]</a></sup> In 2004, the company paid $430<span>&nbsp;</span>million in one of the largest settlements to resolve criminal and civil health care liability charges. It was the first off-label promotion case successfully brought under the <a href="/wiki/False_Claims_Act" title="False Claims Act">False Claims Act</a>.<sup id="cite_ref-161"><a href="#cite_note-161">[161]</a></sup> A Cochrane review concluded that gabapentin is ineffective in migraine prophylaxis.<sup id="cite_ref-162"><a href="#cite_note-162">[162]</a></sup> The <a href="/wiki/American_Academy_of_Neurology" title="American Academy of Neurology">American Academy of Neurology</a> rates it as having unproven efficacy, while the <a href="/wiki/Canadian_Headache_Society" title="Canadian Headache Society">Canadian Headache Society</a> and the <a href="/wiki/European_Federation_of_Neurological_Societies" title="European Federation of Neurological Societies">European Federation of Neurological Societies</a> rate its use as being supported by moderate and low-quality evidence.<sup id="cite_ref-163"><a href="#cite_note-163">[163]</a></sup>
</p>
<h4><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=20" title="Edit section: Illegal marketing of Bextra">edit</a><span>]</span></span></h4>
<p>In September 2009, Pfizer pleaded guilty to the illegal marketing of <a href="/wiki/Arthritis" title="Arthritis">arthritis</a> drug <a href="/wiki/Valdecoxib" title="Valdecoxib">valdecoxib</a> (<i>Bextra</i>) and agreed to a $2.3<span>&nbsp;</span>billion settlement, the largest <a href="/wiki/Health_care_fraud" title="Health care fraud">health care fraud</a> settlement at that time. Pfizer promoted the sale of the drug for several uses and dosages that the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> specifically declined to approve due to safety concerns. The drug was pulled from the market in 2005.<sup id="cite_ref-164"><a href="#cite_note-164">[164]</a></sup><sup id="cite_ref-largestdoj_165-0"><a href="#cite_note-largestdoj-165">[165]</a></sup> It was Pfizer's fourth such settlement in a decade.<sup id="cite_ref-Settle_166-0"><a href="#cite_note-Settle-166">[166]</a></sup><sup id="cite_ref-Improper_167-0"><a href="#cite_note-Improper-167">[167]</a></sup><sup id="cite_ref-fine_168-0"><a href="#cite_note-fine-168">[168]</a></sup> The payment included $1.3<span>&nbsp;</span>billion in criminal penalties for felony violations of the <a href="/wiki/Federal_Food,_Drug,_and_Cosmetic_Act" title="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</a>, and $1.0<span>&nbsp;</span>billion to settle allegations it had illegally promoted the drugs for uses that were not approved by the <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) leading to violations under the <a href="/wiki/False_Claims_Act" title="False Claims Act">False Claims Act</a> as reimbursements were requested from Federal and State programs. The criminal fine was the largest ever assessed in the United States to date.<sup id="cite_ref-largestdoj_165-1"><a href="#cite_note-largestdoj-165">[165]</a></sup><sup id="cite_ref-Settle_166-1"><a href="#cite_note-Settle-166">[166]</a></sup><sup id="cite_ref-Improper_167-1"><a href="#cite_note-Improper-167">[167]</a></sup><sup id="cite_ref-fine_168-1"><a href="#cite_note-fine-168">[168]</a></sup> Pfizer entered a <a href="/wiki/Corporate_integrity_agreement" title="Corporate integrity agreement">corporate integrity agreement</a> with the <a href="/wiki/Office_of_Inspector_General_(United_States)" title="Office of Inspector General (United States)">Office of Inspector General</a> that required it to make substantial structural reforms within the company, and publish to its website its post approval commitments and a searchable database of all payments to physicians made by the company.<sup id="cite_ref-169"><a href="#cite_note-169">[169]</a></sup>
</p>
<h4><span id="Termination_of_Peter_Rost">Termination of Peter Rost</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=21" title="Edit section: Termination of Peter Rost">edit</a><span>]</span></span></h4>
<p><a href="/wiki/Peter_Rost_(doctor)" title="Peter Rost (doctor)">Peter Rost</a> was vice president in charge of the <a href="/wiki/Endocrinology" title="Endocrinology">endocrinology</a> division at <a href="/wiki/Pharmacia" title="Pharmacia">Pharmacia</a> before its acquisition by Pfizer. During that time he raised concerns internally about <a href="/wiki/Kickback_(bribery)" title="Kickback (bribery)">kickbacks</a> and off-label marketing of Genotropin, Pharmacia's <a href="/wiki/Human_growth_hormone" title="Human growth hormone">human growth hormone</a> drug. Pfizer reported the Pharmacia marketing practices to the FDA and Department of Justice; Rost was unaware of this and filed an FCA lawsuit against Pfizer. Pfizer kept him employed, but isolated him until the FCA suit was unsealed in 2005. The Justice Department declined to intervene, and Pfizer fired him, and he filed a wrongful termination suit against Pfizer. Pfizer won a summary dismissal of the case, with the court ruling that the evidence showed Pfizer had decided to fire Rost prior to learning of his whistleblower activities.<sup id="cite_ref-170"><a href="#cite_note-170">[170]</a></sup><sup id="cite_ref-171"><a href="#cite_note-171">[171]</a></sup>
</p>
<h4><span id="Illegal_marketing_of_Rapamune">Illegal marketing of Rapamune</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=22" title="Edit section: Illegal marketing of Rapamune">edit</a><span>]</span></span></h4>
<p>A "whistleblower suit" was filed in 2005 against <a href="/wiki/Wyeth" title="Wyeth">Wyeth</a>, which was acquired by Pfizer in 2009, alleging that the company illegally marketed <a href="/wiki/Sirolimus" title="Sirolimus">sirolimus</a> (<i>Rapamune</i>) for <a href="/wiki/Off-label_use" title="Off-label use">off-label uses</a>, targeted specific doctors and medical facilities to increase sales of Rapamune, tried to get transplant patients to change from their transplant drugs to Rapamune, and specifically targeted <a href="/wiki/African-Americans" title="African-Americans">African-Americans</a>. According to the whistleblowers, Wyeth also provided doctors and hospitals that prescribed the drug with kickbacks such as grants, donations, and other money.<sup id="cite_ref-172"><a href="#cite_note-172">[172]</a></sup> In 2013, the company pleaded guilty to criminal mis-branding violations under the <a href="/wiki/Federal_Food,_Drug,_and_Cosmetic_Act" title="Federal Food, Drug, and Cosmetic Act">Federal Food, Drug, and Cosmetic Act</a>. By August 2014, it had paid $491<span>&nbsp;</span>million in civil and criminal penalties related to Rapamune.<sup id="cite_ref-173"><a href="#cite_note-173">[173]</a></sup>
</p>
<h4><span id="Illegal_marketing">Illegal marketing</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=23" title="Edit section: Illegal marketing">edit</a><span>]</span></span></h4>
<p>In June 2010, health insurance network <a href="/wiki/Blue_Cross_Blue_Shield" title="Blue Cross Blue Shield">Blue Cross Blue Shield</a> (BCBS) filed a lawsuit against Pfizer for allegedly illegally marketing drugs Bextra, Geodon and Lyrica. BCBS alleged that Pfizer used kickbacks and wrongly persuaded doctors to prescribe the drugs.<sup id="cite_ref-174"><a href="#cite_note-174">[174]</a></sup><sup id="cite_ref-175"><a href="#cite_note-175">[175]</a></sup> According to the lawsuit, Pfizer handed out 'misleading' materials on <a href="/wiki/Off-label_use" title="Off-label use">off-label uses</a>, sent over 5,000 doctors on trips to the <a href="/wiki/Caribbean" title="Caribbean">Caribbean</a> or around the United States, and paid them $2,000 honoraria in return for listening to lectures about Bextra.<sup id="cite_ref-176"><a href="#cite_note-176">[176]</a></sup><sup id="cite_ref-177"><a href="#cite_note-177">[177]</a></sup> Despite Pfizer's claims that "the company's intent was pure" in fostering a legal exchange of information among doctors, an internal marketing plan revealed that Pfizer intended to train physicians "to serve as public relations spokespeople."<sup id="cite_ref-toobig_178-0"><a href="#cite_note-toobig-178">[178]</a></sup> The case was settled in 2014 for $325<span>&nbsp;</span>million.<sup id="cite_ref-179"><a href="#cite_note-179">[179]</a></sup> Fearing that Pfizer is "<a href="/wiki/Too_big_to_fail" title="Too big to fail">too big to fail</a>" and that prosecuting the company would result in disruptions to <a href="/wiki/Medicare_(United_States)" title="Medicare (United States)">Medicare</a> and <a href="/wiki/Medicaid" title="Medicaid">Medicaid</a>, federal prosecutors instead charged a subsidiary of a subsidiary of a subsidiary of Pfizer, which is "nothing more than a shell company whose only function is to plead guilty."<sup id="cite_ref-toobig_178-1"><a href="#cite_note-toobig-178">[178]</a></sup>
</p>
<h3><span id="Removal_of_ads_after_unflattering_article">Removal of ads after unflattering article</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=24" title="Edit section: Removal of ads after unflattering article">edit</a><span>]</span></span></h3>
<p>According to <i><a href="/wiki/Harper%27s_Magazine" title="Harper's Magazine">Harper's Magazine</a></i> publisher <a href="/wiki/John_R._MacArthur" title="John R. MacArthur">John R. MacArthur</a>, Pfizer withdrew "between $400,000 and a million dollars" worth of ads from <i><a href="/wiki/Harper%27s_Magazine" title="Harper's Magazine">Harper's Magazine</a></i> following an unflattering article on depression medication.<sup id="cite_ref-180"><a href="#cite_note-180">[180]</a></sup>
</p>
<h3><span id="Quigley_Company_asbestos">Quigley Company asbestos</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=25" title="Edit section: Quigley Company asbestos">edit</a><span>]</span></span></h3>
<p>The Quigley Company, which sold <a href="/wiki/Asbestos" title="Asbestos">asbestos</a>-containing insulation products until the early 1970s, was acquired by Pfizer in 1968. In June 2013, asbestos victims and Pfizer negotiated a settlement that required Pfizer to pay a total of $964<span>&nbsp;</span>million: $430<span>&nbsp;</span>million to 80% of existing plaintiffs and place an additional $535<span>&nbsp;</span>million into a settlement trust that will compensate future plaintiffs as well as the remaining 20% of plaintiffs with claims against Pfizer and Quigley. Of that $535<span>&nbsp;</span>million, $405<span>&nbsp;</span>million is in a 40-year note from Pfizer, while $100<span>&nbsp;</span>million is from insurance policies.<sup id="cite_ref-181"><a href="#cite_note-181">[181]</a></sup>
</p>
<h3><span id="Shiley_defective_heart_valves">Shiley defective heart valves</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=26" title="Edit section: Shiley defective heart valves">edit</a><span>]</span></span></h3>
<p>Pfizer purchased Shiley in 1979, at the onset of its Convexo-Concave valve ordeal, involving the <a href="/wiki/Bjork%E2%80%93Shiley_valve" title="Bjork–Shiley valve">Bjork–Shiley valve</a>. Approximately 500 people died when defective <a href="/wiki/Heart_valve" title="Heart valve">heart valves</a> fractured and, in 1994, Pfizer agreed to pay $10.75<span>&nbsp;</span>million to settle claims by the <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a> that the company lied to get approval for the valves.<sup id="cite_ref-182"><a href="#cite_note-182">[182]</a></sup>
</p>
<h3><span id="Firing_of_employee_that_filed_suit">Firing of employee that filed suit</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=27" title="Edit section: Firing of employee that filed suit">edit</a><span>]</span></span></h3>
<p>A federal lawsuit was filed by a scientist claiming she got an infection by a genetically modified <a href="/wiki/Lentivirus" title="Lentivirus">lentivirus</a> while working for Pfizer, resulting in intermittent <a href="/wiki/Paralysis" title="Paralysis">paralysis</a>.<sup id="cite_ref-183"><a href="#cite_note-183">[183]</a></sup> A judge dismissed the case citing a lack of evidence that the illness was caused by the virus but the jury ruled that by firing the employee, Pfizer violated laws protecting <a href="/wiki/Freedom_of_speech" title="Freedom of speech">freedom of speech</a> and <a href="/wiki/Whistleblower" title="Whistleblower">whistleblowers</a> and awarded her $1.37<span>&nbsp;</span>million.<sup id="cite_ref-184"><a href="#cite_note-184">[184]</a></sup>
</p>
<h3><span id="Celebrex_intellectual_property">Celebrex intellectual property</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=28" title="Edit section: Celebrex intellectual property">edit</a><span>]</span></span></h3>
<p><a href="/wiki/Brigham_Young_University" title="Brigham Young University">Brigham Young University</a> (BYU) said a professor of chemistry, Dr. <a href="/wiki/Daniel_L._Simmons" title="Daniel L. Simmons">Daniel L. Simmons</a>, discovered an enzyme in the 1990s that led towards development of <a href="/wiki/Celebrex" title="Celebrex">Celebrex</a>. BYU was originally seeking a 15% royalty on sales, equating to $9.7<span>&nbsp;</span>billion. A research agreement had been made between BYU and <a href="/wiki/Monsanto" title="Monsanto">Monsanto</a>, whose pharmaceutical business was later acquired by Pfizer, to develop a better <a href="/wiki/Aspirin" title="Aspirin">aspirin</a>. The enzyme Dr. Simmons claims to have discovered would induce pain and inflammation while causing gastrointestinal problems and Celebrex is used to reduce those issues. A six-year battle ensued because BYU claimed that Pfizer did not give Dr. Simmons credit or compensation, while Pfizer claimed that it had met all obligations regarding the Monsanto agreement. In May 2012, Pfizer settled the allegations, agreeing to pay $450<span>&nbsp;</span>million.<sup id="cite_ref-185"><a href="#cite_note-185">[185]</a></sup>
</p>
<h3><span id="Nigeria_Trovafloxacin_lawsuit">Nigeria Trovafloxacin lawsuit</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=29" title="Edit section: Nigeria Trovafloxacin lawsuit">edit</a><span>]</span></span></h3>

<p>In 1996, an outbreak of measles, cholera, and bacterial meningitis occurred in Nigeria. Pfizer representatives and personnel from a contract research organization (CRO) traveled to <a href="/wiki/Kano_(city)" title="Kano (city)">Kano</a> to set up a clinical trial and administer an experimental <a href="/wiki/Antibiotic" title="Antibiotic">antibiotic</a>, <a href="/wiki/Trovafloxacin" title="Trovafloxacin">trovafloxacin</a>, to approximately 200 children.<sup id="cite_ref-186"><a href="#cite_note-186">[186]</a></sup> Local Kano officials reported that more than fifty children died in the experiment, while many others developed mental and physical deformities.<sup id="cite_ref-187"><a href="#cite_note-187">[187]</a></sup> The nature and frequency of both fatalities and other adverse outcomes were similar to those historically found among pediatric patients treated for meningitis in sub-Saharan Africa.<sup id="cite_ref-188"><a href="#cite_note-188">[188]</a></sup> In 2001, families of the children, as well as the governments of Kano and Nigeria, filed lawsuits regarding the treatment.<sup id="cite_ref-189"><a href="#cite_note-189">[189]</a></sup> According to <i><a href="/wiki/Democracy_Now!" title="Democracy Now!">Democracy Now!</a></i>, "[r]esearchers did not obtain signed consent forms, and medical personnel said Pfizer did not tell parents their children were getting the experimental drug."<sup id="cite_ref-DN_190-0"><a href="#cite_note-DN-190">[190]</a></sup> The lawsuits also accused Pfizer of using the outbreak to perform unapproved human testing, as well as allegedly under-dosing a control group being treated with traditional antibiotics in order to skew the results of the trial in favor of Trovan. Nigerian medical personnel as well as at least one Pfizer physician said the trial was conducted without regulatory approval.<sup id="cite_ref-191"><a href="#cite_note-191">[191]</a></sup><sup id="cite_ref-192"><a href="#cite_note-192">[192]</a></sup>
</p><p>In 2007, Pfizer published a Statement of Defense letter.<sup id="cite_ref-193"><a href="#cite_note-193">[193]</a></sup> The letter stated that the drug's oral form was safer and easier to administer, that Trovan had been used safely in more than five thousand Americans prior to the Nigerian trial, that mortality in the patients treated by Pfizer was lower than that observed historically in African meningitis epidemics, and that no unusual side effects, unrelated to meningitis, were observed after four weeks.
</p><p>In June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed.<sup id="cite_ref-194"><a href="#cite_note-194">[194]</a></sup>
</p><p>In December 2010, a <a href="/wiki/United_States_diplomatic_cables_leak" title="United States diplomatic cables leak">United States diplomatic cables leak</a> was released by <a href="/wiki/WikiLeaks" title="WikiLeaks">WikiLeaks</a> indicating that Pfizer hired investigators to find evidence of corruption against Nigerian attorney general Aondoakaa to persuade him to drop legal action.<sup id="cite_ref-195"><a href="#cite_note-195">[195]</a></sup> <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i> reporter Joe Stephens, who helped break the story in 2000, called these actions "dangerously close to blackmail".<sup id="cite_ref-DN_190-1"><a href="#cite_note-DN-190">[190]</a></sup> In response, the company released a press statement describing the allegations as "preposterous" and saying that it acted in good faith.<sup id="cite_ref-196"><a href="#cite_note-196">[196]</a></sup> Aondoakka, who had allegedly demanded bribes from Pfizer in return for a settlement of the case,<sup id="cite_ref-197"><a href="#cite_note-197">[197]</a></sup> was declared unfit for office and had his U.S. visa revoked in association with corruption charges in 2010.<sup id="cite_ref-198"><a href="#cite_note-198">[198]</a></sup><sup id="cite_ref-199"><a href="#cite_note-199">[199]</a></sup>
</p><p>The lawsuits were eventually settled out of court. Pfizer committed to paying US$35 million "to compensate the families of children in the study", another US$30 million to "support healthcare initiatives in Kano", and 10 million to cover legal costs. Payouts began in 2011.<sup id="cite_ref-200"><a href="#cite_note-200">[200]</a></sup>
</p>
<h2><span id="Environmental_record">Environmental record</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=30" title="Edit section: Environmental record">edit</a><span>]</span></span></h2>
<p>Since 2000, the company has implemented more than 4,000 <a href="/wiki/Greenhouse_gas" title="Greenhouse gas">greenhouse gas</a> reduction projects.<sup id="cite_ref-201"><a href="#cite_note-201">[201]</a></sup>
</p><p>In 2012, the company was named to the <a href="/wiki/Carbon_Disclosure_Project" title="Carbon Disclosure Project">Carbon Disclosure Project</a>'s Carbon Leadership Index in recognition of its efforts to reduce <a href="/wiki/Greenhouse_gas_emissions" title="Greenhouse gas emissions">greenhouse gas emissions</a>.<sup id="cite_ref-202"><a href="#cite_note-202">[202]</a></sup>
</p><p>Pfizer has inherited Wyeth's liabilities in the <a href="/wiki/American_Cyanamid" title="American Cyanamid">American Cyanamid</a> site in <a href="/wiki/Bridgewater_Township,_New_Jersey" title="Bridgewater Township, New Jersey">Bridgewater Township, New Jersey</a>, a highly toxic EPA <a href="/wiki/Superfund" title="Superfund">Superfund</a> site. Pfizer has since attempted to remediate this land in order to clean and develop it for future profits and potential public uses.<sup id="cite_ref-203"><a href="#cite_note-203">[203]</a></sup> The <a href="/wiki/Sierra_Club" title="Sierra Club">Sierra Club</a> and the <a href="/wiki/Edison_Wetlands_Association" title="Edison Wetlands Association">Edison Wetlands Association</a> have opposed the cleanup plan, arguing that the area is subject to flooding, which could cause pollutants to leach. The EPA considers the plan the most reasonable from considerations of safety and cost-effectiveness, arguing that an alternative plan involving trucking <a href="/wiki/Contaminated_soil" title="Contaminated soil">contaminated soil</a> off site could expose cleanup workers. The EPA's position is backed by the environmental watchdog group CRISIS.<sup id="cite_ref-204"><a href="#cite_note-204">[204]</a></sup>
</p><p>In June 2002, a chemical explosion at the Groton plant injured 7 people and caused the evacuation of more than 100 homes in the surrounding area.<sup id="cite_ref-205"><a href="#cite_note-205">[205]</a></sup>
</p>
<h2><span id="Outreach">Outreach</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=31" title="Edit section: Outreach">edit</a><span>]</span></span></h2>
<h3><span id="Political_lobbying">Political lobbying</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=32" title="Edit section: Political lobbying">edit</a><span>]</span></span></h3>
<p>Pfizer is a member of the <a href="/wiki/U.S._Global_Leadership_Coalition" title="U.S. Global Leadership Coalition">U.S. Global Leadership Coalition</a>, a Washington D.C.-based coalition of more than 400 major companies and NGOs that advocates for a larger International Affairs budget, which funds American diplomatic, humanitarian, and development efforts abroad.<sup id="cite_ref-206"><a href="#cite_note-206">[206]</a></sup>
</p><p>Pfizer is a member company of <a href="/wiki/Pharmaceutical_Research_and_Manufacturers_of_America" title="Pharmaceutical Research and Manufacturers of America">Pharmaceutical Research and Manufacturers of America</a> (PhRMA), a trade association that lobbies the <a href="/wiki/U.S._Government" title="U.S. Government">U.S. Government</a> on behalf of the <a href="/wiki/Pharmaceutical_industry" title="Pharmaceutical industry">pharmaceutical industry</a>.<sup id="cite_ref-207"><a href="#cite_note-207">[207]</a></sup> PhRMA has offices in <a href="/wiki/Washington,_D.C." title="Washington, D.C.">Washington, D.C.</a>, <a href="/wiki/Japan" title="Japan">Japan</a> and the <a href="/wiki/United_Arab_Emirates" title="United Arab Emirates">United Arab Emirates</a>.<sup id="cite_ref-208"><a href="#cite_note-208">[208]</a></sup>
</p><p>Pfizer is a member organization of the <a href="/wiki/National_Health_Council" title="National Health Council">National Health Council</a>, a non-profit organization that lobbies the <a href="/wiki/U.S._Government" title="U.S. Government">U.S. Government</a> on issues related to <a href="/wiki/Healthcare_reform_in_the_United_States" title="Healthcare reform in the United States">healthcare reform</a>.<sup id="cite_ref-209"><a href="#cite_note-209">[209]</a></sup>
</p><p>Pfizer is a member organization of Research!America, a medical research advocacy group.<sup id="cite_ref-210"><a href="#cite_note-210">[210]</a></sup>
</p><p>Pfizer is a partner organization of the <a href="/wiki/World_Economic_Forum" title="World Economic Forum">World Economic Forum</a>,<sup id="cite_ref-211"><a href="#cite_note-211">[211]</a></sup> through which CEO <a href="/wiki/Albert_Bourla" title="Albert Bourla">Albert Bourla</a> wrote in 2018 about the need to explore the consequences of tech-based personalized health care through filters of society, economy and politics.<sup id="cite_ref-212"><a href="#cite_note-212">[212]</a></sup>
</p><p><a href="/wiki/Scott_Gottlieb" title="Scott Gottlieb">Scott Gottlieb</a>, who resigned as <a href="/wiki/FDA_commissioner" title="FDA commissioner">FDA commissioner</a> in April 2019, joined the Pfizer <a href="/wiki/Board_of_directors" title="Board of directors">board of directors</a> three months later, in July 2019.<sup id="cite_ref-213"><a href="#cite_note-213">[213]</a></sup>
</p><p>Pfizer is a member of the Personalized Medicine Coalition, a lobbying group with ties to members of the <a href="/wiki/United_States_Congress" title="United States Congress">United States Congress</a>.<sup id="cite_ref-214"><a href="#cite_note-214">[214]</a></sup>
</p><p>Pfizer is a member company of Innovative Medicines Canada, an association of pharmaceutical companies doing business in Canada.<sup id="cite_ref-215"><a href="#cite_note-215">[215]</a></sup> The group lobbies the <a href="/wiki/Government_of_Ontario" title="Government of Ontario">Government of Ontario</a> through Rubicon Strategy, a firm owned by <a href="/wiki/Progressive_Conservative_Party_of_Ontario" title="Progressive Conservative Party of Ontario">Progressive Conservative Party of Ontario</a> campaign manager <a href="/wiki/Kory_Teneycke" title="Kory Teneycke">Kory Teneycke</a>.<sup id="cite_ref-216"><a href="#cite_note-216">[216]</a></sup><sup id="cite_ref-217"><a href="#cite_note-217">[217]</a></sup>
</p><p>Pfizer has donated between $5,000,000 and $9,999,999 to the <a href="/wiki/Foundation_for_the_National_Institutes_of_Health" title="Foundation for the National Institutes of Health">Foundation for the National Institutes of Health</a> between 1997 and 2020.<sup id="cite_ref-218"><a href="#cite_note-218">[218]</a></sup>
</p>
<h3><span id="Media">Media</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=33" title="Edit section: Media">edit</a><span>]</span></span></h3>
<p>During the <a href="/wiki/COVID-19_pandemic" title="COVID-19 pandemic">COVID-19 pandemic</a>, Pfizer engaged many forms of media to promote their <a href="/wiki/Pfizer_COVID-19_vaccine" title="Pfizer COVID-19 vaccine">COVID-19 vaccine</a>, including paid editorial content on <a href="/wiki/CNBC" title="CNBC">CNBC</a> and a commissioned <a href="/wiki/National_Geographic" title="National Geographic">National Geographic</a> documentary.<sup id="cite_ref-219"><a href="#cite_note-219">[219]</a></sup>
</p>
<h3><span id="Public_health">Public health</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=34" title="Edit section: Public health">edit</a><span>]</span></span></h3>
<p>Pfizer is one of several pharmaceutical companies disclosed as supporters of the <a href="/wiki/Canadian_Public_Health_Association" title="Canadian Public Health Association">Canadian Public Health Association</a> in their 2018 annual report.<sup id="cite_ref-220"><a href="#cite_note-220">[220]</a></sup> 
</p><p>Pfizer has provided funding to the <a href="/wiki/Canadian_Paediatric_Society" title="Canadian Paediatric Society">Canadian Paediatric Society</a>, the organization that administers the Canadian Immunization Monitoring Program, Active (IMPACT) vaccine safety program.<sup id="cite_ref-:2_221-0"><a href="#cite_note-:2-221">[221]</a></sup> 
</p><p>Pfizer sponsored a presentation in January 2020 delivered through the <a href="/wiki/Provincial_Health_Services_Authority" title="Provincial Health Services Authority">Provincial Health Services Authority</a> titled "Vaccine hesitancy: It doesn't matter if the vaccine works if nobody gets it."<sup id="cite_ref-:2_221-1"><a href="#cite_note-:2-221">[221]</a></sup><sup id="cite_ref-222"><a href="#cite_note-222">[222]</a></sup> 
</p>
<h3><span id="Medical_research">Medical research</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=35" title="Edit section: Medical research">edit</a><span>]</span></span></h3>
<p>Pfizer is an Industry Partner of the Canadian Frailty Network,<sup id="cite_ref-223"><a href="#cite_note-223">[223]</a></sup> which has provided research grants related to <a href="/wiki/COVID-19" title="COVID-19">COVID-19</a>.<sup id="cite_ref-224"><a href="#cite_note-224">[224]</a></sup>
</p>
<h2><span id="See_also">See also</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=36" title="Edit section: See also">edit</a><span>]</span></span></h2>

<ul><li><a href="/wiki/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area" title="Biotech and pharmaceutical companies in the New York metropolitan area">Biotech and pharmaceutical companies in the New York metropolitan area</a></li>
<li><a href="/wiki/Companies_of_the_United_States_with_untaxed_profits" title="Companies of the United States with untaxed profits">Companies of the United States with untaxed profits</a></li>
<li><a href="/wiki/Fire_in_the_Blood_(2013_film)" title="Fire in the Blood (2013 film)">Fire in the Blood (2013 film)</a></li>
<li><a href="/wiki/List_of_pharmaceutical_companies" title="List of pharmaceutical companies">List of pharmaceutical companies</a></li></ul>
<h2><span id="References">References</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=37" title="Edit section: References">edit</a><span>]</span></span></h2>
<div><ol>
<li id="cite_note-10K-1"><span>^ <a href="#cite_ref-10K_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-10K_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-10K_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-10K_1-3"><sup><i><b>d</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://s21.q4cdn.com/317678438/files/doc_financials/2020/ar/PFE-2020-Form-10K-FINAL.pdf">"Pfizer Inc. 2020 Form 10-K Annual Report"</a> <span>(PDF)</span>. Pfizer.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Inc.+2020+Form+10-K+Annual+Report&amp;rft.pub=Pfizer&amp;rft_id=https%3A%2F%2Fs21.q4cdn.com%2F317678438%2Ffiles%2Fdoc_financials%2F2020%2Far%2FPFE-2020-Form-10K-FINAL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-2"><span><b><a href="#cite_ref-2">^</a></b></span> <span><cite id="CITEREFWells2008">Wells, John C. (2008), <i>Longman Pronunciation Dictionary</i> (3rd&nbsp;ed.), <a href="/wiki/Longman" title="Longman">Longman</a>, <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/9781405881180" title="Special:BookSources/9781405881180"><bdi>9781405881180</bdi></a></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Longman+Pronunciation+Dictionary&amp;rft.edition=3rd&amp;rft.pub=Longman&amp;rft.date=2008&amp;rft.isbn=9781405881180&amp;rft.aulast=Wells&amp;rft.aufirst=John+C.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-3"><span><b><a href="#cite_ref-3">^</a></b></span> <span><cite id="CITEREFBomey2020">Bomey, Nathan (August 25, 2020). <a rel="nofollow" href="https://www.usatoday.com/story/money/2020/08/25/exxon-pfizer-dow-jones-industrial-average-salesforce-djia/5630916002/">"Exxon Mobil, Pfizer removed from Dow Jones Industrial Average; Salesforce, Honeywell added"</a>. <i><a href="/wiki/USA_Today" title="USA Today">USA Today</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=USA+Today&amp;rft.atitle=Exxon+Mobil%2C+Pfizer+removed+from+Dow+Jones+Industrial+Average%3B+Salesforce%2C+Honeywell+added&amp;rft.date=2020-08-25&amp;rft.aulast=Bomey&amp;rft.aufirst=Nathan&amp;rft_id=https%3A%2F%2Fwww.usatoday.com%2Fstory%2Fmoney%2F2020%2F08%2F25%2Fexxon-pfizer-dow-jones-industrial-average-salesforce-djia%2F5630916002%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-4"><span><b><a href="#cite_ref-4">^</a></b></span> <span><cite id="CITEREFStevens2020">Stevens, Pippa (August 24, 2020). <a rel="nofollow" href="https://www.cnbc.com/2020/08/24/salesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html">"Salesforce, Amgen and Honeywell added to Dow in major shake-up to the average"</a>. <i><a href="/wiki/CNBC" title="CNBC">CNBC</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNBC&amp;rft.atitle=Salesforce%2C+Amgen+and+Honeywell+added+to+Dow+in+major+shake-up+to+the+average&amp;rft.date=2020-08-24&amp;rft.aulast=Stevens&amp;rft.aufirst=Pippa&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2020%2F08%2F24%2Fsalesforce-amgen-and-honeywell-added-to-dow-in-major-shakeup-to-the-average.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-5"><span><b><a href="#cite_ref-5">^</a></b></span> <span><cite id="CITEREFPonczekGreifeld2020">Ponczek, Sarah; Greifeld, Katherine (August 24, 2020). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.bloomberg.com/news/articles/2020-08-24/dow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013">"Exxon Booted from Dow Industrials in Major Embrace of Tech"</a></span>. <i><a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Exxon+Booted+from+Dow+Industrials+in+Major+Embrace+of+Tech&amp;rft.date=2020-08-24&amp;rft.aulast=Ponczek&amp;rft.aufirst=Sarah&amp;rft.au=Greifeld%2C+Katherine&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2020-08-24%2Fdow-industrials-kicks-out-exxon-in-biggest-shakeup-since-2013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-6"><span><b><a href="#cite_ref-6">^</a></b></span> <span>
<cite id="CITEREFLevisohn2020">Levisohn, Ben (August 25, 2020). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.barrons.com/articles/exxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204">"Exxon and Pfizer Just Got Booted From the Dow. Here's What's Replacing Them"</a></span>. <i><a href="/wiki/Barron%27s_(newspaper)" title="Barron's (newspaper)">Barron's</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Barron%27s&amp;rft.atitle=Exxon+and+Pfizer+Just+Got+Booted+From+the+Dow.+Here%27s+What%27s+Replacing+Them.&amp;rft.date=2020-08-25&amp;rft.aulast=Levisohn&amp;rft.aufirst=Ben&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fexxon-and-pfizer-just-got-booted-from-the-dow-jones-industrial-average-heres-whats-replacing-them-51598307204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-7"><span><b><a href="#cite_ref-7">^</a></b></span> <span><cite><a rel="nofollow" href="https://fortune.com/company/pfizer/fortune500/">"Fortune 500: Pfizer"</a>. <a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fortune+500%3A+Pfizer&amp;rft.pub=Fortune&amp;rft_id=https%3A%2F%2Ffortune.com%2Fcompany%2Fpfizer%2Ffortune500%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-8"><span><b><a href="#cite_ref-8">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.forbes.com/companies/pfizer/?sh=67d299422d6b">"Forbes Global 2000: Pfizer"</a>. <i><a href="/wiki/Forbes" title="Forbes">Forbes</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=Forbes+Global+2000%3A+Pfizer&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fcompanies%2Fpfizer%2F%3Fsh%3D67d299422d6b&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Citycyclopedia-9"><span>^ <a href="#cite_ref-Citycyclopedia_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Citycyclopedia_9-1"><sup><i><b>b</b></i></sup></a></span> <span>Kenneth T. Jackson. <i>The Encyclopedia of New York City</i>. The New York Historical Society; Yale University Press; September 1995. P. 895. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-300-05536-8" title="Special:BookSources/978-0-300-05536-8">978-0-300-05536-8</a></span>
</li>
<li id="cite_note-10"><span><b><a href="#cite_ref-10">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.nytimes.com/2007/01/28/nyregion/28pfizer.html">"Pfizer's Birthplace, Soon Without Pfizer"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. January 28, 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Birthplace%2C+Soon+Without+Pfizer&amp;rft.date=2007-01-28&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2007%2F01%2F28%2Fnyregion%2F28pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-collection-11"><span>^ <a href="#cite_ref-collection_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-collection_11-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="http://dlib.nyu.edu/findingaids/html/bhs/arc_084_pfizer/bioghist.html">"Guide to the Pfizer Inc. collection ARC.084"</a>. <a href="/wiki/Brooklyn_Public_Library" title="Brooklyn Public Library">Brooklyn Public Library</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guide+to+the+Pfizer+Inc.+collection+ARC.084&amp;rft.pub=Brooklyn+Public+Library&amp;rft_id=http%3A%2F%2Fdlib.nyu.edu%2Ffindingaids%2Fhtml%2Fbhs%2Farc_084_pfizer%2Fbioghist.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-history-12"><span>^ <a href="#cite_ref-history_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-history_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-history_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-history_12-3"><sup><i><b>d</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/people/history">"Our People – The Journey"</a>. <i>Pfizer</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pfizer&amp;rft.atitle=Our+People+%E2%80%93+The+Journey&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fpeople%2Fhistory&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span><span><code>{{<a href="/wiki/Template:Cite_web" title="Template:Cite web">cite web</a>}}</code>:  CS1 maint: url-status (<a href="/wiki/Category:CS1_maint:_url-status" title="Category:CS1 maint: url-status">link</a>)</span></span>
</li>
<li id="cite_note-Fermentation-13"><span>^ <a href="#cite_ref-Fermentation_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fermentation_13-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.acs.org/content/acs/en/education/whatischemistry/landmarks/penicillin.html">"Penicillin Production through Deep-tank Fermentation – National Historic Chemical Landmark"</a>. <a href="/wiki/American_Chemical_Society" title="American Chemical Society">American Chemical Society</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Penicillin+Production+through+Deep-tank+Fermentation+%E2%80%93+National+Historic+Chemical+Landmark&amp;rft.pub=American+Chemical+Society&amp;rft_id=https%3A%2F%2Fwww.acs.org%2Fcontent%2Facs%2Fen%2Feducation%2Fwhatischemistry%2Flandmarks%2Fpenicillin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-14"><span><b><a href="#cite_ref-14">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.drugs.com/monograph/fluconazole.html">"Fluconazole"</a>. The American Society of Health-System Pharmacists. <a rel="nofollow" href="https://web.archive.org/web/20161220231218/https://www.drugs.com/monograph/fluconazole.html">Archived</a> from the original on December 20, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Fluconazole&amp;rft.pub=The+American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Ffluconazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-best-15"><span><b><a href="#cite_ref-best_15-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.wipo.int/ipadvantage/en/details.jsp?id=906">"Azithromycin: A world best-selling Antibiotic"</a>. <a href="/wiki/World_Intellectual_Property_Organization" title="World Intellectual Property Organization">World Intellectual Property Organization</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Azithromycin%3A+A+world+best-selling+Antibiotic&amp;rft.pub=World+Intellectual+Property+Organization&amp;rft_id=https%3A%2F%2Fwww.wipo.int%2Fipadvantage%2Fen%2Fdetails.jsp%3Fid%3D906&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-16"><span><b><a href="#cite_ref-16">^</a></b></span> <span><cite id="CITEREFMandellWunderinkAnzueto2007">Mandell LA, Wunderink RG, Anzueto A,  et&nbsp;al. (March 2007). <a rel="nofollow" href="https://www.thoracic.org/statements/resources/mtpi/idsaats-cap.pdf">"Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults"</a> <span>(PDF)</span>. <i>Clin. Infect. Dis</i>. 44 Suppl 2: S27–72. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1086%2F511159">10.1086/511159</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC7107997">7107997</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/17278083">17278083</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin.+Infect.+Dis.&amp;rft.atitle=Infectious+Diseases+Society+of+America%2FAmerican+Thoracic+Society+consensus+guidelines+on+the+management+of+community-acquired+pneumonia+in+adults&amp;rft.volume=44+Suppl+2&amp;rft.pages=S27-72&amp;rft.date=2007-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7107997%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17278083&amp;rft_id=info%3Adoi%2F10.1086%2F511159&amp;rft.aulast=Mandell&amp;rft.aufirst=LA&amp;rft.au=Wunderink%2C+RG&amp;rft.au=Anzueto%2C+A&amp;rft_id=https%3A%2F%2Fwww.thoracic.org%2Fstatements%2Fresources%2Fmtpi%2Fidsaats-cap.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-17"><span><b><a href="#cite_ref-17">^</a></b></span> <span><cite id="CITEREFWilson2013">Wilson, Jacque (March 27, 2013). <a rel="nofollow" href="https://www.cnn.com/2013/03/27/health/viagra-anniversary-timeline/index.html">"Viagra: The little blue pill that could"</a>. <i><a href="/wiki/CNN" title="CNN">CNN</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Viagra%3A+The+little+blue+pill+that+could&amp;rft.date=2013-03-27&amp;rft.aulast=Wilson&amp;rft.aufirst=Jacque&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2013%2F03%2F27%2Fhealth%2Fviagra-anniversary-timeline%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-18"><span><b><a href="#cite_ref-18">^</a></b></span> <span><cite id="CITEREFCox2019">Cox, David (June 9, 2019). <a rel="nofollow" href="https://www.theguardian.com/science/2019/jun/09/race-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon">"The race to replace Viagra"</a>. <i><a href="/wiki/The_Guardian" title="The Guardian">The Guardian</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=The+race+to+replace+Viagra&amp;rft.date=2019-06-09&amp;rft.aulast=Cox&amp;rft.aufirst=David&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fscience%2F2019%2Fjun%2F09%2Frace-to-replace-viagra-patents-erectile-dysfunction-drug-medical-research-cialis-eroxon&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-19"><span><b><a href="#cite_ref-19">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.latimes.com/archives/la-xpm-1991-03-29-fi-903-story.html">"Pfizer Inc., New York, has elected its..."</a> <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i>. March 29, 1991.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer+Inc.%2C+New+York%2C+has+elected+its...&amp;rft.date=1991-03-29&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Farchives%2Fla-xpm-1991-03-29-fi-903-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-20"><span><b><a href="#cite_ref-20">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.reed.edu/reed-magazine/in-memoriam/obituaries/_online_only/kenneth-koe-1945.html">"Kenneth Koe '45"</a>. <i>Reed Magazine</i>. <a href="/wiki/Reed_College" title="Reed College">Reed College</a>. December 2015<span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reed+Magazine&amp;rft.atitle=Kenneth+Koe+%2745&amp;rft.date=2015-12&amp;rft_id=https%3A%2F%2Fwww.reed.edu%2Freed-magazine%2Fin-memoriam%2Fobituaries%2F_online_only%2Fkenneth-koe-1945.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span><span><code>{{<a href="/wiki/Template:Cite_web" title="Template:Cite web">cite web</a>}}</code>:  CS1 maint: url-status (<a href="/wiki/Category:CS1_maint:_url-status" title="Category:CS1 maint: url-status">link</a>)</span></span>
</li>
<li id="cite_note-21"><span><b><a href="#cite_ref-21">^</a></b></span> <span><cite id="CITEREFSmith2006">Smith, Aaron (April 4, 2006). <a rel="nofollow" href="https://money.cnn.com/2006/04/04/news/companies/antidepressants/">"Who stands to gain when Zoloft goes generic?"</a>. <i><a href="/wiki/CNN_Money" title="CNN Money">CNN Money</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN+Money&amp;rft.atitle=Who+stands+to+gain+when+Zoloft+goes+generic%3F&amp;rft.date=2006-04-04&amp;rft.aulast=Smith&amp;rft.aufirst=Aaron&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F04%2F04%2Fnews%2Fcompanies%2Fantidepressants%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-22"><span><b><a href="#cite_ref-22">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020690s035,021720s008,022568s005lbl.pdf">"Highlights of Prescribing Information"</a> <span>(PDF)</span>. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Highlights+of+Prescribing+Information&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Flabel%2F2012%2F020690s035%2C021720s008%2C022568s005lbl.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-23"><span><b><a href="#cite_ref-23">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/19-787s007_Amlodipine.cfm">"Drug Approval Package"</a>. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F96%2F19-787s007_Amlodipine.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-24"><span><b><a href="#cite_ref-24">^</a></b></span> <span><cite id="CITEREFMehta2011">Mehta, Praful (November 29, 2011). <a rel="nofollow" href="https://ihsmarkit.com/research-analysis/lipitor-patent-expiration-atorvastatin-sales.html">"Lipitor Patent Expiration - The End of an Era for Atorvastatin Sales"</a>. <i><a href="/wiki/IHS_Markit" title="IHS Markit">IHS Markit</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=IHS+Markit&amp;rft.atitle=Lipitor+Patent+Expiration+-+The+End+of+an+Era+for+Atorvastatin+Sales&amp;rft.date=2011-11-29&amp;rft.aulast=Mehta&amp;rft.aufirst=Praful&amp;rft_id=https%3A%2F%2Fihsmarkit.com%2Fresearch-analysis%2Flipitor-patent-expiration-atorvastatin-sales.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-longshot-25"><span>^ <a href="#cite_ref-longshot_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-longshot_25-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFBerenson2006"><a href="/wiki/Alex_Berenson" title="Alex Berenson">Berenson, Alex</a> (July 29, 2006). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2006/07/29/business/29pfizer.html">"A Long Shot Becomes Pfizer's Latest Chief Executive"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Long+Shot+Becomes+Pfizer%27s+Latest+Chief+Executive&amp;rft.date=2006-07-29&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F07%2F29%2Fbusiness%2F29pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-26"><span><b><a href="#cite_ref-26">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.drugs.com/monograph/pregabalin.html">"Pregabalin"</a>. <a href="/wiki/American_Society_of_Health-System_Pharmacists" title="American Society of Health-System Pharmacists">American Society of Health-System Pharmacists</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pregabalin&amp;rft.pub=American+Society+of+Health-System+Pharmacists&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fpregabalin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-27"><span><b><a href="#cite_ref-27">^</a></b></span> <span><cite id="CITEREFFrampton2014">Frampton, James E. (September 2014). "Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder". <i>CNS Drugs</i>. <b>28</b> (9): 835–854. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1007%2Fs40263-014-0192-0">10.1007/s40263-014-0192-0</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/25149863">25149863</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:5349255">5349255</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNS+Drugs&amp;rft.atitle=Pregabalin%3A+A+Review+of+its+Use+in+Adults+with+Generalized+Anxiety+Disorder&amp;rft.volume=28&amp;rft.issue=9&amp;rft.pages=835-854&amp;rft.date=2014-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5349255%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25149863&amp;rft_id=info%3Adoi%2F10.1007%2Fs40263-014-0192-0&amp;rft.aulast=Frampton&amp;rft.aufirst=James+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-28"><span><b><a href="#cite_ref-28">^</a></b></span> <span><cite id="CITEREFIftikharAlghothaniTrotti2017">Iftikhar, I. H.; Alghothani, L.; Trotti, L. M. (December 2017). "Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis". <i>European Journal of Neurology</i>. <b>24</b> (12): 1446–1456. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1111%2Fene.13449">10.1111/ene.13449</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/28888061">28888061</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:22262972">22262972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Neurology&amp;rft.atitle=Gabapentin+enacarbil%2C+pregabalin+and+rotigotine+are+equally+effective+in+restless+legs+syndrome%3A+a+comparative+meta-analysis&amp;rft.volume=24&amp;rft.issue=12&amp;rft.pages=1446-1456&amp;rft.date=2017-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22262972%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28888061&amp;rft_id=info%3Adoi%2F10.1111%2Fene.13449&amp;rft.aulast=Iftikhar&amp;rft.aufirst=I.+H.&amp;rft.au=Alghothani%2C+L.&amp;rft.au=Trotti%2C+L.+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-29"><span><b><a href="#cite_ref-29">^</a></b></span> <span><cite id="CITEREFDecker2014">Decker, Susan (February 6, 2014). <span title="Paid subscription required"><a rel="nofollow" href="https://www.bloomberg.com/news/2014-02-06/pfizer-wins-ruling-to-block-generic-lyrica-until-2018.html">"Pfizer Wins Ruling to Block Generic Lyrica Until 2018"</a></span>. <i><a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Wins+Ruling+to+Block+Generic+Lyrica+Until+2018&amp;rft.date=2014-02-06&amp;rft.aulast=Decker&amp;rft.aufirst=Susan&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-02-06%2Fpfizer-wins-ruling-to-block-generic-lyrica-until-2018.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-30"><span><b><a href="#cite_ref-30">^</a></b></span> <span><cite id="CITEREFSpeights2017">Speights, Keith (April 17, 2017). <a rel="nofollow" href="https://www.fool.com/investing/2017/04/17/how-pfizer-inc-makes-most-of-its-money.aspx">"How Pfizer Inc. Makes Most of Its Money"</a>. <i><a href="/wiki/The_Motley_Fool" title="The Motley Fool">The Motley Fool</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Motley+Fool&amp;rft.atitle=How+Pfizer+Inc.+Makes+Most+of+Its+Money&amp;rft.date=2017-04-17&amp;rft.aulast=Speights&amp;rft.aufirst=Keith&amp;rft_id=https%3A%2F%2Fwww.fool.com%2Finvesting%2F2017%2F04%2F17%2Fhow-pfizer-inc-makes-most-of-its-money.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-31"><span><b><a href="#cite_ref-31">^</a></b></span> <span><cite><a rel="nofollow" href="https://money.cnn.com/2006/07/28/news/companies/pfizer_ceo/index.htm">"Pfizer names new CEO"</a>. <i><a href="/wiki/CNN" title="CNN">CNN</a></i>. July 28, 2006.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+names+new+CEO&amp;rft.date=2006-07-28&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2006%2F07%2F28%2Fnews%2Fcompanies%2Fpfizer_ceo%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-32"><span><b><a href="#cite_ref-32">^</a></b></span> <span><cite id="CITEREFBerensonPollack2006">Berenson, Alex; Pollack, Andrew (December 5, 2006). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2006/12/05/health/05pfizer.html">"Pfizer Shares Plummet on Loss of a Promising Heart Drug"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Shares+Plummet+on+Loss+of+a+Promising+Heart+Drug&amp;rft.date=2006-12-05&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft.au=Pollack%2C+Andrew&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F05%2Fhealth%2F05pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-33"><span><b><a href="#cite_ref-33">^</a></b></span> <span><cite id="CITEREFBerenson2006"><a href="/wiki/Alex_Berenson" title="Alex Berenson">Berenson, Alex</a> (December 3, 2006). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2006/12/03/health/03pfizer.html">"Pfizer Ends Studies on Drug for Heart Disease"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Ends+Studies+on+Drug+for+Heart+Disease&amp;rft.date=2006-12-03&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2006%2F12%2F03%2Fhealth%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-34"><span><b><a href="#cite_ref-34">^</a></b></span> <span><cite id="CITEREFAgovino2006">Agovino, Theresa (December 3, 2006). <a rel="nofollow" href="https://www.seattletimes.com/nation-world/cholesterol-drug-trials-are-halted/">"Pfizer ends cholesterol drug development"</a>. <a href="/wiki/The_Seattle_Times" title="The Seattle Times">The Seattle Times</a>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+ends+cholesterol+drug+development&amp;rft.date=2006-12-03&amp;rft.aulast=Agovino&amp;rft.aufirst=Theresa&amp;rft_id=https%3A%2F%2Fwww.seattletimes.com%2Fnation-world%2Fcholesterol-drug-trials-are-halted%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-35"><span><b><a href="#cite_ref-35">^</a></b></span> <span><cite id="CITEREFTanne2006">Tanne, Janice Hopkins (December 16, 2006). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474">"Pfizer stops clinical trials of heart drug"</a>. <i>BMJ</i>. <b>333</b> (7581): 1237.2–1237. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1136%2Fbmj.39059.438044.DB">10.1136/bmj.39059.438044.DB</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1702474">1702474</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/17170401">17170401</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+stops+clinical+trials+of+heart+drug&amp;rft.volume=333&amp;rft.issue=7581&amp;rft.pages=1237.2-1237&amp;rft.date=2006-12-16&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F17170401&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.39059.438044.DB&amp;rft.aulast=Tanne&amp;rft.aufirst=Janice+Hopkins&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1702474&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-36"><span><b><a href="#cite_ref-36">^</a></b></span> <span><cite id="CITEREFBennett2010">Bennett, Simeon (July 8, 2010). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.bloomberg.com/news/articles/2010-07-08/pfizer-civil-suits-for-drug-counterfeiters">"Pfizer: Civil Suits for Drug Counterfeiters"</a></span>. <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=Pfizer%3A+Civil+Suits+for+Drug+Counterfeiters&amp;rft.date=2010-07-08&amp;rft.aulast=Bennett&amp;rft.aufirst=Simeon&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2010-07-08%2Fpfizer-civil-suits-for-drug-counterfeiters&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-37"><span><b><a href="#cite_ref-37">^</a></b></span> <span><cite id="CITEREFJones2008">Jones, Al (July 15, 2008). <a rel="nofollow" href="https://www.mlive.com/kzgazette/2008/07/pfizer_job_cuts_dont_equal_a_r.html">"Pfizer job cuts don't equal a reduction in work load, says company spokesman"</a>. <i><a href="/wiki/Booth_Newspapers" title="Booth Newspapers">Booth Newspapers</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Booth+Newspapers&amp;rft.atitle=Pfizer+job+cuts+don%27t+equal+a+reduction+in+work+load%2C+says+company+spokesman&amp;rft.date=2008-07-15&amp;rft.aulast=Jones&amp;rft.aufirst=Al&amp;rft_id=https%3A%2F%2Fwww.mlive.com%2Fkzgazette%2F2008%2F07%2Fpfizer_job_cuts_dont_equal_a_r.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-:0-38"><span>^ <a href="#cite_ref-:0_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_38-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://money.cnn.com/2003/04/16/news/companies/pfizer_pharma/">"It's official: Pfizer buys Pharmacia"</a>. <i><a href="/wiki/CNN" title="CNN">CNN</a></i>. April 16, 2003.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=It%27s+official%3A+Pfizer+buys+Pharmacia&amp;rft.date=2003-04-16&amp;rft_id=https%3A%2F%2Fmoney.cnn.com%2F2003%2F04%2F16%2Fnews%2Fcompanies%2Fpfizer_pharma%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-39"><span><b><a href="#cite_ref-39">^</a></b></span> <span><cite id="CITEREFHensley2000">Hensley, Scott (June 20, 2000). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/SB961456765639278103">"Pfizer Completes Stormy Takeover Of Warner-Lambert for $116 Billion"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Completes+Stormy+Takeover+Of+Warner-Lambert+for+%24116+Billion&amp;rft.date=2000-06-20&amp;rft.aulast=Hensley&amp;rft.aufirst=Scott&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB961456765639278103&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-40"><span><b><a href="#cite_ref-40">^</a></b></span> <span><cite id="CITEREFCampbell2017">Campbell, Todd (May 15, 2017). <a rel="nofollow" href="https://www.businessinsider.com/here-are-the-7-biggest-mergers-of-all-time-2017-5#6-warner-lambert-warms-up-to-pfizer-89-billion-2">"Here are the 7 biggest mergers of all time"</a>. <a href="/wiki/Business_Insider" title="Business Insider">Business Insider</a>. <a href="/wiki/The_Motley_Fool" title="The Motley Fool">The Motley Fool</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Here+are+the+7+biggest+mergers+of+all+time&amp;rft.date=2017-05-15&amp;rft.aulast=Campbell&amp;rft.aufirst=Todd&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fhere-are-the-7-biggest-mergers-of-all-time-2017-5%236-warner-lambert-warms-up-to-pfizer-89-billion-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-41"><span><b><a href="#cite_ref-41">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.drugs.com/monograph/metronidazole.html">"Metronidazole Monograph for Professionals"</a>. <a href="/wiki/Drugs.com" title="Drugs.com">Drugs.com</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Metronidazole+Monograph+for+Professionals&amp;rft.pub=Drugs.com&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fmetronidazole.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-42"><span><b><a href="#cite_ref-42">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.drugs.com/monograph/celecoxib.html">"Celecoxib Monograph for Professionals"</a>. <i>Drugs.com</i>. American Society of Health-System Pharmacists. November 11, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Drugs.com&amp;rft.atitle=Celecoxib+Monograph+for+Professionals&amp;rft.date=2019-11-11&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Fmonograph%2Fcelecoxib.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-43"><span><b><a href="#cite_ref-43">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bloomberg.com/news/articles/2005-11-20/the-spirit-of-a-startup-lives-on">"The Spirit Of A Startup Lives On"</a>. <i><a href="/wiki/Bloomberg_Businessweek" title="Bloomberg Businessweek">Bloomberg Businessweek</a></i>. November 21, 2005.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+Businessweek&amp;rft.atitle=The+Spirit+Of+A+Startup+Lives+On&amp;rft.date=2005-11-21&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2005-11-20%2Fthe-spirit-of-a-startup-lives-on&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-44"><span><b><a href="#cite_ref-44">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bizjournals.com/sanfrancisco/stories/2003/04/28/daily24.html">"Pfizer expects to shutter South City biotech outpost"</a>. <i><a href="/wiki/American_City_Business_Journals" title="American City Business Journals">American City Business Journals</a></i>. April 30, 2003.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Pfizer+expects+to+shutter+South+City+biotech+outpost&amp;rft.date=2003-04-30&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Fsanfrancisco%2Fstories%2F2003%2F04%2F28%2Fdaily24.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-45"><span><b><a href="#cite_ref-45">^</a></b></span> <span><cite id="CITEREFRockoff2011">Rockoff, Jonathan D. (August 26, 2011). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/SB10001424053111904009304576532892704206326">"FDA Approves Pfizer Lung-Cancer Drug"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=FDA+Approves+Pfizer+Lung-Cancer+Drug&amp;rft.date=2011-08-26&amp;rft.aulast=Rockoff&amp;rft.aufirst=Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424053111904009304576532892704206326&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-46"><span><b><a href="#cite_ref-46">^</a></b></span> <span><cite id="CITEREFMortlockWilsonKettleGoldberg2017">Mortlock, A.A.; Wilson, D.M.; Kettle, J.G.; Goldberg, F.W.; Foote, K.M. (2017). "Selective Kinase Inhibitors in Cancer". <i>Comprehensive Medicinal Chemistry III</i>. pp.&nbsp;39–75. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1016%2FB978-0-12-409547-2.12391-1">10.1016/B978-0-12-409547-2.12391-1</a>. <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/978-0-12-803201-5" title="Special:BookSources/978-0-12-803201-5"><bdi>978-0-12-803201-5</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Selective+Kinase+Inhibitors+in+Cancer&amp;rft.btitle=Comprehensive+Medicinal+Chemistry+III&amp;rft.pages=39-75&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.1016%2FB978-0-12-409547-2.12391-1&amp;rft.isbn=978-0-12-803201-5&amp;rft.aulast=Mortlock&amp;rft.aufirst=A.A.&amp;rft.au=Wilson%2C+D.M.&amp;rft.au=Kettle%2C+J.G.&amp;rft.au=Goldberg%2C+F.W.&amp;rft.au=Foote%2C+K.M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-47"><span><b><a href="#cite_ref-47">^</a></b></span> <span><cite id="CITEREFBarriaux2006">Barriaux, Marianne (October 9, 2006). <a rel="nofollow" href="https://www.theguardian.com/business/2006/oct/09/money5">"Pfizer buys vaccine developer PowderMed"</a>. <i><a href="/wiki/The_Guardian" title="The Guardian">The Guardian</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=Pfizer+buys+vaccine+developer+PowderMed&amp;rft.date=2006-10-09&amp;rft.aulast=Barriaux&amp;rft.aufirst=Marianne&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2006%2Foct%2F09%2Fmoney5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-48"><span><b><a href="#cite_ref-48">^</a></b></span> <span><cite id="CITEREFSorkinWilson2009"><a href="/wiki/Andrew_Ross_Sorkin" title="Andrew Ross Sorkin">Sorkin, Andrew Ross</a>; <a href="/wiki/Duff_Wilson" title="Duff Wilson">Wilson, Duff</a> (January 25, 2009). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2009/01/26/business/26drug.html">"Pfizer Agrees to Pay $68 Billion for Rival Drug Maker Wyeth"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/0362-4331">0362-4331</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Agrees+to+Pay+%2468+Billion+for+Rival+Drug+Maker+Wyeth&amp;rft.date=2009-01-25&amp;rft.issn=0362-4331&amp;rft.aulast=Sorkin&amp;rft.aufirst=Andrew+Ross&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F26%2Fbusiness%2F26drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-49"><span><b><a href="#cite_ref-49">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.reuters.com/article/instant-article/idUSTRE59E4S320091015">"Pfizer completes $67 billion deal for rival Wyeth"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>. October 15, 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+completes+%2467+billion+deal+for+rival+Wyeth&amp;rft.date=2009-10-15&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Finstant-article%2FidUSTRE59E4S320091015&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-50"><span><b><a href="#cite_ref-50">^</a></b></span> <span><cite id="CITEREFKarnitschnigRockoff2009">Karnitschnig, Matthew; Rockoff, Jonathan D. (January 23, 2009). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/SB123268511212809429">"Pfizer in Talks to Buy Wyeth"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+in+Talks+to+Buy+Wyeth&amp;rft.date=2009-01-23&amp;rft.aulast=Karnitschnig&amp;rft.aufirst=Matthew&amp;rft.au=Rockoff%2C+Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB123268511212809429&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-worst-51"><span><b><a href="#cite_ref-worst_51-0">^</a></b></span> <span><cite id="CITEREFEdwards2009">Edwards, Jim (January 23, 2009). <a rel="nofollow" href="https://www.cbsnews.com/news/the-pfizer-wyeth-deal-worst-case-scenario/">"The Pfizer–Wyeth Deal Worst-Case Scenario"</a>. <i><a href="/wiki/CBS_News" title="CBS News">CBS News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=The+Pfizer%E2%80%93Wyeth+Deal+Worst-Case+Scenario&amp;rft.date=2009-01-23&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fthe-pfizer-wyeth-deal-worst-case-scenario%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-wyethpr-52"><span>^ <a href="#cite_ref-wyethpr_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-wyethpr_52-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_wyeth">"PFIZER COMPLETES ACQUISITION OF WYETH"</a> (Press release). Pfizer. October 14, 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=PFIZER+COMPLETES+ACQUISITION+OF+WYETH&amp;rft.pub=Pfizer&amp;rft.date=2009-10-14&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_completes_acquisition_of_wyeth&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-cdc.gov-53"><span><b><a href="#cite_ref-cdc.gov_53-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cdc.gov/abcs/reports-findings/surv-reports.html">"CDC – ABCs: Surveillance Reports main page – Active Bacterial Core surveillance"</a>. April 5, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=CDC+%E2%80%93+ABCs%3A+Surveillance+Reports+main+page+%E2%80%93+Active+Bacterial+Core+surveillance&amp;rft.date=2019-04-05&amp;rft_id=https%3A%2F%2Fwww.cdc.gov%2Fabcs%2Freports-findings%2Fsurv-reports.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-54"><span><b><a href="#cite_ref-54">^</a></b></span> <span><cite id="CITEREFHerper2020">Herper, Matthew (August 24, 2020). <a rel="nofollow" href="https://www.statnews.com/2020/08/24/pfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit/">"In the race for a Covid-19 vaccine, Pfizer turns to a scientist with a history of defying skeptics – and getting results"</a>. <i><a href="/wiki/Stat_(website)" title="Stat (website)">Stat</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Stat&amp;rft.atitle=In+the+race+for+a+Covid-19+vaccine%2C+Pfizer+turns+to+a+scientist+with+a+history+of+defying+skeptics+%E2%80%93+and+getting+results&amp;rft.date=2020-08-24&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.statnews.com%2F2020%2F08%2F24%2Fpfizer-edge-in-the-race-for-a-covid-19-vaccine-could-be-a-scientist-with-two-best-sellers-to-her-credit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-55"><span><b><a href="#cite_ref-55">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20190927005072/en/Ian-Read-to-Retire-as-Executive-Chairman-of-Pfizer%E2%80%99s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman">"Ian Read to Retire as Executive Chairman of Pfizer's Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman"</a> (Press release). <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>. September 27, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Ian+Read+to+Retire+as+Executive+Chairman+of+Pfizer%27s+Board+of+Directors%3B+Chief+Executive+Officer+Dr.+Albert+Bourla+Named+Chairman&amp;rft.pub=Business+Wire&amp;rft.date=2019-09-27&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190927005072%2Fen%2FIan-Read-to-Retire-as-Executive-Chairman-of-Pfizer%25E2%2580%2599s-Board-of-Directors-Chief-Executive-Officer-Dr.-Albert-Bourla-Named-Chairman&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-56"><span><b><a href="#cite_ref-56">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bbc.co.uk/news/business-12335801">"Pfizer to close UK research site"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. February 1, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+close+UK+research+site&amp;rft.date=2011-02-01&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-12335801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-57"><span><b><a href="#cite_ref-57">^</a></b></span> <span><cite id="CITEREFMckinney2011">Mckinney, Maureen (March 1, 2011). <a rel="nofollow" href="https://www.modernhealthcare.com/article/20110301/NEWS/303019922/pfizer-closes-king-pharmaceuticals-acquisition">"Pfizer closes King Pharmaceuticals acquisition"</a>. <i><a href="/wiki/Modern_Healthcare" title="Modern Healthcare">Modern Healthcare</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Modern+Healthcare&amp;rft.atitle=Pfizer+closes+King+Pharmaceuticals+acquisition&amp;rft.date=2011-03-01&amp;rft.aulast=Mckinney&amp;rft.aufirst=Maureen&amp;rft_id=https%3A%2F%2Fwww.modernhealthcare.com%2Farticle%2F20110301%2FNEWS%2F303019922%2Fpfizer-closes-king-pharmaceuticals-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-58"><span><b><a href="#cite_ref-58">^</a></b></span> <span><cite id="CITEREFYukhananov2012">Yukhananov, Anna (September 4, 2012). <a rel="nofollow" href="https://www.reuters.com/article/us-pfizer-leukemia/fda-approves-pfizer-leukemia-drug-idUSBRE88314720120904">"FDA approves Pfizer leukemia drug"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=FDA+approves+Pfizer+leukemia+drug&amp;rft.date=2012-09-04&amp;rft.aulast=Yukhananov&amp;rft.aufirst=Anna&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-leukemia%2Ffda-approves-pfizer-leukemia-drug-idUSBRE88314720120904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-59"><span><b><a href="#cite_ref-59">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203214orig1s000toc.cfm">"Drug Approval Package"</a>. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Drug+Approval+Package&amp;rft.pub=Food+and+Drug+Administration&amp;rft_id=https%3A%2F%2Fwww.accessdata.fda.gov%2Fdrugsatfda_docs%2Fnda%2F2012%2F203214orig1s000toc.cfm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-60"><span><b><a href="#cite_ref-60">^</a></b></span> <span><cite id="CITEREFSagonowsky2019">Sagonowsky, Eric (February 20, 2019). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/postmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns">"Pfizer switches RA patients to lower dose of fast-growing Xeljanz as safety issues arise in postmarketing study"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+switches+RA+patients+to+lower+dose+of+fast-growing+Xeljanz+as+safety+issues+arise+in+postmarketing+study&amp;rft.date=2019-02-20&amp;rft.aulast=Sagonowsky&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpostmarketing-study-pfizer-switches-ra-patients-to-lower-xeljanz-dose-safety-concerns&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-61"><span><b><a href="#cite_ref-61">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.zoetisus.com/news-and-media/zoetis-files-ipo-registration-statement.aspx">"Zoetis™ Files IPO Registration Statement"</a> (Press release). <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>. August 13, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Zoetis%E2%84%A2+Files+IPO+Registration+Statement&amp;rft.pub=Business+Wire&amp;rft.date=2012-08-13&amp;rft_id=https%3A%2F%2Fwww.zoetisus.com%2Fnews-and-media%2Fzoetis-files-ipo-registration-statement.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-62"><span><b><a href="#cite_ref-62">^</a></b></span> <span><cite id="CITEREFJ._de_la_Merced2013">J. de la Merced, Michael (February 1, 2013). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://dealbook.nytimes.com/2013/02/01/shares-of-zoetis-surge-on-debut/">"Shares of Zoetis Surge on Debut"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Shares+of+Zoetis+Surge+on+Debut&amp;rft.date=2013-02-01&amp;rft.aulast=J.+de+la+Merced&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2013%2F02%2F01%2Fshares-of-zoetis-surge-on-debut%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-63"><span><b><a href="#cite_ref-63">^</a></b></span> <span><cite id="CITEREFDieterich2013">Dieterich, Chris (January 31, 2013). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/SB10001424127887323701904578276530830057770">"Zoetis Raises $2.2 Billion in IPO"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Zoetis+Raises+%242.2+Billion+in+IPO&amp;rft.date=2013-01-31&amp;rft.aulast=Dieterich&amp;rft.aufirst=Chris&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323701904578276530830057770&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-64"><span><b><a href="#cite_ref-64">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cbsnews.com/news/shares-of-animal-health-company-zoetis-soar-in-ipo/">"Shares of animal health company Zoetis soar in IPO"</a>. <a href="/wiki/CBS_News" title="CBS News">CBS News</a>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a>. February 1, 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Shares+of+animal+health+company+Zoetis+soar+in+IPO&amp;rft.date=2013-02-01&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fshares-of-animal-health-company-zoetis-soar-in-ipo%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-65"><span><b><a href="#cite_ref-65">^</a></b></span> <span><cite id="CITEREFLoftus2013">Loftus, Peter (May 22, 2013). <a rel="nofollow" href="https://www.wsj.com/articles/SB10001424127887323975004578498994013821124">"Pfizer to Spin Off Remaining Zoetis Stake"</a>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Spin+Off+Remaining+Zoetis+Stake&amp;rft.date=2013-05-22&amp;rft.aulast=Loftus&amp;rft.aufirst=Peter&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2FSB10001424127887323975004578498994013821124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-66"><span><b><a href="#cite_ref-66">^</a></b></span> <span><cite id="CITEREFHumerPierson2013">Humer, Caroline; Pierson, Ransdell (May 22, 2013). <a rel="nofollow" href="https://www.reuters.com/article/us-pfizer-zoetis/pfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522">"Pfizer to spin off Zoetis stake to shareholders"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+spin+off+Zoetis+stake+to+shareholders&amp;rft.date=2013-05-22&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Pierson%2C+Ransdell&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-zoetis%2Fpfizer-to-spin-off-zoetis-stake-to-shareholders-idUSBRE94L0JB20130522&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-67"><span><b><a href="#cite_ref-67">^</a></b></span> <span><cite id="CITEREFWasserman2014">Wasserman, Emily (September 29, 2014). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/pfizer-completes-acquisition-of-innopharma">"Pfizer Completes Acquisition Of InnoPharma"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+Completes+Acquisition+Of+InnoPharma&amp;rft.date=2014-09-29&amp;rft.aulast=Wasserman&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-completes-acquisition-of-innopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-68"><span><b><a href="#cite_ref-68">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-to-acquire-innopharma-for-up-to-360m/">"Pfizer to Acquire InnoPharma for Up to $360M"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. July 16, 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+InnoPharma+for+Up+to+%24360M&amp;rft.date=2014-07-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-innopharma-for-up-to-360m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-69"><span><b><a href="#cite_ref-69">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/topics/drug-discovery/pfizer-buys-redvax-boosting-vaccine-portfolio/">"Pfizer Buys Redvax, Boosting Vaccine Portfolio"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. January 5, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Redvax%2C+Boosting+Vaccine+Portfolio&amp;rft.date=2015-01-05&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-redvax-boosting-vaccine-portfolio%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-70"><span><b><a href="#cite_ref-70">^</a></b></span> <span><cite id="CITEREFBeaverAmiri-KordestaniCharlabChen2015">Beaver, Julia A.; Amiri-Kordestani, Laleh; Charlab, Rosane; Chen, Wei; Palmby, Todd; Tilley, Amy; Zirkelbach, Jeanne Fourie; Yu, Jingyu; Liu, Qi; Zhao, Liang; Crich, Joyce; Chen, Xiao Hong; Hughes, Minerva; Bloomquist, Erik; Tang, Shenghui; Sridhara, Rajeshwari; Kluetz, Paul G.; Kim, Geoffrey; Ibrahim, Amna; Pazdur, Richard; Cortazar, Patricia (November 1, 2015). <a rel="nofollow" href="https://doi.org/10.1158%2F1078-0432.CCR-15-1185">"FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer"</a>. <i>Clinical Cancer Research</i>. <b>21</b> (21): 4760–4766. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1158%2F1078-0432.CCR-15-1185">10.1158/1078-0432.CCR-15-1185</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/26324739">26324739</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:24762535">24762535</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Cancer+Research&amp;rft.atitle=FDA+Approval%3A+Palbociclib+for+the+Treatment+of+Postmenopausal+Patients+with+Estrogen+Receptor%E2%80%93Positive%2C+HER2-Negative+Metastatic+Breast+Cancer&amp;rft.volume=21&amp;rft.issue=21&amp;rft.pages=4760-4766&amp;rft.date=2015-11-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24762535%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26324739&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-15-1185&amp;rft.aulast=Beaver&amp;rft.aufirst=Julia+A.&amp;rft.au=Amiri-Kordestani%2C+Laleh&amp;rft.au=Charlab%2C+Rosane&amp;rft.au=Chen%2C+Wei&amp;rft.au=Palmby%2C+Todd&amp;rft.au=Tilley%2C+Amy&amp;rft.au=Zirkelbach%2C+Jeanne+Fourie&amp;rft.au=Yu%2C+Jingyu&amp;rft.au=Liu%2C+Qi&amp;rft.au=Zhao%2C+Liang&amp;rft.au=Crich%2C+Joyce&amp;rft.au=Chen%2C+Xiao+Hong&amp;rft.au=Hughes%2C+Minerva&amp;rft.au=Bloomquist%2C+Erik&amp;rft.au=Tang%2C+Shenghui&amp;rft.au=Sridhara%2C+Rajeshwari&amp;rft.au=Kluetz%2C+Paul+G.&amp;rft.au=Kim%2C+Geoffrey&amp;rft.au=Ibrahim%2C+Amna&amp;rft.au=Pazdur%2C+Richard&amp;rft.au=Cortazar%2C+Patricia&amp;rft_id=%2F%2Fdoi.org%2F10.1158%252F1078-0432.CCR-15-1185&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-71"><span><b><a href="#cite_ref-71">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.fda.gov/drugs/resources-information-approved-drugs/palbociclib-ibrance">"Palbociclib (IBRANCE)"</a>. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. February 9, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Palbociclib+%28IBRANCE%29&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2019-02-09&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Fpalbociclib-ibrance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-72"><span><b><a href="#cite_ref-72">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/topics/drug-discovery/pfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program/">"Pfizer, Lilly to Resume Phase III Tanezumab Clinical Program"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. March 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer%2C+Lilly+to+Resume+Phase+III+Tanezumab+Clinical+Program&amp;rft.date=2015-03-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-lilly-to-resume-phase-iii-tanezumab-clinical-program%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-73"><span><b><a href="#cite_ref-73">^</a></b></span> <span><cite id="CITEREFGali2015">Gali, Weinreb (May 14, 2015). <a rel="nofollow" href="https://en.globes.co.il/en/article-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703">"Pfizer to collaborate on Bar-Ilan DNA robots"</a>. <i><a href="/wiki/Globes_(newspaper)" title="Globes (newspaper)">Globes</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Globes&amp;rft.atitle=Pfizer+to+collaborate+on+Bar-Ilan+DNA+robots&amp;rft.date=2015-05-14&amp;rft.aulast=Gali&amp;rft.aufirst=Weinreb&amp;rft_id=https%3A%2F%2Fen.globes.co.il%2Fen%2Farticle-pfizer-to-collaborate-on-bar-ilan-dna-robots-1001036703&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-74"><span><b><a href="#cite_ref-74">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/topics/drug-discovery/pfizer-buys-two-gsk-meningitis-vaccines-for-130m/">"Pfizer Buys Two GSK Meningitis Vaccines for $130M"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. June 22, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+Two+GSK+Meningitis+Vaccines+for+%24130M&amp;rft.date=2015-06-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-two-gsk-meningitis-vaccines-for-130m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-75"><span><b><a href="#cite_ref-75">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20150903005752/en/Pfizer-Completes-Acquisition-of-Hospira">"Pfizer Completes Acquisition of Hospira"</a> (Press release). Pfizer. September 3, 2015 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Hospira&amp;rft.pub=Pfizer&amp;rft.date=2015-09-03&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20150903005752%2Fen%2FPfizer-Completes-Acquisition-of-Hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-76"><span><b><a href="#cite_ref-76">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.thepharmaletter.com/article/pfizer-completes-17-billion-hospira-acquisition">"Pfizer completes $17-billion Hospira acquisition"</a>. <i><a href="/wiki/The_Pharma_Letter" title="The Pharma Letter">The Pharma Letter</a></i>. September 4, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Pharma+Letter&amp;rft.atitle=Pfizer+completes+%2417-billion+Hospira+acquisition&amp;rft.date=2015-09-04&amp;rft_id=https%3A%2F%2Fwww.thepharmaletter.com%2Farticle%2Fpfizer-completes-17-billion-hospira-acquisition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-77"><span><b><a href="#cite_ref-77">^</a></b></span> <span><cite id="CITEREFGellesThomas2015">Gelles, David; Thomas, Katie (February 5, 2015). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://dealbook.nytimes.com/2015/02/05/pfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash">"Pfizer Bets $15 Billion on New Class of Generic Drugs"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Bets+%2415+Billion+on+New+Class+of+Generic+Drugs&amp;rft.date=2015-02-05&amp;rft.aulast=Gelles&amp;rft.aufirst=David&amp;rft.au=Thomas%2C+Katie&amp;rft_id=https%3A%2F%2Fdealbook.nytimes.com%2F2015%2F02%2F05%2Fpfizer-to-buy-hospira-a-drug-maker-for-15-2-billion-in-cash&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-78"><span><b><a href="#cite_ref-78">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.sec.gov/Archives/edgar/data/78003/000119312515037588/d866443d8k.htm">"8-K"</a>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a>. February 6, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=8-K&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft.date=2015-02-06&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F78003%2F000119312515037588%2Fd866443d8k.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-79"><span><b><a href="#cite_ref-79">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_to_acquire_hospira">"Pfizer to Acquire Hospira"</a>. <i>Pfizer</i> (Press release).</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Hospira&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_to_acquire_hospira&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-80"><span><b><a href="#cite_ref-80">^</a></b></span> <span><cite id="CITEREFNeilan2015">Neilan, Catherine (February 5, 2015). <a rel="nofollow" href="https://www.cityam.com/pfizer-hospira-share-prices-soar-after-17bn-deal-announced/">"Pfizer, Hospira share prices to soar after $17bn deal announced"</a>. <i><a href="/wiki/City_A.M." title="City A.M.">City A.M.</a></i></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=City+A.M.&amp;rft.atitle=Pfizer%2C+Hospira+share+prices+to+soar+after+%2417bn+deal+announced&amp;rft.date=2015-02-05&amp;rft.aulast=Neilan&amp;rft.aufirst=Catherine&amp;rft_id=https%3A%2F%2Fwww.cityam.com%2Fpfizer-hospira-share-prices-soar-after-17bn-deal-announced%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-81"><span><b><a href="#cite_ref-81">^</a></b></span> <span><cite id="CITEREFBhallaSingh2009">Bhalla, Mohit; Singh, Khomba (December 16, 2009). <a rel="nofollow" href="https://m.economictimes.com/industry/healthcare/biotech/pharmaceuticals/us-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn/articleshow/5342003.cms">"US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mn"</a>. <i><a href="/wiki/The_Economic_Times" title="The Economic Times">The Economic Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Economic+Times&amp;rft.atitle=US-based+Hospira+to+buy+Orchid+Chemicals%27+injectables+biz+for+%24400+mn&amp;rft.date=2009-12-16&amp;rft.aulast=Bhalla&amp;rft.aufirst=Mohit&amp;rft.au=Singh%2C+Khomba&amp;rft_id=https%3A%2F%2Fm.economictimes.com%2Findustry%2Fhealthcare%2Fbiotech%2Fpharmaceuticals%2Fus-based-hospira-to-buy-orchid-chemicals-injectables-biz-for-400-mn%2Farticleshow%2F5342003.cms&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-82"><span><b><a href="#cite_ref-82">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bbc.co.uk/news/business-34900344">"Pfizer seals $160bn Allergan deal to create drugs giant"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. November 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+seals+%24160bn+Allergan+deal+to+create+drugs+giant&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-34900344&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-83"><span><b><a href="#cite_ref-83">^</a></b></span> <span><cite id="CITEREFPiersonBerkrot2015">Pierson, Ransdell; Berkrot, Bill (November 24, 2015). <a rel="nofollow" href="https://www.reuters.com/article/us-allergan-m-a-pfizer/pfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124">"Pfizer to buy Allergan in $160 billion deal"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+Allergan+in+%24160+billion+deal&amp;rft.date=2015-11-24&amp;rft.aulast=Pierson&amp;rft.aufirst=Ransdell&amp;rft.au=Berkrot%2C+Bill&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer%2Fpfizer-to-buy-allergan-in-160-billion-deal-idUSKBN0TB0UT20151124&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-84"><span><b><a href="#cite_ref-84">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-to-acquire-allergan-for-160b/">"Pfizer to Acquire Allergan for $160B"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. November 23, 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Allergan+for+%24160B&amp;rft.date=2015-11-23&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-allergan-for-160b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-85"><span><b><a href="#cite_ref-85">^</a></b></span> <span><cite id="CITEREFKoons2015">Koons, Cynthia (November 22, 2015). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.bloomberg.com/news/articles/2015-11-22/pfizer-allergan-said-to-be-close-to-150-billion-merger">"Pfizer and Allergan to Combine With Joint Value of $160 Billion"</a></span>. <i><a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+and+Allergan+to+Combine+With+Joint+Value+of+%24160+Billion&amp;rft.date=2015-11-22&amp;rft.aulast=Koons&amp;rft.aufirst=Cynthia&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2Farticles%2F2015-11-22%2Fpfizer-allergan-said-to-be-close-to-150-billion-merger&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-86"><span><b><a href="#cite_ref-86">^</a></b></span> <span><cite id="CITEREFBray2016">Bray, Chad (April 6, 2016). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2016/04/07/business/dealbook/pfizer-allergan-merger.html">"Pfizer and Allergan Call Off Merger After Tax-Rule Changes"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+and+Allergan+Call+Off+Merger+After+Tax-Rule+Changes&amp;rft.date=2016-04-06&amp;rft.aulast=Bray&amp;rft.aufirst=Chad&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2016%2F04%2F07%2Fbusiness%2Fdealbook%2Fpfizer-allergan-merger.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-87"><span><b><a href="#cite_ref-87">^</a></b></span> <span><cite id="CITEREFHumerBanerjee2016">Humer, Caroline; Banerjee, Ankur (April 6, 2016). <a rel="nofollow" href="https://www.reuters.com/article/us-allergan-m-a-pfizer-idUSKCN0X3188">"Pfizer, Allergan scrap $160 billion deal after U.S. tax rule change"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer%2C+Allergan+scrap+%24160+billion+deal+after+U.S.+tax+rule+change&amp;rft.date=2016-04-06&amp;rft.aulast=Humer&amp;rft.aufirst=Caroline&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-allergan-m-a-pfizer-idUSKCN0X3188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-88"><span><b><a href="#cite_ref-88">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20160624005299/en/Pfizer-Completes-Acquisition-of-Anacor">"Pfizer Completes Acquisition of Anacor"</a> (Press release). Pfizer. June 24, 2016 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Anacor&amp;rft.pub=Pfizer&amp;rft.date=2016-06-24&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160624005299%2Fen%2FPfizer-Completes-Acquisition-of-Anacor&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-89"><span><b><a href="#cite_ref-89">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-to-acquire-anacor-pharmaceuticals-for-5-2b/">"Pfizer to Acquire Anacor Pharmaceuticals for $5.2B"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. May 16, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Anacor+Pharmaceuticals+for+%245.2B&amp;rft.date=2016-05-16&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-anacor-pharmaceuticals-for-5-2b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-90"><span><b><a href="#cite_ref-90">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-places-high-bid-of-40m-for-bind-therapeutics/">"Pfizer Places High Bid of $40M for BIND Therapeutics"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. July 27, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Places+High+Bid+of+%2440M+for+BIND+Therapeutics&amp;rft.date=2016-07-27&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-places-high-bid-of-40m-for-bind-therapeutics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-91"><span><b><a href="#cite_ref-91">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-acquires-bamboo-therapeutics-in-a-645m-deal/">"Pfizer Acquires Bamboo Therapeutics in a $645M Deal"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. August 1, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Acquires+Bamboo+Therapeutics+in+a+%24645M+Deal&amp;rft.date=2016-08-01&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-acquires-bamboo-therapeutics-in-a-645m-deal%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-92"><span><b><a href="#cite_ref-92">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/news/pfizer-to-acquire-medivation-for-14b/">"Pfizer to Acquire Medivation for $14B"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. August 22, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+to+Acquire+Medivation+for+%2414B&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Fnews%2Fpfizer-to-acquire-medivation-for-14b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-93"><span><b><a href="#cite_ref-93">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bbc.co.uk/news/business-37150531">"Pfizer to buy cancer drug firm Medivation for $14bn"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. August 22, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+to+buy+cancer+drug+firm+Medivation+for+%2414bn&amp;rft.date=2016-08-22&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-37150531&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-94"><span><b><a href="#cite_ref-94">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20160928005824/en/">"Pfizer Completes Acquisition of Medivation"</a> (Press release). OncoImmune. September 28, 2016 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Medivation&amp;rft.pub=OncoImmune&amp;rft.date=2016-09-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160928005824%2Fen%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-95"><span><b><a href="#cite_ref-95">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/topics/drug-discovery/oncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m/">"OncoImmune Licenses ONC-392 to Pfizer for Up to $250M"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. October 15, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=OncoImmune+Licenses+ONC-392+to+Pfizer+for+Up+to+%24250M&amp;rft.date=2016-10-15&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Foncoimmune-licenses-onc-392-to-pfizer-for-up-to-250m%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-96"><span><b><a href="#cite_ref-96">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20160915005151/en/OncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.">"OncoImmune Announces Option and License Agreement with Pfizer Inc"</a> (Press release). Pfizer. September 15, 2016 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=OncoImmune+Announces+Option+and+License+Agreement+with+Pfizer+Inc.&amp;rft.pub=Pfizer&amp;rft.date=2016-09-15&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20160915005151%2Fen%2FOncoImmune-Announces-Option-and-License-Agreement-with-Pfizer-Inc.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-97"><span><b><a href="#cite_ref-97">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20161222005395/en/Pfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca">"Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca"</a> (Press release). Pfizer. December 23, 2016 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Small+Molecule+Anti-Infective+Business+From+AstraZeneca&amp;rft.pub=Pfizer&amp;rft.date=2016-12-23&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20161222005395%2Fen%2FPfizer-Completes-Acquisition-of-Small-Molecule-Anti-Infective-Business-From-AstraZeneca&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-98"><span><b><a href="#cite_ref-98">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.genengnews.com/topics/drug-discovery/pfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b/">"Pfizer Buys AstraZeneca Antibiotics for Up to $1.575B"</a>. <i><a href="/w/index.php?title=Genengnews.com&amp;action=edit&amp;redlink=1" title="Genengnews.com (page does not exist)">genengnews.com</a></i>. August 24, 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=genengnews.com&amp;rft.atitle=Pfizer+Buys+AstraZeneca+Antibiotics+for+Up+to+%241.575B&amp;rft.date=2016-08-24&amp;rft_id=https%3A%2F%2Fwww.genengnews.com%2Ftopics%2Fdrug-discovery%2Fpfizer-buys-astrazeneca-antibiotics-for-up-to-1-575b%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-99"><span><b><a href="#cite_ref-99">^</a></b></span> <span><cite id="CITEREFStaton2016">Staton, Tracy (August 24, 2016). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/pfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy">"Pfizer grabs AZ antibiotics in $1.5B deal. Pre-split prep or just another sales-boosting buy?"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+grabs+AZ+antibiotics+in+%241.5B+deal.+Pre-split+prep+or+just+another+sales-boosting+buy%3F&amp;rft.date=2016-08-24&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fpfizer-grabs-az-antibiotics-1-5b-deal-pre-split-prep-or-just-another-sales-boosting-buy&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-100"><span><b><a href="#cite_ref-100">^</a></b></span> <span><cite id="CITEREFHiltzik2018"><a href="/wiki/Michael_Hiltzik" title="Michael Hiltzik">Hiltzik, Michael</a> (January 8, 2018). <span title="Paid subscription required"><a rel="nofollow" href="https://www.latimes.com/business/hiltzik/la-fi-hiltzik-pfizer-20180108-story.html">"Pfizer, pocketing a big tax cut from Trump, will end investment in Alzheimer's and Parkinson's research"</a></span>. <i><a href="/wiki/Los_Angeles_Times" title="Los Angeles Times">Los Angeles Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Pfizer%2C+pocketing+a+big+tax+cut+from+Trump%2C+will+end+investment+in+Alzheimer%27s+and+Parkinson%27s+research&amp;rft.date=2018-01-08&amp;rft.aulast=Hiltzik&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Fbusiness%2Fhiltzik%2Fla-fi-hiltzik-pfizer-20180108-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-101"><span><b><a href="#cite_ref-101">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-enzalutamide-castration-resistant-prostate-cancer">"FDA approves enzalutamide for castration-resistant prostate cancer"</a> (Press release). <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. July 13, 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=FDA+approves+enzalutamide+for+castration-resistant+prostate+cancer&amp;rft.pub=Food+and+Drug+Administration&amp;rft.date=2018-07-13&amp;rft_id=https%3A%2F%2Fwww.fda.gov%2Fdrugs%2Fresources-information-approved-drugs%2Ffda-approves-enzalutamide-castration-resistant-prostate-cancer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-102"><span><b><a href="#cite_ref-102">^</a></b></span> <span><cite><a rel="nofollow" href="https://biontechse.gcs-web.com/news-releases/news-release-details/biontech-signs-collaboration-agreement-pfizer-develop-mrna-based">"BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza"</a> (Press release). <a href="/wiki/BioNTech" title="BioNTech">BioNTech</a>. August 16, 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=BioNTech+Signs+Collaboration+Agreement+with+Pfizer+to+Develop+mRNA-based+Vaccines+for+Prevention+of+Influenza&amp;rft.pub=BioNTech&amp;rft.date=2018-08-16&amp;rft_id=https%3A%2F%2Fbiontechse.gcs-web.com%2Fnews-releases%2Fnews-release-details%2Fbiontech-signs-collaboration-agreement-pfizer-develop-mrna-based&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-103"><span><b><a href="#cite_ref-103">^</a></b></span> <span><cite id="CITEREFMathiasBanerjee2018">Mathias, Tamara; Banerjee, Ankur (October 1, 2018). <a rel="nofollow" href="https://www.reuters.com/article/us-pfizer-ceo/pfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D">"Pfizer to replace longtime CEO Read with veteran Bourla"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+replace+longtime+CEO+Read+with+veteran+Bourla&amp;rft.date=2018-10-01&amp;rft.aulast=Mathias&amp;rft.aufirst=Tamara&amp;rft.au=Banerjee%2C+Ankur&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-ceo%2Fpfizer-to-replace-longtime-ceo-read-with-veteran-bourla-idUSKCN1MB29D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-104"><span><b><a href="#cite_ref-104">^</a></b></span> <span><cite id="CITEREFMaidenberg2018">Maidenberg, Micah (October 9, 2018). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/pfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075">"Pfizer Prepares for CEO Transition With Executive Suite Changes"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Prepares+for+CEO+Transition+With+Executive+Suite+Changes&amp;rft.date=2018-10-09&amp;rft.aulast=Maidenberg&amp;rft.aufirst=Micah&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-prepares-for-ceo-transition-with-executive-suite-changes-1539095075&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-105"><span><b><a href="#cite_ref-105">^</a></b></span> <span><cite id="CITEREFRamsey2018">Ramsey, Lydia (October 1, 2018). <span title="Paid subscription required"><a rel="nofollow" href="https://www.businessinsider.com/who-is-albert-bourla-next-pfizer-ceo-2018-10">"Pfizer's CEO is stepping down after 8 years — meet the man who will be replacing him"</a></span>. <i><a href="/wiki/Business_Insider" title="Business Insider">Business Insider</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Business+Insider&amp;rft.atitle=Pfizer%27s+CEO+is+stepping+down+after+8+years+%E2%80%94+meet+the+man+who+will+be+replacing+him&amp;rft.date=2018-10-01&amp;rft.aulast=Ramsey&amp;rft.aufirst=Lydia&amp;rft_id=https%3A%2F%2Fwww.businessinsider.com%2Fwho-is-albert-bourla-next-pfizer-ceo-2018-10&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-106"><span><b><a href="#cite_ref-106">^</a></b></span> <span><cite id="CITEREFJarvis2018">Jarvis, Lisa M. (October 3, 2018). <a rel="nofollow" href="https://cen.acs.org/pharmaceuticals/Pfizer-unveils-CEO-succession-plan/96/i40">"Pfizer unveils CEO succession plan"</a>. <i><a href="/wiki/Chemical_%26_Engineering_News" title="Chemical &amp; Engineering News">Chemical &amp; Engineering News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Chemical+%26+Engineering+News&amp;rft.atitle=Pfizer+unveils+CEO+succession+plan&amp;rft.date=2018-10-03&amp;rft.aulast=Jarvis&amp;rft.aufirst=Lisa+M.&amp;rft_id=https%3A%2F%2Fcen.acs.org%2Fpharmaceuticals%2FPfizer-unveils-CEO-succession-plan%2F96%2Fi40&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-107"><span><b><a href="#cite_ref-107">^</a></b></span> <span><cite id="CITEREFBakolia2019">Bakolia, Ravikash (July 1, 2019). <a rel="nofollow" href="https://www.spglobal.com/marketintelligence/en/news-insights/trending/sWCcSrMgL8UmeCJXuuGp-w2">"Pfizer completes acquisition of Therachon to bolster rare disease drug portfolio"</a>. <i><a href="/wiki/S%26P_Global" title="S&amp;P Global">S&amp;P Global</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=S%26P+Global&amp;rft.atitle=Pfizer+completes+acquisition+of+Therachon+to+bolster+rare+disease+drug+portfolio&amp;rft.date=2019-07-01&amp;rft.aulast=Bakolia&amp;rft.aufirst=Ravikash&amp;rft_id=https%3A%2F%2Fwww.spglobal.com%2Fmarketintelligence%2Fen%2Fnews-insights%2Ftrending%2FsWCcSrMgL8UmeCJXuuGp-w2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-108"><span><b><a href="#cite_ref-108">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20190730005590/en/Pfizer-Completes-Acquisition-of-Array-Biopharma">"Pfizer Completes Acquisition of Array Biopharma"</a> (Press release). Pfizer. July 30, 2019 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Acquisition+of+Array+Biopharma&amp;rft.pub=Pfizer&amp;rft.date=2019-07-30&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20190730005590%2Fen%2FPfizer-Completes-Acquisition-of-Array-Biopharma&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-109"><span><b><a href="#cite_ref-109">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.gsk.com/en-gb/media/press-releases/gsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture/">"GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture"</a> (Press release). <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>. August 1, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GSK+completes+transaction+with+Pfizer+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2019-08-01&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fgsk-completes-transaction-with-pfizer-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-110"><span><b><a href="#cite_ref-110">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.gsk.com/en-gb/media/press-releases/glaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture/">"GlaxoSmithKline plc and Pfizer Inc to form new world-leading Consumer Healthcare Joint Venture"</a> (Press release). <a href="/wiki/GlaxoSmithKline" title="GlaxoSmithKline">GlaxoSmithKline</a>. December 19, 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=GlaxoSmithKline+plc+and+Pfizer+Inc+to+form+new+world-leading+Consumer+Healthcare+Joint+Venture&amp;rft.pub=GlaxoSmithKline&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.gsk.com%2Fen-gb%2Fmedia%2Fpress-releases%2Fglaxosmithkline-plc-and-pfizer-inc-to-form-new-world-leading-consumer-healthcare-joint-venture%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-111"><span><b><a href="#cite_ref-111">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company">"Pfizer and GlaxoSmithKline Announce Joint Venture to Create a Premier Global Consumer Healthcare Company"</a>. <i>Pfizer</i> (Press release). December 18, 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+GlaxoSmithKline+Announce+Joint+Venture+to+Create+a+Premier+Global+Consumer+Healthcare+Company&amp;rft.date=2018-12-18&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer_and_glaxosmithkline_announce_joint_venture_to_create_a_premier_global_consumer_healthcare_company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-112"><span><b><a href="#cite_ref-112">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bbc.co.uk/news/business-46616713">"GlaxoSmithKline and Pfizer merge healthcare arms"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. December 19, 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=GlaxoSmithKline+and+Pfizer+merge+healthcare+arms&amp;rft.date=2018-12-19&amp;rft_id=https%3A%2F%2Fwww.bbc.co.uk%2Fnews%2Fbusiness-46616713&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-113"><span><b><a href="#cite_ref-113">^</a></b></span> <span><cite id="CITEREFHelfand2017">Helfand, Carly (October 16, 2017). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/reckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one">"Reckitt Benckiser's still keen on a Pfizer OTC buy. But can it afford one?"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Reckitt+Benckiser%27s+still+keen+on+a+Pfizer+OTC+buy.+But+can+it+afford+one%3F&amp;rft.date=2017-10-16&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Freckitt-benckiser-s-still-keen-a-pfizer-otc-buy-but-can-it-afford-one&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-114"><span><b><a href="#cite_ref-114">^</a></b></span> <span><cite id="CITEREFHelfand2017">Helfand, Carly (October 26, 2017). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/sanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report">"Sanofi, J&amp;J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Sanofi%2C+J%26J+could+join+GlaxoSmithKline%2C+Reckitt+in+%2420B+bidding+war+for+Pfizer+OTC%3A+report&amp;rft.date=2017-10-26&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fsanofi-j-j-could-join-gsk-reckitt-20b-bidding-war-for-pfizer-otc-report&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-115"><span><b><a href="#cite_ref-115">^</a></b></span> <span><cite id="CITEREFHelfand2017">Helfand, Carly (October 25, 2017). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/glaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend">"GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=GlaxoSmithKline+eyes+Pfizer%27s+OTC+unit.+But+will+a+buy+imperil+its+dividend%3F&amp;rft.date=2017-10-25&amp;rft.aulast=Helfand&amp;rft.aufirst=Carly&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fglaxosmithkline-s-eyeing-pfizer-s-otc-unit-but-will-a-buy-imperil-its-dividend&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-116"><span><b><a href="#cite_ref-116">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.reuters.com/article/us-cstone-pfizer/pfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D">"Pfizer to buy 9.9% of CStone for $200 million, eyes collaboration"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>. September 29, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+9.9%25+of+CStone+for+%24200+million%2C+eyes+collaboration&amp;rft.date=2020-09-29&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-cstone-pfizer%2Fpfizer-to-buy-9-9-of-cstone-for-200-million-eyes-collaboration-idUKKBN26L01D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-117"><span><b><a href="#cite_ref-117">^</a></b></span> <span><cite id="CITEREFAl_Idrus2020">Al Idrus, Amirah (October 22, 2020). <a rel="nofollow" href="https://www.fiercebiotech.com/biotech/pfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up">"Biotech Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Biotech+Pfizer+snaps+up+antibiotics+maker+Arixa+and+its+oral+Avycaz+follow-up&amp;rft.date=2020-10-22&amp;rft.aulast=Al+Idrus&amp;rft.aufirst=Amirah&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-snaps-up-antibiotics-maker-arixa-and-its-oral-avycaz-follow-up&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-118"><span><b><a href="#cite_ref-118">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20201116005378/en/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan">"Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan"</a> (Press release). Pfizer. November 16, 2020 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Completes+Transaction+to+Combine+Its+Upjohn+Business+with+Mylan&amp;rft.pub=Pfizer&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20201116005378%2Fen%2FPfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-119"><span><b><a href="#cite_ref-119">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.nasdaq.com/articles/pfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020">"Pfizer Completes Combination Of Upjohn And Mylan; Viatris To Begin Trading On Nov. 17"</a>. <i><a href="/wiki/Nasdaq" title="Nasdaq">Nasdaq</a></i>. November 16, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nasdaq&amp;rft.atitle=Pfizer+Completes+Combination+Of+Upjohn+And+Mylan%3B+Viatris+To+Begin+Trading+On+Nov.+17&amp;rft.date=2020-11-16&amp;rft_id=https%3A%2F%2Fwww.nasdaq.com%2Farticles%2Fpfizer-completes-combination-of-upjohn-and-mylan-viatris-to-begin-trading-on-nov.-17-2020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-120"><span><b><a href="#cite_ref-120">^</a></b></span> <span><cite id="CITEREFSabatini2020">Sabatini, Patricia (November 16, 2020). <a rel="nofollow" href="https://www.post-gazette.com/business/healthcare-business/2020/11/16/Mylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs/stories/202011160111">"Mylan completes merger with Upjohn to form Viatris"</a>. <i><a href="/wiki/Pittsburgh_Post-Gazette" title="Pittsburgh Post-Gazette">Pittsburgh Post-Gazette</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pittsburgh+Post-Gazette&amp;rft.atitle=Mylan+completes+merger+with+Upjohn+to+form+Viatris&amp;rft.date=2020-11-16&amp;rft.aulast=Sabatini&amp;rft.aufirst=Patricia&amp;rft_id=https%3A%2F%2Fwww.post-gazette.com%2Fbusiness%2Fhealthcare-business%2F2020%2F11%2F16%2FMylan-merger-Upjohn-Viatris-bresch-coury-Pfizer-cost-cuts-generic-drugs%2Fstories%2F202011160111&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-121"><span><b><a href="#cite_ref-121">^</a></b></span> <span><cite id="CITEREFBruell2021">Bruell, Alexandra (January 5, 2021). <span title="Paid subscription required"><a rel="nofollow" href="https://www.wsj.com/articles/pfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400">"Pfizer Introduces New Logo Playing Up Role in Drug Creation"</a></span>. <i><a href="/wiki/The_Wall_Street_Journal" title="The Wall Street Journal">The Wall Street Journal</a></i>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/0099-9660">0099-9660</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Introduces+New+Logo+Playing+Up+Role+in+Drug+Creation&amp;rft.date=2021-01-05&amp;rft.issn=0099-9660&amp;rft.aulast=Bruell&amp;rft.aufirst=Alexandra&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-introduces-new-logo-playing-up-role-in-drug-creation-11609844400&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-122"><span><b><a href="#cite_ref-122">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20210428005147/en/Pfizer-Acquires-Amplyx-Pharmaceuticals">"Pfizer Acquires Amplyx Pharmaceuticals"</a> (Press release). Pfizer. April 28, 2021 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Acquires+Amplyx+Pharmaceuticals&amp;rft.pub=Pfizer&amp;rft.date=2021-04-28&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20210428005147%2Fen%2FPfizer-Acquires-Amplyx-Pharmaceuticals&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-123"><span><b><a href="#cite_ref-123">^</a></b></span> <span><cite id="CITEREFTaylor2021">Taylor, Nick Paul (April 28, 2021). <a rel="nofollow" href="https://www.fiercebiotech.com/biotech/pfizer-buys-amplyx-to-grow-infectious-disease-pipeline">"Pfizer buys Amplyx to grow infectious disease pipeline"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+buys+Amplyx+to+grow+infectious+disease+pipeline&amp;rft.date=2021-04-28&amp;rft.aulast=Taylor&amp;rft.aufirst=Nick+Paul&amp;rft_id=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-buys-amplyx-to-grow-infectious-disease-pipeline&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-124"><span><b><a href="#cite_ref-124">^</a></b></span> <span><cite id="CITEREFWosen2021">Wosen, Jonathan (April 28, 2021). <a rel="nofollow" href="https://www.sandiegouniontribune.com/business/biotech/story/2021-04-28/pfizer-acquires-fungus-fighting-san-diego-biotech-amplyx">"Pfizer acquires fungus-fighting San Diego biotech"</a>. <i><a href="/wiki/The_San_Diego_Union-Tribune" title="The San Diego Union-Tribune">The San Diego Union-Tribune</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+San+Diego+Union-Tribune&amp;rft.atitle=Pfizer+acquires+fungus-fighting+San+Diego+biotech&amp;rft.date=2021-04-28&amp;rft.aulast=Wosen&amp;rft.aufirst=Jonathan&amp;rft_id=https%3A%2F%2Fwww.sandiegouniontribune.com%2Fbusiness%2Fbiotech%2Fstory%2F2021-04-28%2Fpfizer-acquires-fungus-fighting-san-diego-biotech-amplyx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-125"><span><b><a href="#cite_ref-125">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.reuters.com/business/pfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23/">"Pfizer to buy cancer drug developer Trillium in $2.3 BLN deal"</a>. <i>Reuters</i>. August 23, 2021.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+to+buy+cancer+drug+developer+Trillium+in+%242.3+BLN+deal&amp;rft.date=2021-08-23&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fbusiness%2Fpfizer-buy-trillium-therapeutics-226-bln-deal-2021-08-23%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-126"><span><b><a href="#cite_ref-126">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.biospace.com/article/releases/pfizer-to-acquire-trillium-therapeutics-inc-/?s=79">"Pfizer to Acquire Trillium Therapeutics Inc"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+to+Acquire+Trillium+Therapeutics+Inc&amp;rft_id=https%3A%2F%2Fwww.biospace.com%2Farticle%2Freleases%2Fpfizer-to-acquire-trillium-therapeutics-inc-%2F%3Fs%3D79&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-127"><span><b><a href="#cite_ref-127">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.reuters.com/markets/deals/pfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13">"Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>. December 13, 2021<span>. Retrieved <span>December 13,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reuters&amp;rft.atitle=Pfizer+bets+on+Arena%27s+promising+bowel+disease+treatment+in+%246.7+bln+deal&amp;rft.date=2021-12-13&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Fmarkets%2Fdeals%2Fpfizer-acquire-arena-pharmaceuticals-67-bln-deal-2021-12-13&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-128"><span><b><a href="#cite_ref-128">^</a></b></span> <span><cite id="CITEREFWalker2021">Walker, Joseph (December 13, 2021). <a rel="nofollow" href="https://www.wsj.com/articles/pfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813">"Pfizer to Acquire Arena Pharmaceuticals in $6.7 Billion Deal"</a>. <i><a href="/wiki/Wall_Street_Journal" title="Wall Street Journal">Wall Street Journal</a></i><span>. Retrieved <span>December 13,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Pfizer+to+Acquire+Arena+Pharmaceuticals+in+%246.7+Billion+Deal&amp;rft.date=2021-12-13&amp;rft.aulast=Walker&amp;rft.aufirst=Joseph&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-to-acquire-arena-pharmaceuticals-in-6-7-billion-deal-11639414813&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-129"><span><b><a href="#cite_ref-129">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.pharmaceutical-technology.com/news/pfizer-arena-pharmaceuticals-acquisition/">"Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn"</a>. <i>Pharmaceutical Technology</i>. March 14, 2022<span>. Retrieved <span>March 14,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Pharmaceutical+Technology&amp;rft.atitle=Pfizer+concludes+Arena+Pharmaceuticals+acquisition+for+%246.7bn&amp;rft.date=2022-03-14&amp;rft_id=https%3A%2F%2Fwww.pharmaceutical-technology.com%2Fnews%2Fpfizer-arena-pharmaceuticals-acquisition%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-130"><span><b><a href="#cite_ref-130">^</a></b></span> <span><cite id="CITEREFCzachor2020">Czachor, Emily (November 9, 2020). <a rel="nofollow" href="https://www.newsweek.com/pfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110">"Pfizer Avoided R&amp;D Funding From Trump's Operation Warp Speed Because of Bureaucracy, Politics"</a>. <i><a href="/wiki/Newsweek" title="Newsweek">Newsweek</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Newsweek&amp;rft.atitle=Pfizer+Avoided+R%26D+Funding+From+Trump%27s+Operation+Warp+Speed+Because+of+Bureaucracy%2C+Politics&amp;rft.date=2020-11-09&amp;rft.aulast=Czachor&amp;rft.aufirst=Emily&amp;rft_id=https%3A%2F%2Fwww.newsweek.com%2Fpfizer-avoided-rd-funding-trumps-operation-warp-speed-because-bureaucracy-politics-1546110&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-131"><span><b><a href="#cite_ref-131">^</a></b></span> <span><cite id="CITEREFMinkoff2020">Minkoff, Yoel (May 13, 2020). <a rel="nofollow" href="https://seekingalpha.com/news/3573714-pfizer-sees-expanded-coronavirus-vaccine-trials">"Pfizer sees expanded coronavirus vaccine trials"</a>. <i>Seeking Alpha</i><span>. Retrieved <span>May 13,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Seeking+Alpha&amp;rft.atitle=Pfizer+sees+expanded+coronavirus+vaccine+trials&amp;rft.date=2020-05-13&amp;rft.aulast=Minkoff&amp;rft.aufirst=Yoel&amp;rft_id=https%3A%2F%2Fseekingalpha.com%2Fnews%2F3573714-pfizer-sees-expanded-coronavirus-vaccine-trials&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-132"><span><b><a href="#cite_ref-132">^</a></b></span> <span><cite><a rel="nofollow" href="http://www.globenewswire.com/news-release/2020/07/13/2061084/0/en/Pfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html">"Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2"</a> (Press release). BioNTech. July 13, 2020<span>. Retrieved <span>July 15,</span> 2020</span> – via GlobeNewswire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+Granted+FDA+Fast+Track+Designation+for+Two+Investigational+mRNA-based+Vaccine+Candidates+Against+SARS-CoV-2&amp;rft.pub=BioNTech&amp;rft.date=2020-07-13&amp;rft_id=http%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2020%2F07%2F13%2F2061084%2F0%2Fen%2FPfizer-and-BioNTech-Granted-FDA-Fast-Track-Designation-for-Two-Investigational-mRNA-based-Vaccine-Candidates-Against-SARS-CoV-2.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-133"><span><b><a href="#cite_ref-133">^</a></b></span> <span><cite id="CITEREFDeArment2020">DeArment, Alaric (July 13, 2020). <a rel="nofollow" href="https://medcitynews.com/2020/07/pfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines/">"Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines"</a>. <i>MedCity News</i><span>. Retrieved <span>July 15,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MedCity+News&amp;rft.atitle=Pfizer%2C+BioNTech+get+fast-track+from+FDA+for+Covid-19+vaccines&amp;rft.date=2020-07-13&amp;rft.aulast=DeArment&amp;rft.aufirst=Alaric&amp;rft_id=https%3A%2F%2Fmedcitynews.com%2F2020%2F07%2Fpfizer-biontech-get-fast-track-from-fda-for-covid-19-vaccines%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-134"><span><b><a href="#cite_ref-134">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.wsj.com/articles/pfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314">"Pfizer Beats Forecasts as Vaccine Trial Enters Final Stage"</a>. <i>The Wall Street Journal</i>. July 29, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Wall+Street+Journal&amp;rft.atitle=Pfizer+Beats+Forecasts+as+Vaccine+Trial+Enters+Final+Stage&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fpfizer-sales-fall-as-company-races-toward-covid-19-vaccine-11595936314&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-135"><span><b><a href="#cite_ref-135">^</a></b></span> <span><cite><a rel="nofollow" href="https://news.yahoo.com/pfizer-charge-39-per-coronavirus-065224983.html">"Pfizer To Charge $39 Per Coronavirus Vaccine Course To All Developed Countries For Similar Volume Commitments As US"</a>. <i>Benzinga</i>. <a href="/wiki/Yahoo!" title="Yahoo!">Yahoo!</a>. July 29, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Benzinga&amp;rft.atitle=Pfizer+To+Charge+%2439+Per+Coronavirus+Vaccine+Course+To+All+Developed+Countries+For+Similar+Volume+Commitments+As+US&amp;rft.date=2020-07-29&amp;rft_id=https%3A%2F%2Fnews.yahoo.com%2Fpfizer-charge-39-per-coronavirus-065224983.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-136"><span><b><a href="#cite_ref-136">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.barrons.com/articles/pfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611">"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines"</a>. Barron's.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+CEO+Says+Companies+Should+Make+Profit+On+Covid-19+Vaccines&amp;rft.pub=Barron%27s&amp;rft_id=https%3A%2F%2Fwww.barrons.com%2Farticles%2Fpfizer-ceo-says-companies-should-make-profit-on-covid-19-vaccines-51595968611&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-137"><span><b><a href="#cite_ref-137">^</a></b></span> <span><cite id="CITEREFKilgore">Kilgore, Tomi. <a rel="nofollow" href="https://www.marketwatch.com/story/pfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09">"Pfizer, BioNTech conclude talks over supplying EU with SARS-CoV-2 vaccine candidate"</a>. <i>MarketWatch</i><span>. Retrieved <span>September 10,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MarketWatch&amp;rft.atitle=Pfizer%2C+BioNTech+conclude+talks+over+supplying+EU+with+SARS-CoV-2+vaccine+candidate&amp;rft.aulast=Kilgore&amp;rft.aufirst=Tomi&amp;rft_id=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Fpfizer-biontech-conclude-talks-over-supplying-eu-with-sars-cov-2-vaccine-candidate-2020-09-09&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-138"><span><b><a href="#cite_ref-138">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-potentially-supply-eu-200-million-doses">"Pfizer and BioNTech to Potentially Supply the EU with 200 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2"</a>. <i>Pfizer</i> (Press release)<span>. Retrieved <span>September 10,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+and+BioNTech+to+Potentially+Supply+the+EU+with+200+Million+Doses+of+mRNA-based+Vaccine+Candidate+Against+SARS-CoV-2&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizer-and-biontech-potentially-supply-eu-200-million-doses&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-139"><span><b><a href="#cite_ref-139">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.bbc.com/news/health-54873105">"Covid vaccine: First 'milestone' vaccine offers 90% protection"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. November 9, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid+vaccine%3A+First+%27milestone%27+vaccine+offers+90%25+protection&amp;rft.date=2020-11-09&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-54873105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-:1-140"><span>^ <a href="#cite_ref-:1_140-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_140-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFKounang2020">Kounang, Nadia (November 9, 2020). <a rel="nofollow" href="https://www.cnn.com/2020/11/18/health/pfizer-coronavirus-vaccine-safety/index.html">"Pfizer and BioNTech say final analysis shows coronavirus vaccine is 95% effective with no safety concerns"</a>. <i>CNN</i><span>. Retrieved <span>November 9,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNN&amp;rft.atitle=Pfizer+and+BioNTech+say+final+analysis+shows+coronavirus+vaccine+is+95%25+effective+with+no+safety+concerns&amp;rft.date=2020-11-09&amp;rft.aulast=Kounang&amp;rft.aufirst=Nadia&amp;rft_id=https%3A%2F%2Fwww.cnn.com%2F2020%2F11%2F18%2Fhealth%2Fpfizer-coronavirus-vaccine-safety%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-141"><span><b><a href="#cite_ref-141">^</a></b></span> <span><cite id="CITEREFThomasGellesZimmer2020">Thomas, Katie; Gelles, David; Zimmer, Carl (November 9, 2020). <a rel="nofollow" href="https://www.nytimes.com/2020/11/09/health/covid-vaccine-pfizer.html">"Pfizer's Early Data Shows Vaccine Is More Than 90% Effective"</a>. <i>The New York Times</i>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer%27s+Early+Data+Shows+Vaccine+Is+More+Than+90%25+Effective&amp;rft.date=2020-11-09&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=Gelles%2C+David&amp;rft.au=Zimmer%2C+Carl&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F11%2F09%2Fhealth%2Fcovid-vaccine-pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-142"><span><b><a href="#cite_ref-142">^</a></b></span> <span><cite id="CITEREFRoberts2020">Roberts, Michelle (December 2, 2020). <a rel="nofollow" href="https://www.bbc.com/news/health-55145696">"Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i><span>. Retrieved <span>December 2,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BBC+News&amp;rft.atitle=Covid-19%3A+Pfizer%2FBioNTech+vaccine+judged+safe+for+use+in+UK&amp;rft.date=2020-12-02&amp;rft.aulast=Roberts&amp;rft.aufirst=Michelle&amp;rft_id=https%3A%2F%2Fwww.bbc.com%2Fnews%2Fhealth-55145696&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)-143"><span><b><a href="#cite_ref-Bahrain_Approves_Covid-19_Vaccine_(Al_Jazeera)_143-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine">"Bahrain becomes second country to approve Pfizer COVID-19 vaccine"</a>. <i>www.aljazeera.com</i>. Al Jazeera. December 4, 2020<span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=www.aljazeera.com&amp;rft.atitle=Bahrain+becomes+second+country+to+approve+Pfizer+COVID-19+vaccine&amp;rft.date=2020-12-04&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2020%2F12%2F4%2Fbahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Canada_Approves_Covid-19_Vaccine_(NYT)-144"><span><b><a href="#cite_ref-Canada_Approves_Covid-19_Vaccine_(NYT)_144-0">^</a></b></span> <span><cite id="CITEREFAusten2020">Austen, Ian (December 9, 2020). <a rel="nofollow" href="https://www.nytimes.com/2020/12/09/world/americas/canada-vaccine-approve.html">"Canada Approves Vaccine and Could Start Shots Next Week"</a>. <i>The New York Times</i><span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Canada+Approves+Vaccine+and+Could+Start+Shots+Next+Week&amp;rft.date=2020-12-09&amp;rft.aulast=Austen&amp;rft.aufirst=Ian&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F09%2Fworld%2Famericas%2Fcanada-vaccine-approve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)-145"><span><b><a href="#cite_ref-Saudi_Arabia_Approves_Covid-19_Vaccine,_Bahrain_To_Distribute_Free_to_Public_(KTLA)_145-0">^</a></b></span> <span><cite><a rel="nofollow" href="https://ktla.com/news/nationworld/saudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots/">"Saudi Arabia approves Pfizer COVID-19 vaccine as Bahrain plans to give the public free shots"</a>. <i>KTLA</i>. December 11, 2020<span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=KTLA&amp;rft.atitle=Saudi+Arabia+approves+Pfizer+COVID-19+vaccine+as+Bahrain+plans+to+give+the+public+free+shots&amp;rft.date=2020-12-11&amp;rft_id=https%3A%2F%2Fktla.com%2Fnews%2Fnationworld%2Fsaudi-arabia-approves-pfizer-covid-19-vaccine-as-bahrain-plans-to-give-the-public-free-shots%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)-146"><span>^ <a href="#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-US_FDA_Advisory_Panel_Backs_Covid-19_Vaccine_Approval_(Reuters)_146-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFSteenhuysen2020">Steenhuysen, Manas Mishra, Julie (December 11, 2020). <a rel="nofollow" href="https://www.reuters.com/article/health-coronavirus-pfizer-vaccine/us-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5">"U.S. FDA advisers overwhelmingly back authorizing Pfizer–BioNTech COVID-19 vaccine"</a>. <i>Reuters</i><span>. Retrieved <span>December 11,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=U.S.+FDA+advisers+overwhelmingly+back+authorizing+Pfizer%E2%80%93BioNTech+COVID-19+vaccine&amp;rft.date=2020-12-11&amp;rft.aulast=Steenhuysen&amp;rft.aufirst=Manas+Mishra%2C+Julie&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fhealth-coronavirus-pfizer-vaccine%2Fus-fda-advisers-wrestle-with-ethical-issues-linked-to-authorizing-pfizers-covid-19-vaccine-idUSKBN28K1O5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-147"><span><b><a href="#cite_ref-147">^</a></b></span> <span><cite id="CITEREFThomasLaFraniereWeilandGoodnough2020">Thomas, Katie; LaFraniere, Sharon; Weiland, Noah; Goodnough, Abby; Haberman, Maggie (December 12, 2020). <a rel="nofollow" href="https://www.nytimes.com/2020/12/11/health/pfizer-vaccine-authorized.html">"F.D.A. Clears Pfizer Vaccine, and Millions of Doses Will Be Shipped Right Away"</a>. <i>The New York Times</i>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span>. Retrieved <span>December 12,</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=F.D.A.+Clears+Pfizer+Vaccine%2C+and+Millions+of+Doses+Will+Be+Shipped+Right+Away&amp;rft.date=2020-12-12&amp;rft.issn=0362-4331&amp;rft.aulast=Thomas&amp;rft.aufirst=Katie&amp;rft.au=LaFraniere%2C+Sharon&amp;rft.au=Weiland%2C+Noah&amp;rft.au=Goodnough%2C+Abby&amp;rft.au=Haberman%2C+Maggie&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2020%2F12%2F11%2Fhealth%2Fpfizer-vaccine-authorized.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-148"><span><b><a href="#cite_ref-148">^</a></b></span> <span><cite id="CITEREFAbdullah2020">Abdullah, Zhaki (December 14, 2020). <a rel="nofollow" href="https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570">"Pfizer–BioNTech COVID-19 vaccine approved by Singapore, first shipment expected by end-December"</a>. <i>CNA</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNA&amp;rft.atitle=Pfizer%E2%80%93BioNTech+COVID-19+vaccine+approved+by+Singapore%2C+first+shipment+expected+by+end-December&amp;rft.date=2020-12-14&amp;rft.aulast=Abdullah&amp;rft.aufirst=Zhaki&amp;rft_id=https%3A%2F%2Fwww.channelnewsasia.com%2Fnews%2Fsingapore%2Fsingapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-149"><span><b><a href="#cite_ref-149">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu">"EMA recommends first COVID-19 vaccine for authorisation in the EU"</a>. <i><a href="/wiki/Europa_(web_portal)" title="Europa (web portal)">Europa</a></i>. December 21, 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Europa&amp;rft.atitle=EMA+recommends+first+COVID-19+vaccine+for+authorisation+in+the+EU&amp;rft.date=2020-12-21&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fnews%2Fema-recommends-first-covid-19-vaccine-authorisation-eu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-150"><span><b><a href="#cite_ref-150">^</a></b></span> <span><cite id="CITEREFHiggins-Dunn2021">Higgins-Dunn, Noah (May 4, 2021). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/thanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021">"BioNTech, with partner Pfizer, on track to make 3B COVID vaccine doses in 2021, CEO says"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i><span>. Retrieved <span>May 18,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BioNTech%2C+with+partner+Pfizer%2C+on+track+to+make+3B+COVID+vaccine+doses+in+2021%2C+CEO+says&amp;rft.date=2021-05-04&amp;rft.aulast=Higgins-Dunn&amp;rft.aufirst=Noah&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fthanks-to-revved-up-manufacturing-biontech-ceo-estimates-3b-covid-vaccine-doses-2021&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-bullied-151"><span>^ <a href="#cite_ref-bullied_151-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-bullied_151-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.aljazeera.com/news/2021/3/11/investigation-pfizer-bullied-latin-american-nations">"Investigation: Drugmaker 'bullied' Latin American nations"</a>. <i><a href="/wiki/Al_Jazeera_English" title="Al Jazeera English">Al Jazeera English</a></i>. March 11, 2021.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Al+Jazeera+English&amp;rft.atitle=Investigation%3A+Drugmaker+%27bullied%27+Latin+American+nations&amp;rft.date=2021-03-11&amp;rft_id=https%3A%2F%2Fwww.aljazeera.com%2Fnews%2F2021%2F3%2F11%2Finvestigation-pfizer-bullied-latin-american-nations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-152"><span><b><a href="#cite_ref-152">^</a></b></span> <span><cite id="CITEREFThacker">Thacker, Paul. <a rel="nofollow" href="https://www.bmj.com/content/375/bmj.n2635?utm_term=hootsuite">"Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial"</a>. thebmj<span>. Retrieved <span>November 2,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Covid-19%3A+Researcher+blows+the+whistle+on+data+integrity+issues+in+Pfizer%27s+vaccine+trial&amp;rft.aulast=Thacker&amp;rft.aufirst=Paul&amp;rft_id=https%3A%2F%2Fwww.bmj.com%2Fcontent%2F375%2Fbmj.n2635%3Futm_term%3Dhootsuite&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-153"><span><b><a href="#cite_ref-153">^</a></b></span> <span><cite id="CITEREFEuropean_Medicines_Agency2021"><a href="/wiki/European_Medicines_Agency" title="European Medicines Agency">European Medicines Agency</a> (December 3, 2021). <a rel="nofollow" href="https://www.ema.europa.eu/en/documents/other/ema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf">"Reply letter on the Integrity of clinical data, additional clinical trials and studies, pharmacovigilance and mRNA COVID-19 vaccine safety"</a> <span>(PDF)</span><span>. Retrieved <span>February 2,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Reply+letter+on+the+Integrity+of+clinical+data%2C+additional+clinical+trials+and+studies%2C+pharmacovigilance+and+mRNA+COVID-19+vaccine+safety&amp;rft.date=2021-12-03&amp;rft.au=European+Medicines+Agency&amp;rft_id=https%3A%2F%2Fwww.ema.europa.eu%2Fen%2Fdocuments%2Fother%2Fema-reply-letter-members-european-parliament-ms-m-rivasi-mr-p-pedicini-ms-t-metz-concerning-covid-19_en.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-154"><span><b><a href="#cite_ref-154">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate">"Pfizer's novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89% in Interim Analysis of Phase 2/3 EPIC-HR Study"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer%27s+novel+COVID-19+Oral+Antiviral+Treatment+Candidate+Reduced+Risk+of+Hospitalization+or+Death+by+89%25+in+Interim+Analysis+of+Phase+2%2F3+EPIC-HR+Study&amp;rft_id=https%3A%2F%2Fwww.pfizer.com%2Fnews%2Fpress-release%2Fpress-release-detail%2Fpfizers-novel-covid-19-oral-antiviral-treatment-candidate&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span><span><code>{{<a href="/wiki/Template:Cite_web" title="Template:Cite web">cite web</a>}}</code>:  CS1 maint: url-status (<a href="/wiki/Category:CS1_maint:_url-status" title="Category:CS1 maint: url-status">link</a>)</span></span>
</li>
<li id="cite_note-155"><span><b><a href="#cite_ref-155">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.israelnationalnews.com/news/320624">"Pfizer CEO: Current wave will be last with so many restrictions"</a>. <i>Israel National News</i><span>. Retrieved <span>January 17,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Israel+National+News&amp;rft.atitle=Pfizer+CEO%3A+Current+wave+will+be+last+with+so+many+restrictions&amp;rft_id=https%3A%2F%2Fwww.israelnationalnews.com%2Fnews%2F320624&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-156"><span><b><a href="#cite_ref-156">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.livemint.com/companies/news/pfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html">"Pfizer CEO shares some good news on covid but cautions virus could circulate for years"</a>. <i>Mint</i><span>. Retrieved <span>January 17,</span> 2021</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Mint&amp;rft.atitle=Pfizer+CEO+shares+some+good+news+on+covid+but+cautions+virus+could+circulate+for+years&amp;rft_id=https%3A%2F%2Fwww.livemint.com%2Fcompanies%2Fnews%2Fpfizer-ceo-shares-some-good-news-on-covid-but-cautions-virus-could-circulate-for-years-11642405004050.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-157"><span><b><a href="#cite_ref-157">^</a></b></span> <span><cite id="CITEREFKirkpatrick2000">Kirkpatrick, David D. (May 15, 2000). <a rel="nofollow" href="https://nymag.com/nymetro/health/features/3122/">"Inside the Happiness Business"</a>. <i><a href="/wiki/New_York_(magazine)" title="New York (magazine)">New York</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+York&amp;rft.atitle=Inside+the+Happiness+Business&amp;rft.date=2000-05-15&amp;rft.aulast=Kirkpatrick&amp;rft.aufirst=David+D.&amp;rft_id=https%3A%2F%2Fnymag.com%2Fnymetro%2Fhealth%2Ffeatures%2F3122%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-158"><span><b><a href="#cite_ref-158">^</a></b></span> <span><cite id="CITEREFOldani2002">Oldani, Michael (2002). <a rel="nofollow" href="https://digitalassets.lib.berkeley.edu/anthpubs/ucb/text/kas087-006.pdf">"Tales from the Script"</a> <span>(PDF)</span>. <i>Kroeber Society Papers</i>. <b>87</b>: 147–176 – via University of California Berkeley.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kroeber+Society+Papers&amp;rft.atitle=Tales+from+the+Script&amp;rft.volume=87&amp;rft.pages=147-176&amp;rft.date=2002&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=https%3A%2F%2Fdigitalassets.lib.berkeley.edu%2Fanthpubs%2Fucb%2Ftext%2Fkas087-006.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-159"><span><b><a href="#cite_ref-159">^</a></b></span> <span><cite id="CITEREFOldani2004">Oldani, Michael J. (2004). "Thick Prescriptions: Toward an Interpretation of Pharmaceutical Sales Practices". <i>Medical Anthropology Quarterly</i>. <b>18</b> (3): 325–356. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1525%2Fmaq.2004.18.3.325">10.1525/maq.2004.18.3.325</a>. <a href="/wiki/ISSN_(identifier)" title="ISSN (identifier)">ISSN</a>&nbsp;<a rel="nofollow" href="//www.worldcat.org/issn/1548-1387">1548-1387</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/15484967">15484967</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Anthropology+Quarterly&amp;rft.atitle=Thick+Prescriptions%3A+Toward+an+Interpretation+of+Pharmaceutical+Sales+Practices&amp;rft.volume=18&amp;rft.issue=3&amp;rft.pages=325-356&amp;rft.date=2004&amp;rft.issn=1548-1387&amp;rft_id=info%3Apmid%2F15484967&amp;rft_id=info%3Adoi%2F10.1525%2Fmaq.2004.18.3.325&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-160"><span><b><a href="#cite_ref-160">^</a></b></span> <span><cite id="CITEREFSteinmanBeroChrenLandefeld2006">Steinman MA, Bero LA, Chren MM, Landefeld CS (August 2006). <a rel="nofollow" href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008">"Narrative review: the promotion of gabapentin: an analysis of internal industry documents"</a>. <i><a href="/wiki/Annals_of_Internal_Medicine" title="Annals of Internal Medicine">Annals of Internal Medicine</a></i>. <b>145</b> (4): 284–93. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00008">10.7326/0003-4819-145-4-200608150-00008</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/16908919">16908919</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Narrative+review%3A+the+promotion+of+gabapentin%3A+an+analysis+of+internal+industry+documents&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=284-93&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00008&amp;rft_id=info%3Apmid%2F16908919&amp;rft.aulast=Steinman&amp;rft.aufirst=MA&amp;rft.au=Bero%2C+LA&amp;rft.au=Chren%2C+MM&amp;rft.au=Landefeld%2C+CS&amp;rft_id=%2F%2Fdoi.org%2F10.7326%252F0003-4819-145-4-200608150-00008&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-161"><span><b><a href="#cite_ref-161">^</a></b></span> <span><cite id="CITEREFHenney_JE2006">Henney JE (August 2006). "Safeguarding patient welfare: who's in charge?". <i><a href="/wiki/Annals_of_Internal_Medicine" title="Annals of Internal Medicine">Annals of Internal Medicine</a></i>. <b>145</b> (4): 305–7. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.7326%2F0003-4819-145-4-200608150-00013">10.7326/0003-4819-145-4-200608150-00013</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/16908923">16908923</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:39262014">39262014</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Safeguarding+patient+welfare%3A+who%27s+in+charge%3F&amp;rft.volume=145&amp;rft.issue=4&amp;rft.pages=305-7&amp;rft.date=2006-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39262014%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F16908923&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-4-200608150-00013&amp;rft.au=Henney+JE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-162"><span><b><a href="#cite_ref-162">^</a></b></span> <span><cite id="CITEREFMullenersMcCroryLinde2014">Mulleners WM, McCrory DC, Linde M (August 2014). "Antiepileptics in migraine prophylaxis: An updated Cochrane review". <i>Cephalalgia</i>. <b>35</b> (1): 51–62. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1177%2F0333102414534325">10.1177/0333102414534325</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/25115844">25115844</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:43079346">43079346</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cephalalgia&amp;rft.atitle=Antiepileptics+in+migraine+prophylaxis%3A+An+updated+Cochrane+review&amp;rft.volume=35&amp;rft.issue=1&amp;rft.pages=51-62&amp;rft.date=2014-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A43079346%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25115844&amp;rft_id=info%3Adoi%2F10.1177%2F0333102414534325&amp;rft.aulast=Mulleners&amp;rft.aufirst=WM&amp;rft.au=McCrory%2C+DC&amp;rft.au=Linde%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-163"><span><b><a href="#cite_ref-163">^</a></b></span> <span><cite id="CITEREFLoderBurchRizzoli2012">Loder E, Burch R, Rizzoli P (June 2012). <a rel="nofollow" href="https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x">"The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines"</a>. <i>Headache</i>. <b>52</b> (6): 930–45. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<span title="Freely accessible"><a rel="nofollow" href="https://doi.org/10.1111%2Fj.1526-4610.2012.02185.x">10.1111/j.1526-4610.2012.02185.x</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/22671714">22671714</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:540800">540800</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Headache&amp;rft.atitle=The+2012+AHS%2FAAN+guidelines+for+prevention+of+episodic+migraine%3A+a+summary+and+comparison+with+other+recent+clinical+practice+guidelines&amp;rft.volume=52&amp;rft.issue=6&amp;rft.pages=930-45&amp;rft.date=2012-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A540800%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F22671714&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1526-4610.2012.02185.x&amp;rft.aulast=Loder&amp;rft.aufirst=E&amp;rft.au=Burch%2C+R&amp;rft.au=Rizzoli%2C+P&amp;rft_id=%2F%2Fdoi.org%2F10.1111%252Fj.1526-4610.2012.02185.x&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-164"><span><b><a href="#cite_ref-164">^</a></b></span> <span><cite id="CITEREFHarris2009">Harris, Gardiner (September 2, 2009). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2009/09/03/business/03health.html">"Pfizer pays $2.3 billion to settle marketing case"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+pays+%242.3+billion+to+settle+marketing+case&amp;rft.date=2009-09-02&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-largestdoj-165"><span>^ <a href="#cite_ref-largestdoj_165-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-largestdoj_165-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.justice.gov/opa/pr/justice-department-announces-largest-health-care-fraud-settlement-its-history">"Justice Department Announces Largest Health Care Fraud Settlement in Its History"</a> (Press release). <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a>. September 2, 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Justice+Department+Announces+Largest+Health+Care+Fraud+Settlement+in+Its+History&amp;rft.pub=United+States+Department+of+Justice&amp;rft.date=2009-09-02&amp;rft_id=https%3A%2F%2Fwww.justice.gov%2Fopa%2Fpr%2Fjustice-department-announces-largest-health-care-fraud-settlement-its-history&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Settle-166"><span>^ <a href="#cite_ref-Settle_166-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Settle_166-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFHarris2009">Harris, Gardiner (September 3, 2009). <a rel="nofollow" href="https://www.nytimes.com/2009/09/03/business/03health.html">"Pfizer Pays $2.3 billion to Settle Marketing Case"</a>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Pays+%242.3+billion+to+Settle+Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F09%2F03%2Fbusiness%2F03health.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-Improper-167"><span>^ <a href="#cite_ref-Improper_167-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Improper_167-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFJohnson2009">Johnson, Carrie (September 3, 2009). <a rel="nofollow" href="https://www.washingtonpost.com/wp-dyn/content/article/2009/09/02/AR2009090201449_pf.html">"In Settlement, A Warning To Drugmakers: Pfizer to Pay Record Penalty In Improper-Marketing Case"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=In+Settlement%2C+A+Warning+To+Drugmakers%3A+Pfizer+to+Pay+Record+Penalty+In+Improper-Marketing+Case&amp;rft.date=2009-09-03&amp;rft.aulast=Johnson&amp;rft.aufirst=Carrie&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2009%2F09%2F02%2FAR2009090201449_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-fine-168"><span>^ <a href="#cite_ref-fine_168-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-fine_168-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/business/8234533.stm">"Pfizer agrees record fraud fine"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. September 2, 2009.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer+agrees+record+fraud+fine&amp;rft.date=2009-09-02&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F8234533.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-169"><span><b><a href="#cite_ref-169">^</a></b></span> <span><cite><a rel="nofollow" href="https://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf">"Corporate Integrity Agreement between the Office of the Inspector General of the Department of Health and Human Services and Pfizer Inc"</a> <span>(PDF)</span>. <i><a href="/wiki/Office_of_Inspector_General_(United_States)" title="Office of Inspector General (United States)">Office of Inspector General</a></i>. August 31, 2009. <a rel="nofollow" href="https://web.archive.org/web/20110715112330/http://oig.hhs.gov/fraud/cia/agreements/pfizer_inc.pdf">Archived</a> <span>(PDF)</span> from the original on July 15, 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+Inspector+General&amp;rft.atitle=Corporate+Integrity+Agreement+between+the+Office+of+the+Inspector+General+of+the+Department+of+Health+and+Human+Services+and+Pfizer+Inc.&amp;rft.date=2009-08-31&amp;rft_id=https%3A%2F%2Foig.hhs.gov%2Ffraud%2Fcia%2Fagreements%2Fpfizer_inc.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-170"><span><b><a href="#cite_ref-170">^</a></b></span> <span><cite><a rel="nofollow" href="https://casetext.com/case/rost-v-pfizer-2">"ROST v. PFIZER, INC"</a>. Casetext.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=ROST+v.+PFIZER%2C+INC.&amp;rft.pub=Casetext&amp;rft_id=https%3A%2F%2Fcasetext.com%2Fcase%2Frost-v-pfizer-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-171"><span><b><a href="#cite_ref-171">^</a></b></span> <span><cite id="CITEREFBerenson2005"><a href="/wiki/Alex_Berenson" title="Alex Berenson">Berenson, Alex</a> (June 8, 2005). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2005/06/08/business/at-pfizer-the-isolation-increases-for-a-whistleblower.html">"At Pfizer, the Isolation Increases for a Whistle-Blower"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=At+Pfizer%2C+the+Isolation+Increases+for+a+Whistle-Blower&amp;rft.date=2005-06-08&amp;rft.aulast=Berenson&amp;rft.aufirst=Alex&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2005%2F06%2F08%2Fbusiness%2Fat-pfizer-the-isolation-increases-for-a-whistleblower.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-172"><span><b><a href="#cite_ref-172">^</a></b></span> <span><cite id="CITEREFStaton2010">Staton, Tracy (June 14, 2010). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/congress-joins-probe-into-wyeth-s-rapamune-marketing">"Congress joins probe into Wyeth's Rapamune marketing"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Congress+joins+probe+into+Wyeth%27s+Rapamune+marketing&amp;rft.date=2010-06-14&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fcongress-joins-probe-into-wyeth-s-rapamune-marketing&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-173"><span><b><a href="#cite_ref-173">^</a></b></span> <span><cite id="CITEREFPalmer2010">Palmer, Eric (June 14, 2010). <a rel="nofollow" href="https://www.fiercepharma.com/regulatory/pfizer-settles-more-off-label-marketing-cases-tied-to-rapamune">"Pfizer settles more off-label marketing cases tied to Rapamune"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=Pfizer+settles+more+off-label+marketing+cases+tied+to+Rapamune&amp;rft.date=2010-06-14&amp;rft.aulast=Palmer&amp;rft.aufirst=Eric&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fregulatory%2Fpfizer-settles-more-off-label-marketing-cases-tied-to-rapamune&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-174"><span><b><a href="#cite_ref-174">^</a></b></span> <span><cite id="CITEREFEdwards2010">Edwards, Jim (June 10, 2010). <a rel="nofollow" href="https://www.cbsnews.com/news/blue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push/">"Blue Cross Names and Shames Pfizer Execs Linked to Massages-for-Prescriptions Push"</a>. <i><a href="/wiki/CBS_News" title="CBS News">CBS News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Blue+Cross+Names+and+Shames+Pfizer+Execs+Linked+to+Massages-for-Prescriptions+Push&amp;rft.date=2010-06-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fblue-cross-names-and-shames-pfizer-execs-linked-to-massages-for-prescriptions-push%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-175"><span><b><a href="#cite_ref-175">^</a></b></span> <span><cite id="CITEREFBounds2010">Bounds, Jeff (June 10, 2010). <a rel="nofollow" href="https://www.bizjournals.com/austin/stories/2010/06/07/daily52.html">"Blue Cross Blue Shield of Texas sues Pfizer"</a>. <i><a href="/wiki/American_City_Business_Journals" title="American City Business Journals">American City Business Journals</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+City+Business+Journals&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer&amp;rft.date=2010-06-10&amp;rft.aulast=Bounds&amp;rft.aufirst=Jeff&amp;rft_id=https%3A%2F%2Fwww.bizjournals.com%2Faustin%2Fstories%2F2010%2F06%2F07%2Fdaily52.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-176"><span><b><a href="#cite_ref-176">^</a></b></span> <span><cite id="CITEREFStaton2010">Staton, Tracy (June 11, 2010). <a rel="nofollow" href="https://www.fiercepharma.com/pharma/bcbs-names-pfizer-managers-kickback-suit">"BCBS names Pfizer managers in kickback suit"</a>. <i><a href="/w/index.php?title=FiercePharma&amp;action=edit&amp;redlink=1" title="FiercePharma (page does not exist)">FiercePharma</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=FiercePharma&amp;rft.atitle=BCBS+names+Pfizer+managers+in+kickback+suit&amp;rft.date=2010-06-11&amp;rft.aulast=Staton&amp;rft.aufirst=Tracy&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fbcbs-names-pfizer-managers-kickback-suit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-177"><span><b><a href="#cite_ref-177">^</a></b></span> <span><cite><span title="Paid subscription required"><a rel="nofollow" href="https://www.dallasnews.com/business/2010/06/11/blue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing/">"Blue Cross Blue Shield of Texas sues Pfizer over drug marketing"</a></span>. <i><a href="/wiki/The_Dallas_Morning_News" title="The Dallas Morning News">The Dallas Morning News</a></i>. June 11, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Dallas+Morning+News&amp;rft.atitle=Blue+Cross+Blue+Shield+of+Texas+sues+Pfizer+over+drug+marketing&amp;rft.date=2010-06-11&amp;rft_id=https%3A%2F%2Fwww.dallasnews.com%2Fbusiness%2F2010%2F06%2F11%2Fblue-cross-blue-shield-of-texas-sues-pfizer-over-drug-marketing%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-toobig-178"><span>^ <a href="#cite_ref-toobig_178-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-toobig_178-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFGriffinSegal2010">Griffin, Drew; Segal, Andy (April 2, 2010). <a rel="nofollow" href="https://edition.cnn.com/2010/HEALTH/04/02/pfizer.bextra/index.html">"Feds found Pfizer too big to nail"</a>. <i><a href="/wiki/CNN" title="CNN">CNN</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Feds+found+Pfizer+too+big+to+nail&amp;rft.date=2010-04-02&amp;rft.aulast=Griffin&amp;rft.aufirst=Drew&amp;rft.au=Segal%2C+Andy&amp;rft_id=https%3A%2F%2Fedition.cnn.com%2F2010%2FHEALTH%2F04%2F02%2Fpfizer.bextra%2Findex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-179"><span><b><a href="#cite_ref-179">^</a></b></span> <span><cite id="CITEREFSmythe2014">Smythe, Christie (June 2, 2014). <span title="Paid subscription required"><a rel="nofollow" href="https://www.bloomberg.com/news/2014-06-02/pfizer-agrees-to-325-million-settlment-over-neurontin.html">"Pfizer Agrees to $325 Million Neurontin Marketing Accord"</a></span>. <i><a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bloomberg+News&amp;rft.atitle=Pfizer+Agrees+to+%24325+Million+Neurontin+Marketing+Accord&amp;rft.date=2014-06-02&amp;rft.aulast=Smythe&amp;rft.aufirst=Christie&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-06-02%2Fpfizer-agrees-to-325-million-settlment-over-neurontin.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-180"><span><b><a href="#cite_ref-180">^</a></b></span> <span><cite id="CITEREFPetrovich2013">Petrovich, Dushko (March 15, 2013). <a rel="nofollow" href="https://www.bookforum.com/culture/-11264">"The Art of Making Magazines edited by Victor S. Navasky and Evan Cornog"</a>. <i><a href="/wiki/Bookforum" title="Bookforum">Bookforum</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bookforum&amp;rft.atitle=The+Art+of+Making+Magazines+edited+by+Victor+S.+Navasky+and+Evan+Cornog&amp;rft.date=2013-03-15&amp;rft.aulast=Petrovich&amp;rft.aufirst=Dushko&amp;rft_id=https%3A%2F%2Fwww.bookforum.com%2Fculture%2F-11264&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-181"><span><b><a href="#cite_ref-181">^</a></b></span> <span><cite id="CITEREFKary2013">Kary, Tiffany (June 27, 2013). <a rel="nofollow" href="https://www.theday.com/article/20130627/BIZ03/306279581">"Pfizer to pay $958M to end asbestos litigation"</a>. <a href="/wiki/Bloomberg_News" title="Bloomberg News">Bloomberg News</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+to+pay+%24958M+to+end+asbestos+litigation&amp;rft.date=2013-06-27&amp;rft.aulast=Kary&amp;rft.aufirst=Tiffany&amp;rft_id=https%3A%2F%2Fwww.theday.com%2Farticle%2F20130627%2FBIZ03%2F306279581&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-182"><span><b><a href="#cite_ref-182">^</a></b></span> <span><cite id="CITEREFMeier1994"><a href="/wiki/Barry_Meier" title="Barry Meier">Meier, Barry</a> (July 2, 1994). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/1994/07/02/business/pfizer-unit-to-settle-charges-of-lying-about-heart-valve.html">"Pfizer Unit to Settle Charges Of Lying About Heart Valve"</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Pfizer+Unit+to+Settle+Charges+Of+Lying+About+Heart+Valve&amp;rft.date=1994-07-02&amp;rft.aulast=Meier&amp;rft.aufirst=Barry&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1994%2F07%2F02%2Fbusiness%2Fpfizer-unit-to-settle-charges-of-lying-about-heart-valve.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-183"><span><b><a href="#cite_ref-183">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.courant.com/news/connecticut/hc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html">"Ex-Pfizer Worker Cites Genetically Engineered Virus In Lawsuit Over Firing"</a>. <i><a href="/wiki/Hartford_Courant" title="Hartford Courant">Hartford Courant</a></i>. March 14, 2010. <a rel="nofollow" href="https://archive.today/20120728144301/http://www.courant.com/news/connecticut/hc-pfizer-virus-lawsuit-0314.artmar14,0,5614508,print.story">Archived</a> from the original on July 28, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hartford+Courant&amp;rft.atitle=Ex-Pfizer+Worker+Cites+Genetically+Engineered+Virus+In+Lawsuit+Over+Firing&amp;rft.date=2010-03-14&amp;rft_id=https%3A%2F%2Fwww.courant.com%2Fnews%2Fconnecticut%2Fhc-xpm-2010-03-14-hc-pfizer-virus-lawsuit-0314-artmar14-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-184"><span><b><a href="#cite_ref-184">^</a></b></span> <span><cite id="CITEREFPollackWilson2010">Pollack, Andrew; <a href="/wiki/Duff_Wilson" title="Duff Wilson">Wilson, Duff</a> (April 2, 2010). <span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2010/04/03/business/03pfizer.html">"A Pfizer Whistle-Blower Is Awarded $1.4 Million"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=A+Pfizer+Whistle-Blower+Is+Awarded+%241.4+Million&amp;rft.date=2010-04-02&amp;rft.aulast=Pollack&amp;rft.aufirst=Andrew&amp;rft.au=Wilson%2C+Duff&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2010%2F04%2F03%2Fbusiness%2F03pfizer.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-185"><span><b><a href="#cite_ref-185">^</a></b></span> <span><cite><span title="Free access subject to limited trial, subscription normally required"><a rel="nofollow" href="https://www.nytimes.com/2012/05/02/health/pfizer-settles-byu-lawsuit-over-development-of-celebrex.html">"Pfizer Settles B.Y.U. Lawsuit Over Development of Celebrex"</a></span>. <i><a href="/wiki/The_New_York_Times" title="The New York Times">The New York Times</a></i>. <a href="/wiki/Associated_Press" title="Associated Press">Associated Press</a>. May 1, 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Pfizer+Settles+B.Y.U.+Lawsuit+Over+Development+of+Celebrex&amp;rft.date=2012-05-01&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2012%2F05%2F02%2Fhealth%2Fpfizer-settles-byu-lawsuit-over-development-of-celebrex.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-186"><span><b><a href="#cite_ref-186">^</a></b></span> <span><cite id="CITEREFOldani2016">Oldani, Michael (2016), <a rel="nofollow" href="http://sk.sagepub.com/reference/the-sage-encyclopedia-of-pharmacology-and-society/i11727.xml">"Trovafloxacin (Trovan) Controversy"</a>, <i>The SAGE Encyclopedia of Pharmacology and Society</i>, SAGE Publications, Inc., pp.&nbsp;1444–1447, <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.4135%2F9781483349985.n409">10.4135/9781483349985.n409</a>, <a href="/wiki/ISBN_(identifier)" title="ISBN (identifier)">ISBN</a>&nbsp;<a href="/wiki/Special:BookSources/9781483350004" title="Special:BookSources/9781483350004"><bdi>9781483350004</bdi></a><span>, retrieved <span>January 21,</span> 2019</span></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Trovafloxacin+%28Trovan%29+Controversy&amp;rft.btitle=The+SAGE+Encyclopedia+of+Pharmacology+and+Society&amp;rft.pages=1444-1447&amp;rft.pub=SAGE+Publications%2C+Inc.&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.4135%2F9781483349985.n409&amp;rft.isbn=9781483350004&amp;rft.aulast=Oldani&amp;rft.aufirst=Michael&amp;rft_id=http%3A%2F%2Fsk.sagepub.com%2Freference%2Fthe-sage-encyclopedia-of-pharmacology-and-society%2Fi11727.xml&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-187"><span><b><a href="#cite_ref-187">^</a></b></span> <span><cite id="CITEREFMurray2007">Murray, Senan (June 20, 2007). <a rel="nofollow" href="http://news.bbc.co.uk/2/hi/africa/6768799.stm">"Anger at deadly Nigerian drug trials"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Anger+at+deadly+Nigerian+drug+trials&amp;rft.date=2007-06-20&amp;rft.aulast=Murray&amp;rft.aufirst=Senan&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fafrica%2F6768799.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-188"><span><b><a href="#cite_ref-188">^</a></b></span> <span><cite id="CITEREFRamakrishnanUllandSteinhardtMoïsi2009">Ramakrishnan M, Ulland AJ, Steinhardt LC, Moïsi JC, Were F, Levine OS (2009). <a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956">"Sequelae due to bacterial meningitis among African children: a systematic literature review"</a>. <i><a href="/wiki/BMC_Medicine" title="BMC Medicine">BMC Medicine</a></i>. <b>7</b>: 47. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1186%2F1741-7015-7-47">10.1186/1741-7015-7-47</a>. <a href="/wiki/PMC_(identifier)" title="PMC (identifier)">PMC</a>&nbsp;<span title="Freely accessible"><a rel="nofollow" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2759956">2759956</a></span>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/19751516">19751516</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Sequelae+due+to+bacterial+meningitis+among+African+children%3A+a+systematic+literature+review&amp;rft.volume=7&amp;rft.pages=47&amp;rft.date=2009&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F19751516&amp;rft_id=info%3Adoi%2F10.1186%2F1741-7015-7-47&amp;rft.aulast=Ramakrishnan&amp;rft.aufirst=M&amp;rft.au=Ulland%2C+AJ&amp;rft.au=Steinhardt%2C+LC&amp;rft.au=Mo%C3%AFsi%2C+JC&amp;rft.au=Were%2C+F&amp;rft.au=Levine%2C+OS&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2759956&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-189"><span><b><a href="#cite_ref-189">^</a></b></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/business/1517171.stm">"Nigerians sue Pfizer over test deaths"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. August 30, 2001.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Nigerians+sue+Pfizer+over+test+deaths&amp;rft.date=2001-08-30&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fbusiness%2F1517171.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-DN-190"><span>^ <a href="#cite_ref-DN_190-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-DN_190-1"><sup><i><b>b</b></i></sup></a></span> <span><cite><a rel="nofollow" href="https://www.democracynow.org/2010/12/17/wikileaks_cables_pfizer_targeted_nigerian_attorney">"WikiLeaks Cables: Pfizer Targeted Nigerian Attorney General to Undermine Suit over Fatal Drug Tests"</a>. <i><a href="/wiki/Democracy_Now!" title="Democracy Now!">Democracy Now!</a></i>. December 17, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Democracy+Now%21&amp;rft.atitle=WikiLeaks+Cables%3A+Pfizer+Targeted+Nigerian+Attorney+General+to+Undermine+Suit+over+Fatal+Drug+Tests&amp;rft.date=2010-12-17&amp;rft_id=https%3A%2F%2Fwww.democracynow.org%2F2010%2F12%2F17%2Fwikileaks_cables_pfizer_targeted_nigerian_attorney&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-191"><span><b><a href="#cite_ref-191">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.washingtonpost.com/wp-dyn/content/article/2006/05/06/AR2006050601338.html">"Panel Faults Pfizer in '96 Clinical Trial In Nigeria"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>. May 7, 2006.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=Panel+Faults+Pfizer+in+%2796+Clinical+Trial+In+Nigeria&amp;rft.date=2006-05-07&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F06%2FAR2006050601338.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-192"><span><b><a href="#cite_ref-192">^</a></b></span> <span><cite id="CITEREFEdwards2011">Edwards, Jim (February 10, 2011). <a rel="nofollow" href="https://www.cbsnews.com/news/pfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims/">"Pfizer Bribed Nigerian Officials in Fatal Drug Trial, Ex-Employee Claims"</a>. <i><a href="/wiki/CBS_News" title="CBS News">CBS News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=Pfizer+Bribed+Nigerian+Officials+in+Fatal+Drug+Trial%2C+Ex-Employee+Claims&amp;rft.date=2011-02-10&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fpfizer-bribed-nigerian-officials-in-fatal-drug-trial-ex-employee-claims%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-193"><span><b><a href="#cite_ref-193">^</a></b></span> <span><cite><a rel="nofollow" href="https://cdn.pfizer.com/pfizercom/news/trovan_statement_defense_summary.pdf">"Trovan, Kano State Civil Case – Statement Of Defense"</a> <span>(PDF)</span>. Pfizer. July 2007.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Trovan%2C+Kano+State+Civil+Case+%E2%80%93+Statement+Of+Defense&amp;rft.pub=Pfizer&amp;rft.date=2007-07&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Ftrovan_statement_defense_summary.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-194"><span><b><a href="#cite_ref-194">^</a></b></span> <span><cite><a rel="nofollow" href="http://news.bbc.co.uk/2/hi/world/us_and_canada/10454982.stm">"Pfizer-Nigeria appeal dismissed"</a>. <i><a href="/wiki/BBC_News" title="BBC News">BBC News</a></i>. June 29, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BBC+News&amp;rft.atitle=Pfizer-Nigeria+appeal+dismissed&amp;rft.date=2010-06-29&amp;rft_id=http%3A%2F%2Fnews.bbc.co.uk%2F2%2Fhi%2Fworld%2Fus_and_canada%2F10454982.stm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-195"><span><b><a href="#cite_ref-195">^</a></b></span> <span><cite id="CITEREFBoseley2010">Boseley, Sarah (December 9, 2010). <a rel="nofollow" href="https://www.theguardian.com/business/2010/dec/09/wikileaks-cables-pfizer-nigeria">"WikiLeaks cables: Pfizer 'used dirty tricks to avoid clinical trial payout'<span></span>"</a>. <i>The Guardian</i>. London.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Guardian&amp;rft.atitle=WikiLeaks+cables%3A+Pfizer+%27used+dirty+tricks+to+avoid+clinical+trial+payout%27&amp;rft.date=2010-12-09&amp;rft.aulast=Boseley&amp;rft.aufirst=Sarah&amp;rft_id=https%3A%2F%2Fwww.theguardian.com%2Fbusiness%2F2010%2Fdec%2F09%2Fwikileaks-cables-pfizer-nigeria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-196"><span><b><a href="#cite_ref-196">^</a></b></span> <span><cite><a rel="nofollow" href="https://cdn.pfizer.com/pfizercom/news/the_guardian_nigeria_120910.pdf">"Pfizer Statement Regarding Article In The Guardian"</a> <span>(PDF)</span> (Press release). Pfizer. December 9, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Statement+Regarding+Article+In+The+Guardian&amp;rft.pub=Pfizer&amp;rft.date=2010-12-09&amp;rft_id=https%3A%2F%2Fcdn.pfizer.com%2Fpfizercom%2Fnews%2Fthe_guardian_nigeria_120910.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-197"><span><b><a href="#cite_ref-197">^</a></b></span> <span><cite id="CITEREFEdwards2011">Edwards, Jim (January 4, 2011). <a rel="nofollow" href="https://www.cbsnews.com/news/in-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols/">"In Defense of Blackmail: Why Shouldn't Pfizer Dig Dirt on Crooked Pols?"</a>. <i><a href="/wiki/CBS_News" title="CBS News">CBS News</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CBS+News&amp;rft.atitle=In+Defense+of+Blackmail%3A+Why+Shouldn%27t+Pfizer+Dig+Dirt+on+Crooked+Pols%3F&amp;rft.date=2011-01-04&amp;rft.aulast=Edwards&amp;rft.aufirst=Jim&amp;rft_id=https%3A%2F%2Fwww.cbsnews.com%2Fnews%2Fin-defense-of-blackmail-why-shouldnt-pfizer-dig-dirt-on-crooked-pols%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-198"><span><b><a href="#cite_ref-198">^</a></b></span> <span><cite><a rel="nofollow" href="http://saharareporters.com/2010/07/19/michael-aondoakaa-%E2%80%9Cunfit%E2%80%9D-remain-san-says-cdhr-high-powered-petition">"Michael Aondoakaa "Unfit" To Remain SAN, Says CDHR In High-Powered Petition"</a>. <i>Sahara Reporters</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Sahara+Reporters&amp;rft.atitle=Michael+Aondoakaa+%22Unfit%22+To+Remain+SAN%2C+Says+CDHR+In+High-Powered+Petition&amp;rft_id=http%3A%2F%2Fsaharareporters.com%2F2010%2F07%2F19%2Fmichael-aondoakaa-%25E2%2580%259Cunfit%25E2%2580%259D-remain-san-says-cdhr-high-powered-petition&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-199"><span><b><a href="#cite_ref-199">^</a></b></span> <span><cite><a rel="nofollow" href="http://usafricaonline.com/2010/12/12/wikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa/">"Wikileaks on Nigeria's Corrupt Oil Sales at NNPC, Shell, US Ambassador"</a>. December 12, 2010.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Wikileaks+on+Nigeria%27s+Corrupt+Oil+Sales+at+NNPC%2C+Shell%2C+US+Ambassador&amp;rft.date=2010-12-12&amp;rft_id=http%3A%2F%2Fusafricaonline.com%2F2010%2F12%2F12%2Fwikileaks-on-nigerias-oil-corruption-nnpc-shell-us-ambassador-attorney-general-aondoakaa%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-200"><span><b><a href="#cite_ref-200">^</a></b></span> <span><cite id="CITEREFLenzer2011">Lenzer, J. (August 16, 2011). "Pfizer settles with victims of Nigerian drug trial". <i>BMJ</i>. <b>343</b> (aug16 3): d5268. <a href="/wiki/Doi_(identifier)" title="Doi (identifier)">doi</a>:<a rel="nofollow" href="https://doi.org/10.1136%2Fbmj.d5268">10.1136/bmj.d5268</a>. <a href="/wiki/PMID_(identifier)" title="PMID (identifier)">PMID</a>&nbsp;<a rel="nofollow" href="//pubmed.ncbi.nlm.nih.gov/21846712">21846712</a>. <a href="/wiki/S2CID_(identifier)" title="S2CID (identifier)">S2CID</a>&nbsp;<a rel="nofollow" href="https://api.semanticscholar.org/CorpusID:8758603">8758603</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Pfizer+settles+with+victims+of+Nigerian+drug+trial&amp;rft.volume=343&amp;rft.issue=aug16+3&amp;rft.pages=d5268&amp;rft.date=2011-08-16&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A8758603%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21846712&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.d5268&amp;rft.aulast=Lenzer&amp;rft.aufirst=J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-201"><span><b><a href="#cite_ref-201">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.uschamber.com/article/pfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000">"Pfizer Implemented More than 4,000 Greenhouse Gas Reduction Projects Since 2000"</a>. <i><a href="/wiki/United_States_Chamber_of_Commerce" title="United States Chamber of Commerce">United States Chamber of Commerce</a></i>. November 15, 2019.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=United+States+Chamber+of+Commerce&amp;rft.atitle=Pfizer+Implemented+More+than+4%2C000+Greenhouse+Gas+Reduction+Projects+Since+2000&amp;rft.date=2019-11-15&amp;rft_id=https%3A%2F%2Fwww.uschamber.com%2Farticle%2Fpfizer-implemented-more-4000-greenhouse-gas-reduction-projects-2000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-202"><span><b><a href="#cite_ref-202">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.businesswire.com/news/home/20120913006098/en/Pfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance">"Pfizer Recognized by Carbon Disclosure Project for Carbon Performance"</a> (Press release). Pfizer. September 13, 2012 – via <a href="/wiki/Business_Wire" title="Business Wire">Business Wire</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Pfizer+Recognized+by+Carbon+Disclosure+Project+for+Carbon+Performance&amp;rft.pub=Pfizer&amp;rft.date=2012-09-13&amp;rft_id=https%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20120913006098%2Fen%2FPfizer-Recognized-Carbon-Disclosure-Project-Carbon-Performance&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-203"><span><b><a href="#cite_ref-203">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.nj.gov/dep/srp/community/sites/pi/american_cyanamid_fs.pdf">"American Cyanamid Superfund Site Fact Sheet"</a> <span>(PDF)</span>. <i><a href="/wiki/New_Jersey" title="New Jersey">New Jersey</a></i>. December 2011.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=New+Jersey&amp;rft.atitle=American+Cyanamid+Superfund+Site+Fact+Sheet&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fwww.nj.gov%2Fdep%2Fsrp%2Fcommunity%2Fsites%2Fpi%2Famerican_cyanamid_fs.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-204"><span><b><a href="#cite_ref-204">^</a></b></span> <span><cite id="CITEREFPaik2012">Paik, Eugene (March 9, 2012). <a rel="nofollow" href="https://www.nj.com/news/2012/03/activisits_say_epa_fix_for_pol.html">"Activists say EPA $204M fix for polluted American Cyanamid property will not permanently resolve problem"</a>. <i><a href="/wiki/NJ.com" title="NJ.com">NJ.com</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NJ.com&amp;rft.atitle=Activists+say+EPA+%24204M+fix+for+polluted+American+Cyanamid+property+will+not+permanently+resolve+problem&amp;rft.date=2012-03-09&amp;rft.aulast=Paik&amp;rft.aufirst=Eugene&amp;rft_id=https%3A%2F%2Fwww.nj.com%2Fnews%2F2012%2F03%2Factivisits_say_epa_fix_for_pol.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-205"><span><b><a href="#cite_ref-205">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.washingtonpost.com/wp-dyn/content/article/2006/05/23/AR2006052301305_pf.html">"The tempest"</a>. <i><a href="/wiki/The_Washington_Post" title="The Washington Post">The Washington Post</a></i>. May 28, 2006.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Washington+Post&amp;rft.atitle=The+tempest&amp;rft.date=2006-05-28&amp;rft_id=https%3A%2F%2Fwww.washingtonpost.com%2Fwp-dyn%2Fcontent%2Farticle%2F2006%2F05%2F23%2FAR2006052301305_pf.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-206"><span><b><a href="#cite_ref-206">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.usglc.org/about-us/coalition-members/">"U.S. Global Leadership Coalition, Global Trust members"</a>. <a href="/wiki/U.S._Global_Leadership_Coalition" title="U.S. Global Leadership Coalition">U.S. Global Leadership Coalition</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=U.S.+Global+Leadership+Coalition%2C+Global+Trust+members&amp;rft.pub=U.S.+Global+Leadership+Coalition&amp;rft_id=https%3A%2F%2Fwww.usglc.org%2Fabout-us%2Fcoalition-members%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-207"><span><b><a href="#cite_ref-207">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.phrma.org/about">"About"</a>. <i>PhRMA</i>. <a rel="nofollow" href="https://archive.ph/gaGKc">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-208"><span><b><a href="#cite_ref-208">^</a></b></span> <span><cite><a rel="nofollow" href="https://web.archive.org/web/20180926013616/https://www.phrma.org/about">"About"</a>. <i>PhRMA</i>. Archived from the original on September 26, 2018<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=PhRMA&amp;rft.atitle=About&amp;rft_id=https%3A%2F%2Fwww.phrma.org%2Fabout&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span><span><code>{{<a href="/wiki/Template:Cite_web" title="Template:Cite web">cite web</a>}}</code>:  CS1 maint: unfit URL (<a href="/wiki/Category:CS1_maint:_unfit_URL" title="Category:CS1 maint: unfit URL">link</a>)</span></span>
</li>
<li id="cite_note-209"><span><b><a href="#cite_ref-209">^</a></b></span> <span><cite><a rel="nofollow" href="https://nationalhealthcouncil.org/members/">"Our Members"</a>. <i>National Health Council</i>. <a rel="nofollow" href="https://web.archive.org/web/20220406081753/https://nationalhealthcouncil.org/members/?m_cat=74&amp;m_key=">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Health+Council&amp;rft.atitle=Our+Members&amp;rft_id=https%3A%2F%2Fnationalhealthcouncil.org%2Fmembers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-210"><span><b><a href="#cite_ref-210">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.researchamerica.org/about-us/member-organizations">"Member Organizations"</a>. <i>Research!America</i>. September 28, 2007. <a rel="nofollow" href="https://archive.ph/CR4A7">Archived</a> from the original on April 6, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Research%21America&amp;rft.atitle=Member+Organizations&amp;rft.date=2007-09-28&amp;rft_id=https%3A%2F%2Fwww.researchamerica.org%2Fabout-us%2Fmember-organizations&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-211"><span><b><a href="#cite_ref-211">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.weforum.org/organizations/pfizer/">"Pfizer"</a>. <i>World Economic Forum</i>. <a rel="nofollow" href="https://archive.ph/gpwLc">Archived</a> from the original on March 14, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=Pfizer&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Forganizations%2Fpfizer%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-212"><span><b><a href="#cite_ref-212">^</a></b></span> <span><cite id="CITEREFBourla2018">Bourla, Albert (January 19, 2018). <a rel="nofollow" href="https://www.weforum.org/agenda/2018/01/this-is-what-the-future-of-healthcare-looks-like/">"5 key trends for the future of healthcare"</a>. <i>World Economic Forum</i>. <a rel="nofollow" href="https://archive.ph/n5PLQ">Archived</a> from the original on March 14, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=World+Economic+Forum&amp;rft.atitle=5+key+trends+for+the+future+of+healthcare&amp;rft.date=2018-01-19&amp;rft.aulast=Bourla&amp;rft.aufirst=Albert&amp;rft_id=https%3A%2F%2Fwww.weforum.org%2Fagenda%2F2018%2F01%2Fthis-is-what-the-future-of-healthcare-looks-like%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-213"><span><b><a href="#cite_ref-213">^</a></b></span> <span><cite id="CITEREFMishra2019">Mishra, Manas (July 2, 2019).  Kuber, Shailesh (ed.). <a rel="nofollow" href="https://www.reuters.com/article/us-pfizer-board-scott-gottlieb/senator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX">"Senator Warren asks former FDA chief Gottlieb to resign from Pfizer board"</a>. <i><a href="/wiki/Reuters" title="Reuters">Reuters</a></i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Reuters&amp;rft.atitle=Senator+Warren+asks+former+FDA+chief+Gottlieb+to+resign+from+Pfizer+board&amp;rft.date=2019-07-02&amp;rft.aulast=Mishra&amp;rft.aufirst=Manas&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-pfizer-board-scott-gottlieb%2Fsenator-warren-asks-former-fda-chief-gottlieb-to-resign-from-pfizer-board-idUSKCN1TX2IX&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-214"><span><b><a href="#cite_ref-214">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.personalizedmedicinecoalition.org/Members/Current_Members">"Current Members"</a>. <i>Personalized Medicine Coalition</i>. <a rel="nofollow" href="https://web.archive.org/web/20210815032705/https://personalizedmedicinecoalition.org/Members/Current_Members">Archived</a> from the original on August 15, 2021<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Personalized+Medicine+Coalition&amp;rft.atitle=Current+Members&amp;rft_id=https%3A%2F%2Fwww.personalizedmedicinecoalition.org%2FMembers%2FCurrent_Members&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-215"><span><b><a href="#cite_ref-215">^</a></b></span> <span><cite><a rel="nofollow" href="http://innovativemedicines.ca/about/member-companies/">"Member Companies"</a>. <i>Innovative Medicines Canada</i>. <a rel="nofollow" href="https://archive.ph/nA2q9">Archived</a> from the original on November 3, 2021<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Innovative+Medicines+Canada&amp;rft.atitle=Member+Companies&amp;rft_id=http%3A%2F%2Finnovativemedicines.ca%2Fabout%2Fmember-companies%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-216"><span><b><a href="#cite_ref-216">^</a></b></span> <span><cite><a rel="nofollow" href="https://lobbyist.oico.on.ca/Pages/Public/PublicSearch/">"Consultant Lobbyist Registration No. CL4899-20200917025456"</a>. <i>Office of the Integrity Commissioner of Ontario</i>. September 22, 2021. <a rel="nofollow" href="https://ia601407.us.archive.org/2/items/consultant_lobbyist_registration_no._CL4899-20200917025456/screencapture-lobbyist-oico-on-ca-Pages-Public-PublicSearch-ConsultantLobbyistPreview-aspx-2022-03-08-09_54_13.pdf">Archived</a> <span>(PDF)</span> from the original on March 8, 2022<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Office+of+the+Integrity+Commissioner+of+Ontario&amp;rft.atitle=Consultant+Lobbyist+Registration+No.+CL4899-20200917025456&amp;rft.date=2021-09-22&amp;rft_id=https%3A%2F%2Flobbyist.oico.on.ca%2FPages%2FPublic%2FPublicSearch%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-217"><span><b><a href="#cite_ref-217">^</a></b></span> <span><cite id="CITEREFMaher2019">Maher, Stephen (January 29, 2019). <a rel="nofollow" href="https://www.macleans.ca/politics/for-access-to-the-ford-government-two-names-matter-most/">"For access to the Ford government, two names matter most"</a>. <i>MacLean's</i>. <a rel="nofollow" href="https://archive.ph/LJWg5">Archived</a> from the original on March 22, 2021<span>. Retrieved <span>March 8,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MacLean%27s&amp;rft.atitle=For+access+to+the+Ford+government%2C+two+names+matter+most&amp;rft.date=2019-01-29&amp;rft.aulast=Maher&amp;rft.aufirst=Stephen&amp;rft_id=https%3A%2F%2Fwww.macleans.ca%2Fpolitics%2Ffor-access-to-the-ford-government-two-names-matter-most%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-218"><span><b><a href="#cite_ref-218">^</a></b></span> <span><cite><a rel="nofollow" href="https://2020-annual-report.fnih.org/donors/">"2020 Donors"</a>. <i>FNIH 2020 Annual Report</i>. <a rel="nofollow" href="https://web.archive.org/web/20220402180716/https://2020-annual-report.fnih.org/donors/">Archived</a> from the original on April 2, 2022<span>. Retrieved <span>April 6,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=FNIH+2020+Annual+Report&amp;rft.atitle=2020+Donors&amp;rft_id=https%3A%2F%2F2020-annual-report.fnih.org%2Fdonors%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-219"><span><b><a href="#cite_ref-219">^</a></b></span> <span><cite id="CITEREFPfizer2021">Pfizer (October 1, 2021). <a rel="nofollow" href="https://www.cnbc.com/advertorial/2021/10/01/for-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html">"For Pfizer, a COVID-19 vaccine may just be the beginning for the potential revolutionary promise of mRNA technology"</a>. <i>CNBC</i>. <a rel="nofollow" href="https://archive.ph/N7oE7">Archived</a> from the original on October 19, 2021<span>. Retrieved <span>March 28,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=CNBC&amp;rft.atitle=For+Pfizer%2C+a+COVID-19+vaccine+may+just+be+the+beginning+for+the+potential+revolutionary+promise+of+mRNA+technology&amp;rft.date=2021-10-01&amp;rft.au=Pfizer&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2Fadvertorial%2F2021%2F10%2F01%2Ffor-pfizer-a-covid-19-vaccine-may-just-be-the-beginning-for-the-potential-revolutionary-promise-of-mrna-technology.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-220"><span><b><a href="#cite_ref-220">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf">"2018 Annual Report"</a> <span>(PDF)</span>. <i>Canadian Public Health Association</i>. <a rel="nofollow" href="https://web.archive.org/web/20210608184141/https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf">Archived</a> <span>(PDF)</span> from the original on June 8, 2021<span>. Retrieved <span>March 18,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Public+Health+Association&amp;rft.atitle=2018+Annual+Report&amp;rft_id=https%3A%2F%2Fwww.cpha.ca%2Fsites%2Fdefault%2Ffiles%2Fuploads%2Fabout%2Freports%2F2018-annual-report-web-e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-:2-221"><span>^ <a href="#cite_ref-:2_221-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_221-1"><sup><i><b>b</b></i></sup></a></span> <span><cite id="CITEREFPublic_Health_Agency_of_Canada2022">Public Health Agency of Canada (February 25, 2022). <a rel="nofollow" href="https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html">"National Advisory Committee on Immunization (NACI): Membership and representation"</a>. <i>Government of Canada</i>. <a rel="nofollow" href="https://web.archive.org/web/20220323061520/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/naci-membership-representation.html#fn1-rf">Archived</a> from the original on March 23, 2022<span>. Retrieved <span>March 29,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Government+of+Canada&amp;rft.atitle=National+Advisory+Committee+on+Immunization+%28NACI%29%3A+Membership+and+representation&amp;rft.date=2022-02-25&amp;rft.au=Public+Health+Agency+of+Canada&amp;rft_id=https%3A%2F%2Fwww.canada.ca%2Fen%2Fpublic-health%2Fservices%2Fimmunization%2Fnational-advisory-committee-on-immunization-naci%2Fnaci-membership-representation.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-222"><span><b><a href="#cite_ref-222">^</a></b></span> <span><cite id="CITEREFBettinger2020">Bettinger, Julie (January 24, 2020). <a rel="nofollow" href="https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/">"Vaccine Hesitancy: It doesn't matter if the vaccine works if nobody gets it"</a>. <i>Provincial Health Sciences Authority</i>. <a rel="nofollow" href="https://web.archive.org/web/20210118225408/https://mediasite.phsa.ca/Mediasite/Catalog/Mobile/FolderPresentation/22912938f963448cab10cf3719de3d5e21/22912938f963448cab10cf3719de3d5e21/b27eb1456cb14e06af5370550b1c5e431d/">Archived</a> from the original on January 18, 2021<span>. Retrieved <span>March 29,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Provincial+Health+Sciences+Authority&amp;rft.atitle=Vaccine+Hesitancy%3A+It+doesn%27t+matter+if+the+vaccine+works+if+nobody+gets+it&amp;rft.date=2020-01-24&amp;rft.aulast=Bettinger&amp;rft.aufirst=Julie&amp;rft_id=https%3A%2F%2Fmediasite.phsa.ca%2FMediasite%2FCatalog%2FMobile%2FFolderPresentation%2F22912938f963448cab10cf3719de3d5e21%2F22912938f963448cab10cf3719de3d5e21%2Fb27eb1456cb14e06af5370550b1c5e431d%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-223"><span><b><a href="#cite_ref-223">^</a></b></span> <span><cite><a rel="nofollow" href="https://www.cfn-nce.ca/get-involved/our-partners/industry-and-association-partners/">"Industry and Association Partners"</a>. <i>Canadian Frailty Network</i>. <a rel="nofollow" href="https://archive.ph/BkHql">Archived</a> from the original on March 28, 2022<span>. Retrieved <span>March 28,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Industry+and+Association+Partners&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fget-involved%2Four-partners%2Findustry-and-association-partners%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
<li id="cite_note-224"><span><b><a href="#cite_ref-224">^</a></b></span> <span><cite id="CITEREFKim2020">Kim, Perry (April 7, 2020). <a rel="nofollow" href="https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf">"Request for Proposals (RFP) Frailty and COVID-19"</a> <span>(PDF)</span>. <i>Canadian Frailty Network</i>. <a rel="nofollow" href="https://web.archive.org/web/20220302175728/https://www.cfn-nce.ca/wp-content/uploads/2020/04/RFP-Frailty-and-COVID-April-7.pdf">Archived</a> <span>(PDF)</span> from the original on March 2, 2022<span>. Retrieved <span>March 27,</span> 2022</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Canadian+Frailty+Network&amp;rft.atitle=Request+for+Proposals+%28RFP%29+Frailty+and+COVID-19&amp;rft.date=2020-04-07&amp;rft.aulast=Kim&amp;rft.aufirst=Perry&amp;rft_id=https%3A%2F%2Fwww.cfn-nce.ca%2Fwp-content%2Fuploads%2F2020%2F04%2FRFP-Frailty-and-COVID-April-7.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APfizer"></span></span>
</li>
</ol></div>
<h2><span id="External_links">External links</span><span><span>[</span><a href="/w/index.php?title=Pfizer&amp;action=edit&amp;section=38" title="Edit section: External links">edit</a><span>]</span></span></h2>
<table role="presentation">
<tbody><tr>
<td><img alt="" src="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/30px-Commons-logo.svg.png" decoding="async" width="30" height="40" srcset="//upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/45px-Commons-logo.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/4/4a/Commons-logo.svg/59px-Commons-logo.svg.png 2x" data-file-width="1024" data-file-height="1376"></td>
<td>Wikimedia Commons has media related to <span><a href="https://commons.wikimedia.org/wiki/Category:Pfizer" title="commons:Category:Pfizer">Pfizer</a></span>.</td></tr>
</tbody></table>
<ul><li><span><span><a rel="nofollow" href="https://www.pfizer.com/">Official website</a></span></span> <a href="https://www.wikidata.org/wiki/Q206921#P856" title="Edit this at Wikidata"><img alt="Edit this at Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></li>
<li>Business data for Pfizer Inc.: <div><ul><li><a rel="nofollow" href="https://www.google.com/finance?q=PFE">Google Finance</a></li><li><a rel="nofollow" href="https://finance.yahoo.com/q?s=PFE">Yahoo! Finance</a></li><li><a rel="nofollow" href="https://www.bloomberg.com/quote/PFE:US">Bloomberg</a></li><li><a rel="nofollow" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=PFE">SEC filings</a></li></ul></div></li></ul>


<!-- 
NewPP limit report
Parsed by mw1429
Cached time: 20220406185917
Cache expiry: 86400
Reduced expiry: true
Complications: [vary‐revision‐sha1]
CPU time usage: 2.343 seconds
Real time usage: 2.569 seconds
Preprocessor visited node count: 11582/1000000
Post‐expand include size: 425654/2097152 bytes
Template argument size: 5383/2097152 bytes
Highest expansion depth: 16/100
Expensive parser function count: 17/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 667427/5000000 bytes
Lua time usage: 1.367/10.000 seconds
Lua memory usage: 16345398/52428800 bytes
Lua Profile:
    Scribunto_LuaSandboxCallback::callParserFunction                 220 ms       15.7%
    ?                                                                200 ms       14.3%
    Scribunto_LuaSandboxCallback::gsub                               120 ms        8.6%
    type                                                             100 ms        7.1%
    recursiveClone <mwInit.lua:41>                                   100 ms        7.1%
    <mw.lua:690>                                                      80 ms        5.7%
    Scribunto_LuaSandboxCallback::getExpandedArgument                 80 ms        5.7%
    dataWrapper <mw.lua:668>                                          60 ms        4.3%
    Scribunto_LuaSandboxCallback::plain                               40 ms        2.9%
    makeMessage <mw.message.lua:76>                                   40 ms        2.9%
    [others]                                                         360 ms       25.7%
Number of Wikibase entities loaded: 1/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 2217.874      1 -total
 58.59% 1299.434      1 Template:Reflist
 24.94%  553.177    128 Template:Cite_news
 14.27%  316.417     57 Template:Cite_web
 11.71%  259.687      1 Template:Infobox_company
 11.11%  246.478      1 Template:Infobox
  4.27%   94.741      1 Template:Short_description
  3.78%   83.798     22 Template:Cite_press_release
  3.46%   76.811     13 Template:Cite_journal
  3.37%   74.794      1 Template:Official_URL
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:62304-0!canonical and timestamp 20220406185914 and revision id 1081304371. Serialized with JSON.
 -->
</div></div>
                
                </main>
                <footer>

                </footer>
            </div>
            <!--[if !IE]><script>fixScale(document);</script><![endif]-->
        </body>
    </html>
